Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032502 | 0.00000 | 2.71378 | 226 | 413 | 6097 | developmental process |
| GO:0048731 | 0.00000 | 2.79341 | 172 | 343 | 4638 | system development |
| GO:0048856 | 0.00000 | 2.68585 | 211 | 392 | 5712 | anatomical structure development |
| GO:0007275 | 0.00000 | 2.72409 | 193 | 370 | 5227 | multicellular organism development |
| GO:0009653 | 0.00000 | 3.06629 | 98 | 233 | 2652 | anatomical structure morphogenesis |
| GO:0030154 | 0.00000 | 2.62696 | 153 | 302 | 4125 | cell differentiation |
| GO:0048869 | 0.00000 | 2.57096 | 160 | 310 | 4334 | cellular developmental process |
| GO:0051239 | 0.00000 | 2.61427 | 117 | 243 | 3173 | regulation of multicellular organismal process |
| GO:0050793 | 0.00000 | 2.65597 | 99 | 213 | 2681 | regulation of developmental process |
| GO:0007399 | 0.00000 | 2.74624 | 84 | 188 | 2257 | nervous system development |
| GO:0048513 | 0.00000 | 2.43002 | 127 | 247 | 3430 | animal organ development |
| GO:0032501 | 0.00000 | 2.08742 | 298 | 446 | 8064 | multicellular organismal process |
| GO:0009888 | 0.00000 | 2.82660 | 70 | 165 | 1899 | tissue development |
| GO:0048468 | 0.00000 | 2.62379 | 86 | 187 | 2330 | cell development |
| GO:0022008 | 0.00000 | 2.86514 | 63 | 152 | 1712 | neurogenesis |
| GO:2000026 | 0.00000 | 2.63948 | 79 | 174 | 2136 | regulation of multicellular organismal development |
| GO:0009987 | 0.00000 | 2.31899 | 578 | 707 | 15608 | cellular process |
| GO:0045595 | 0.00000 | 2.73294 | 69 | 159 | 1874 | regulation of cell differentiation |
| GO:0007155 | 0.00000 | 3.11296 | 47 | 124 | 1273 | cell adhesion |
| GO:0030182 | 0.00000 | 2.96132 | 54 | 134 | 1447 | neuron differentiation |
| GO:0022610 | 0.00000 | 3.07905 | 48 | 124 | 1285 | biological adhesion |
| GO:0016043 | 0.00000 | 2.04576 | 219 | 348 | 5929 | cellular component organization |
| GO:0048699 | 0.00000 | 2.81102 | 60 | 142 | 1613 | generation of neurons |
| GO:0032879 | 0.00000 | 2.39036 | 102 | 202 | 2749 | regulation of localization |
| GO:0009887 | 0.00000 | 3.27554 | 39 | 108 | 1048 | animal organ morphogenesis |
| GO:0048666 | 0.00000 | 3.12033 | 44 | 116 | 1181 | neuron development |
| GO:0048518 | 0.00000 | 2.01620 | 223 | 350 | 6033 | positive regulation of biological process |
| GO:0071840 | 0.00000 | 2.00672 | 226 | 352 | 6096 | cellular component organization or biogenesis |
| GO:0035295 | 0.00000 | 3.15208 | 41 | 110 | 1105 | tube development |
| GO:0051179 | 0.00000 | 2.00840 | 214 | 338 | 5794 | localization |
| GO:0007166 | 0.00000 | 2.38894 | 92 | 184 | 2473 | cell surface receptor signaling pathway |
| GO:0048522 | 0.00000 | 2.01253 | 198 | 317 | 5349 | positive regulation of cellular process |
| GO:0010646 | 0.00000 | 2.21863 | 120 | 222 | 3256 | regulation of cell communication |
| GO:0048523 | 0.00000 | 2.06054 | 170 | 284 | 4605 | negative regulation of cellular process |
| GO:0040011 | 0.00000 | 2.63548 | 65 | 145 | 1744 | locomotion |
| GO:0035239 | 0.00000 | 3.36276 | 33 | 95 | 892 | tube morphogenesis |
| GO:0023051 | 0.00000 | 2.20099 | 121 | 222 | 3277 | regulation of signaling |
| GO:0051094 | 0.00000 | 2.69732 | 56 | 130 | 1516 | positive regulation of developmental process |
| GO:0065007 | 0.00000 | 1.90901 | 443 | 572 | 11983 | biological regulation |
| GO:0065008 | 0.00000 | 2.07800 | 146 | 251 | 3955 | regulation of biological quality |
| GO:0016477 | 0.00000 | 2.76474 | 52 | 123 | 1397 | cell migration |
| GO:0051270 | 0.00000 | 3.12643 | 37 | 99 | 993 | regulation of cellular component movement |
| GO:0031175 | 0.00000 | 3.05550 | 39 | 102 | 1046 | neuron projection development |
| GO:0006928 | 0.00000 | 2.46316 | 71 | 151 | 1932 | movement of cell or subcellular component |
| GO:0030334 | 0.00000 | 3.26261 | 32 | 90 | 864 | regulation of cell migration |
| GO:0000902 | 0.00000 | 3.03162 | 39 | 101 | 1042 | cell morphogenesis |
| GO:0040012 | 0.00000 | 3.07314 | 36 | 97 | 986 | regulation of locomotion |
| GO:2000145 | 0.00000 | 3.16150 | 34 | 92 | 909 | regulation of cell motility |
| GO:0001568 | 0.00000 | 3.48631 | 26 | 79 | 710 | blood vessel development |
| GO:0051093 | 0.00000 | 2.98441 | 39 | 100 | 1045 | negative regulation of developmental process |
| GO:0120036 | 0.00000 | 2.62843 | 55 | 125 | 1485 | plasma membrane bounded cell projection organization |
| GO:0042127 | 0.00000 | 2.54101 | 61 | 133 | 1636 | regulation of cell proliferation |
| GO:0009966 | 0.00000 | 2.20074 | 100 | 188 | 2712 | regulation of signal transduction |
| GO:0048514 | 0.00000 | 3.68129 | 23 | 72 | 614 | blood vessel morphogenesis |
| GO:0032989 | 0.00000 | 2.86219 | 42 | 105 | 1142 | cellular component morphogenesis |
| GO:0000904 | 0.00000 | 3.33296 | 28 | 82 | 768 | cell morphogenesis involved in differentiation |
| GO:0051241 | 0.00000 | 2.71859 | 48 | 114 | 1305 | negative regulation of multicellular organismal process |
| GO:0048519 | 0.00000 | 1.91798 | 192 | 300 | 5186 | negative regulation of biological process |
| GO:0050789 | 0.00000 | 1.82796 | 421 | 543 | 11369 | regulation of biological process |
| GO:0030030 | 0.00000 | 2.56259 | 57 | 126 | 1531 | cell projection organization |
| GO:0051240 | 0.00000 | 2.40248 | 70 | 145 | 1887 | positive regulation of multicellular organismal process |
| GO:0060429 | 0.00000 | 2.81099 | 43 | 105 | 1160 | epithelium development |
| GO:0050794 | 0.00000 | 1.81246 | 394 | 516 | 10650 | regulation of cellular process |
| GO:0048870 | 0.00000 | 2.54904 | 57 | 126 | 1538 | cell motility |
| GO:0051674 | 0.00000 | 2.54904 | 57 | 126 | 1538 | localization of cell |
| GO:0072359 | 0.00000 | 2.83821 | 41 | 102 | 1115 | circulatory system development |
| GO:0001503 | 0.00000 | 4.58543 | 14 | 53 | 369 | ossification |
| GO:0001944 | 0.00000 | 3.31316 | 27 | 79 | 742 | vasculature development |
| GO:0051960 | 0.00000 | 2.89951 | 38 | 97 | 1037 | regulation of nervous system development |
| GO:0045597 | 0.00000 | 2.83762 | 40 | 99 | 1080 | positive regulation of cell differentiation |
| GO:0072358 | 0.00000 | 3.24750 | 28 | 79 | 755 | cardiovascular system development |
| GO:0050767 | 0.00000 | 2.97465 | 34 | 89 | 925 | regulation of neurogenesis |
| GO:0008283 | 0.00000 | 2.30959 | 73 | 147 | 1981 | cell proliferation |
| GO:0022603 | 0.00000 | 2.80965 | 39 | 96 | 1054 | regulation of anatomical structure morphogenesis |
| GO:0045596 | 0.00000 | 3.12348 | 29 | 79 | 781 | negative regulation of cell differentiation |
| GO:0048646 | 0.00000 | 2.71345 | 42 | 100 | 1135 | anatomical structure formation involved in morphogenesis |
| GO:0060284 | 0.00000 | 2.75869 | 39 | 95 | 1059 | regulation of cell development |
| GO:0045664 | 0.00000 | 3.09334 | 28 | 76 | 756 | regulation of neuron differentiation |
| GO:0061448 | 0.00000 | 4.88017 | 10 | 42 | 275 | connective tissue development |
| GO:0007267 | 0.00000 | 2.32828 | 58 | 119 | 1563 | cell-cell signaling |
| GO:0048858 | 0.00000 | 3.13802 | 25 | 68 | 664 | cell projection morphogenesis |
| GO:0060828 | 0.00000 | 5.38811 | 8 | 36 | 216 | regulation of canonical Wnt signaling pathway |
| GO:0040007 | 0.00000 | 2.59097 | 41 | 94 | 1106 | growth |
| GO:0048589 | 0.00000 | 2.95495 | 28 | 74 | 765 | developmental growth |
| GO:0032990 | 0.00000 | 3.07671 | 25 | 69 | 686 | cell part morphogenesis |
| GO:0010648 | 0.00000 | 2.43521 | 49 | 105 | 1314 | negative regulation of cell communication |
| GO:0048583 | 0.00000 | 1.86804 | 139 | 223 | 3755 | regulation of response to stimulus |
| GO:0001667 | 0.00000 | 3.85164 | 15 | 50 | 403 | ameboidal-type cell migration |
| GO:0023057 | 0.00000 | 2.42672 | 49 | 105 | 1318 | negative regulation of signaling |
| GO:0120039 | 0.00000 | 3.09865 | 24 | 67 | 661 | plasma membrane bounded cell projection morphogenesis |
| GO:0060070 | 0.00000 | 4.65664 | 10 | 40 | 272 | canonical Wnt signaling pathway |
| GO:0050673 | 0.00000 | 3.75435 | 15 | 50 | 412 | epithelial cell proliferation |
| GO:0030855 | 0.00000 | 3.12563 | 23 | 63 | 615 | epithelial cell differentiation |
| GO:0048812 | 0.00000 | 3.06210 | 24 | 65 | 647 | neuron projection morphogenesis |
| GO:0030155 | 0.00000 | 3.02761 | 25 | 66 | 664 | regulation of cell adhesion |
| GO:0048729 | 0.00000 | 3.00694 | 25 | 66 | 668 | tissue morphogenesis |
| GO:0001655 | 0.00000 | 4.02280 | 13 | 44 | 340 | urogenital system development |
| GO:0060349 | 0.00000 | 7.33303 | 4 | 25 | 116 | bone morphogenesis |
| GO:0048667 | 0.00000 | 3.09348 | 22 | 61 | 600 | cell morphogenesis involved in neuron differentiation |
| GO:0051216 | 0.00000 | 5.12192 | 8 | 33 | 206 | cartilage development |
| GO:0023052 | 0.00000 | 1.66806 | 242 | 336 | 6550 | signaling |
| GO:0051128 | 0.00000 | 1.96122 | 93 | 161 | 2513 | regulation of cellular component organization |
| GO:0060350 | 0.00000 | 9.84347 | 3 | 20 | 74 | endochondral bone morphogenesis |
| GO:0008285 | 0.00000 | 2.92272 | 25 | 65 | 674 | negative regulation of cell proliferation |
| GO:0009968 | 0.00000 | 2.39447 | 44 | 94 | 1185 | negative regulation of signal transduction |
| GO:0045444 | 0.00000 | 4.70464 | 9 | 35 | 235 | fat cell differentiation |
| GO:0001822 | 0.00000 | 4.31897 | 10 | 38 | 275 | kidney development |
| GO:0008284 | 0.00000 | 2.53890 | 36 | 82 | 974 | positive regulation of cell proliferation |
| GO:0001525 | 0.00000 | 3.25012 | 19 | 54 | 506 | angiogenesis |
| GO:0001649 | 0.00000 | 5.16043 | 7 | 31 | 192 | osteoblast differentiation |
| GO:0007154 | 0.00000 | 1.64452 | 245 | 336 | 6614 | cell communication |
| GO:0030111 | 0.00000 | 4.17643 | 10 | 38 | 283 | regulation of Wnt signaling pathway |
| GO:0072001 | 0.00000 | 4.07293 | 11 | 39 | 297 | renal system development |
| GO:0051962 | 0.00000 | 2.93164 | 23 | 61 | 629 | positive regulation of nervous system development |
| GO:0006629 | 0.00000 | 2.31576 | 46 | 95 | 1234 | lipid metabolic process |
| GO:0050768 | 0.00000 | 3.86713 | 12 | 41 | 327 | negative regulation of neurogenesis |
| GO:0045926 | 0.00000 | 4.16468 | 10 | 37 | 276 | negative regulation of growth |
| GO:0009790 | 0.00000 | 2.33068 | 44 | 92 | 1186 | embryo development |
| GO:0009967 | 0.00000 | 2.17739 | 55 | 107 | 1478 | positive regulation of signal transduction |
| GO:0030278 | 0.00000 | 4.58701 | 8 | 33 | 226 | regulation of ossification |
| GO:0043062 | 0.00000 | 4.02681 | 11 | 38 | 292 | extracellular structure organization |
| GO:0010647 | 0.00000 | 2.05724 | 67 | 124 | 1818 | positive regulation of cell communication |
| GO:0007167 | 0.00000 | 2.56948 | 32 | 74 | 865 | enzyme linked receptor protein signaling pathway |
| GO:0061564 | 0.00000 | 3.20268 | 18 | 51 | 483 | axon development |
| GO:0050678 | 0.00000 | 3.69147 | 13 | 42 | 349 | regulation of epithelial cell proliferation |
| GO:0023056 | 0.00000 | 2.04939 | 68 | 124 | 1824 | positive regulation of signaling |
| GO:0010975 | 0.00000 | 2.95482 | 22 | 57 | 582 | regulation of neuron projection development |
| GO:0040013 | 0.00000 | 3.76821 | 12 | 40 | 326 | negative regulation of locomotion |
| GO:0010720 | 0.00000 | 2.83893 | 24 | 60 | 636 | positive regulation of cell development |
| GO:0048705 | 0.00000 | 4.17719 | 10 | 35 | 260 | skeletal system morphogenesis |
| GO:0007409 | 0.00000 | 3.24813 | 17 | 48 | 448 | axonogenesis |
| GO:0051234 | 0.00000 | 1.69162 | 164 | 241 | 4428 | establishment of localization |
| GO:0048585 | 0.00000 | 2.10918 | 58 | 110 | 1565 | negative regulation of response to stimulus |
| GO:0010721 | 0.00000 | 3.49509 | 14 | 43 | 375 | negative regulation of cell development |
| GO:0050769 | 0.00000 | 2.95342 | 21 | 55 | 561 | positive regulation of neurogenesis |
| GO:0120035 | 0.00000 | 2.64848 | 28 | 66 | 747 | regulation of plasma membrane bounded cell projection organization |
| GO:0006810 | 0.00000 | 1.69501 | 159 | 235 | 4298 | transport |
| GO:0072006 | 0.00000 | 5.74618 | 5 | 25 | 141 | nephron development |
| GO:0051961 | 0.00000 | 3.57556 | 13 | 41 | 350 | negative regulation of nervous system development |
| GO:0051271 | 0.00000 | 3.77131 | 11 | 38 | 309 | negative regulation of cellular component movement |
| GO:0072073 | 0.00000 | 5.64828 | 5 | 25 | 143 | kidney epithelium development |
| GO:0031344 | 0.00000 | 2.61285 | 28 | 66 | 756 | regulation of cell projection organization |
| GO:0006811 | 0.00000 | 2.09893 | 56 | 107 | 1526 | ion transport |
| GO:0060485 | 0.00000 | 4.01489 | 10 | 35 | 269 | mesenchyme development |
| GO:0016055 | 0.00000 | 3.25752 | 15 | 45 | 418 | Wnt signaling pathway |
| GO:0060348 | 0.00000 | 4.39039 | 8 | 31 | 220 | bone development |
| GO:0198738 | 0.00000 | 3.23985 | 16 | 45 | 420 | cell-cell signaling by wnt |
| GO:0030198 | 0.00000 | 4.11356 | 9 | 33 | 248 | extracellular matrix organization |
| GO:0044255 | 0.00000 | 2.41112 | 34 | 74 | 915 | cellular lipid metabolic process |
| GO:0048762 | 0.00000 | 4.38396 | 8 | 30 | 213 | mesenchymal cell differentiation |
| GO:0072080 | 0.00000 | 6.89610 | 4 | 20 | 97 | nephron tubule development |
| GO:0045667 | 0.00000 | 5.50973 | 5 | 24 | 140 | regulation of osteoblast differentiation |
| GO:0090090 | 0.00000 | 6.09370 | 4 | 22 | 118 | negative regulation of canonical Wnt signaling pathway |
| GO:0007165 | 0.00000 | 1.58916 | 222 | 303 | 6010 | signal transduction |
| GO:1905114 | 0.00000 | 2.95447 | 19 | 50 | 508 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0065009 | 0.00000 | 1.84019 | 90 | 149 | 2437 | regulation of molecular function |
| GO:0001501 | 0.00000 | 2.94136 | 19 | 50 | 510 | skeletal system development |
| GO:0060993 | 0.00000 | 6.80739 | 4 | 20 | 98 | kidney morphogenesis |
| GO:0001659 | 0.00000 | 4.80339 | 7 | 27 | 177 | temperature homeostasis |
| GO:0045665 | 0.00000 | 3.98260 | 9 | 33 | 255 | negative regulation of neuron differentiation |
| GO:0051049 | 0.00000 | 1.94441 | 70 | 123 | 1892 | regulation of transport |
| GO:0072009 | 0.00000 | 6.34022 | 4 | 21 | 109 | nephron epithelium development |
| GO:0051050 | 0.00000 | 2.26615 | 39 | 80 | 1049 | positive regulation of transport |
| GO:0080090 | 0.00000 | 1.60537 | 190 | 266 | 5147 | regulation of primary metabolic process |
| GO:0008610 | 0.00000 | 2.85181 | 20 | 51 | 535 | lipid biosynthetic process |
| GO:2000146 | 0.00000 | 3.78112 | 10 | 34 | 275 | negative regulation of cell motility |
| GO:0031328 | 0.00000 | 1.93797 | 68 | 120 | 1848 | positive regulation of cellular biosynthetic process |
| GO:0048871 | 0.00000 | 2.97914 | 18 | 47 | 473 | multicellular organismal homeostasis |
| GO:0007411 | 0.00000 | 4.15494 | 8 | 30 | 223 | axon guidance |
| GO:0061326 | 0.00000 | 6.39587 | 4 | 20 | 103 | renal tubule development |
| GO:0097485 | 0.00000 | 4.13334 | 8 | 30 | 224 | neuron projection guidance |
| GO:0030335 | 0.00000 | 2.84041 | 19 | 50 | 526 | positive regulation of cell migration |
| GO:0030178 | 0.00000 | 5.11097 | 6 | 24 | 149 | negative regulation of Wnt signaling pathway |
| GO:0051272 | 0.00000 | 2.76518 | 21 | 52 | 561 | positive regulation of cellular component movement |
| GO:0010463 | 0.00000 | 9.44083 | 2 | 15 | 57 | mesenchymal cell proliferation |
| GO:0009891 | 0.00000 | 1.90879 | 70 | 121 | 1889 | positive regulation of biosynthetic process |
| GO:0044237 | 0.00000 | 1.51496 | 340 | 425 | 9199 | cellular metabolic process |
| GO:0061333 | 0.00000 | 7.11908 | 3 | 18 | 85 | renal tubule morphogenesis |
| GO:0090092 | 0.00000 | 4.04911 | 8 | 30 | 228 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0009058 | 0.00000 | 1.59399 | 185 | 258 | 5000 | biosynthetic process |
| GO:0031323 | 0.00000 | 1.58246 | 196 | 270 | 5290 | regulation of cellular metabolic process |
| GO:1990845 | 0.00000 | 4.99051 | 6 | 24 | 152 | adaptive thermogenesis |
| GO:0006796 | 0.00000 | 1.73735 | 107 | 167 | 2893 | phosphate-containing compound metabolic process |
| GO:0051130 | 0.00000 | 2.11348 | 46 | 89 | 1248 | positive regulation of cellular component organization |
| GO:0042592 | 0.00000 | 1.90726 | 69 | 119 | 1857 | homeostatic process |
| GO:0098609 | 0.00000 | 2.51917 | 26 | 60 | 707 | cell-cell adhesion |
| GO:0106106 | 0.00000 | 5.18400 | 5 | 23 | 141 | cold-induced thermogenesis |
| GO:0120161 | 0.00000 | 5.18400 | 5 | 23 | 141 | regulation of cold-induced thermogenesis |
| GO:0060351 | 0.00000 | 9.99259 | 2 | 14 | 51 | cartilage development involved in endochondral bone morphogenesis |
| GO:0009893 | 0.00000 | 1.67776 | 126 | 189 | 3406 | positive regulation of metabolic process |
| GO:0030336 | 0.00000 | 3.73816 | 10 | 32 | 261 | negative regulation of cell migration |
| GO:0006793 | 0.00000 | 1.72222 | 108 | 167 | 2914 | phosphorus metabolic process |
| GO:0019220 | 0.00000 | 1.94232 | 62 | 109 | 1665 | regulation of phosphate metabolic process |
| GO:0072078 | 0.00000 | 7.25881 | 3 | 17 | 79 | nephron tubule morphogenesis |
| GO:0051174 | 0.00000 | 1.94098 | 62 | 109 | 1666 | regulation of phosphorus metabolic process |
| GO:2000147 | 0.00000 | 2.72902 | 20 | 50 | 545 | positive regulation of cell motility |
| GO:0010631 | 0.00000 | 3.60497 | 10 | 33 | 278 | epithelial cell migration |
| GO:0002009 | 0.00000 | 2.72339 | 20 | 50 | 546 | morphogenesis of an epithelium |
| GO:0021700 | 0.00000 | 3.43528 | 11 | 35 | 308 | developmental maturation |
| GO:0031325 | 0.00000 | 1.69335 | 116 | 176 | 3128 | positive regulation of cellular metabolic process |
| GO:0090132 | 0.00000 | 3.57546 | 10 | 33 | 280 | epithelium migration |
| GO:0019222 | 0.00000 | 1.54532 | 216 | 290 | 5833 | regulation of metabolic process |
| GO:0072088 | 0.00000 | 7.03134 | 3 | 17 | 81 | nephron epithelium morphogenesis |
| GO:0008152 | 0.00000 | 1.49143 | 383 | 465 | 10337 | metabolic process |
| GO:0090130 | 0.00000 | 3.54642 | 10 | 33 | 282 | tissue migration |
| GO:0072028 | 0.00000 | 6.92286 | 3 | 17 | 82 | nephron morphogenesis |
| GO:0001657 | 0.00000 | 5.99633 | 4 | 19 | 103 | ureteric bud development |
| GO:0072163 | 0.00000 | 5.99633 | 4 | 19 | 103 | mesonephric epithelium development |
| GO:0072164 | 0.00000 | 5.99633 | 4 | 19 | 103 | mesonephric tubule development |
| GO:0042330 | 0.00000 | 2.63962 | 21 | 51 | 573 | taxis |
| GO:0046903 | 0.00000 | 2.09400 | 44 | 84 | 1184 | secretion |
| GO:0042063 | 0.00000 | 3.39604 | 11 | 34 | 302 | gliogenesis |
| GO:0030510 | 0.00000 | 6.27350 | 3 | 18 | 94 | regulation of BMP signaling pathway |
| GO:0048598 | 0.00000 | 2.54055 | 23 | 54 | 629 | embryonic morphogenesis |
| GO:0040017 | 0.00000 | 2.61907 | 21 | 51 | 577 | positive regulation of locomotion |
| GO:0001823 | 0.00000 | 5.78878 | 4 | 19 | 106 | mesonephros development |
| GO:0007178 | 0.00000 | 3.16943 | 13 | 37 | 350 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0040008 | 0.00000 | 2.39691 | 27 | 60 | 739 | regulation of growth |
| GO:0001935 | 0.00000 | 4.91085 | 5 | 22 | 141 | endothelial cell proliferation |
| GO:0007162 | 0.00000 | 3.50598 | 10 | 32 | 276 | negative regulation of cell adhesion |
| GO:0045666 | 0.00000 | 2.86282 | 17 | 43 | 447 | positive regulation of neuron differentiation |
| GO:1901576 | 0.00000 | 1.55834 | 182 | 250 | 4910 | organic substance biosynthetic process |
| GO:0051171 | 0.00000 | 1.55393 | 185 | 254 | 5008 | regulation of nitrogen compound metabolic process |
| GO:0031589 | 0.00000 | 3.26563 | 12 | 35 | 322 | cell-substrate adhesion |
| GO:0071704 | 0.00000 | 1.47503 | 364 | 444 | 9839 | organic substance metabolic process |
| GO:0010001 | 0.00000 | 3.86862 | 8 | 28 | 221 | glial cell differentiation |
| GO:0043542 | 0.00000 | 4.12160 | 7 | 26 | 194 | endothelial cell migration |
| GO:0044249 | 0.00000 | 1.55788 | 179 | 246 | 4824 | cellular biosynthetic process |
| GO:0051173 | 0.00000 | 1.67568 | 111 | 168 | 3000 | positive regulation of nitrogen compound metabolic process |
| GO:0090287 | 0.00000 | 3.53889 | 10 | 31 | 265 | regulation of cellular response to growth factor stimulus |
| GO:0035265 | 0.00000 | 3.95314 | 8 | 27 | 209 | organ growth |
| GO:0044238 | 0.00000 | 1.47338 | 344 | 423 | 9296 | primary metabolic process |
| GO:0042221 | 0.00000 | 1.59440 | 150 | 213 | 4043 | response to chemical |
| GO:0006935 | 0.00000 | 2.58975 | 21 | 50 | 571 | chemotaxis |
| GO:0009719 | 0.00000 | 1.97411 | 51 | 93 | 1388 | response to endogenous stimulus |
| GO:0045598 | 0.00000 | 4.97624 | 5 | 21 | 133 | regulation of fat cell differentiation |
| GO:0031326 | 0.00000 | 1.63016 | 125 | 184 | 3386 | regulation of cellular biosynthetic process |
| GO:0003013 | 0.00000 | 2.74587 | 18 | 44 | 475 | circulatory system process |
| GO:0060537 | 0.00000 | 2.77193 | 17 | 43 | 460 | muscle tissue development |
| GO:0072132 | 0.00000 | 9.02358 | 2 | 13 | 51 | mesenchyme morphogenesis |
| GO:0097435 | 0.00000 | 2.42597 | 25 | 55 | 668 | supramolecular fiber organization |
| GO:1901342 | 0.00000 | 3.15425 | 12 | 35 | 332 | regulation of vasculature development |
| GO:0048608 | 0.00000 | 2.79988 | 16 | 42 | 445 | reproductive structure development |
| GO:0060675 | 0.00000 | 7.20516 | 3 | 15 | 70 | ureteric bud morphogenesis |
| GO:0003416 | 0.00000 | 10.20146 | 2 | 12 | 43 | endochondral bone growth |
| GO:0071772 | 0.00000 | 4.22599 | 6 | 24 | 175 | response to BMP |
| GO:0071773 | 0.00000 | 4.22599 | 6 | 24 | 175 | cellular response to BMP stimulus |
| GO:0031214 | 0.00000 | 4.56371 | 6 | 22 | 150 | biomineral tissue development |
| GO:0033002 | 0.00000 | 3.67639 | 9 | 28 | 231 | muscle cell proliferation |
| GO:0072171 | 0.00000 | 7.07618 | 3 | 15 | 71 | mesonephric tubule morphogenesis |
| GO:0061458 | 0.00000 | 2.77186 | 17 | 42 | 449 | reproductive system development |
| GO:0008015 | 0.00000 | 2.73187 | 17 | 43 | 466 | blood circulation |
| GO:0030509 | 0.00000 | 4.33390 | 6 | 23 | 164 | BMP signaling pathway |
| GO:0009889 | 0.00000 | 1.61266 | 128 | 186 | 3456 | regulation of biosynthetic process |
| GO:0044281 | 0.00000 | 1.84417 | 63 | 107 | 1708 | small molecule metabolic process |
| GO:0003279 | 0.00000 | 4.90983 | 5 | 20 | 128 | cardiac septum development |
| GO:0071363 | 0.00000 | 2.49646 | 22 | 50 | 590 | cellular response to growth factor stimulus |
| GO:0010464 | 0.00000 | 9.58233 | 2 | 12 | 45 | regulation of mesenchymal cell proliferation |
| GO:0098868 | 0.00000 | 9.58233 | 2 | 12 | 45 | bone growth |
| GO:0002062 | 0.00000 | 5.13649 | 4 | 19 | 117 | chondrocyte differentiation |
| GO:0010604 | 0.00000 | 1.62932 | 117 | 172 | 3149 | positive regulation of macromolecule metabolic process |
| GO:0008219 | 0.00000 | 1.76528 | 76 | 123 | 2056 | cell death |
| GO:0007423 | 0.00000 | 2.47765 | 22 | 50 | 594 | sensory organ development |
| GO:0090596 | 0.00000 | 3.23745 | 11 | 32 | 296 | sensory organ morphogenesis |
| GO:0042325 | 0.00000 | 1.88920 | 56 | 97 | 1508 | regulation of phosphorylation |
| GO:0048863 | 0.00000 | 3.66845 | 8 | 27 | 223 | stem cell differentiation |
| GO:0035567 | 0.00000 | 8.16273 | 2 | 13 | 55 | non-canonical Wnt signaling pathway |
| GO:0071495 | 0.00000 | 1.99123 | 45 | 82 | 1207 | cellular response to endogenous stimulus |
| GO:0001763 | 0.00000 | 3.53573 | 9 | 28 | 239 | morphogenesis of a branching structure |
| GO:0030282 | 0.00000 | 5.29430 | 4 | 18 | 108 | bone mineralization |
| GO:0045765 | 0.00000 | 3.18855 | 11 | 32 | 300 | regulation of angiogenesis |
| GO:0060411 | 0.00000 | 6.04171 | 3 | 16 | 86 | cardiac septum morphogenesis |
| GO:0070848 | 0.00000 | 2.43181 | 22 | 50 | 604 | response to growth factor |
| GO:0048584 | 0.00000 | 1.71878 | 83 | 130 | 2231 | positive regulation of response to stimulus |
| GO:0051716 | 0.00000 | 1.45184 | 285 | 357 | 7705 | cellular response to stimulus |
| GO:0010976 | 0.00000 | 2.97158 | 13 | 35 | 350 | positive regulation of neuron projection development |
| GO:0050873 | 0.00000 | 8.78263 | 2 | 12 | 48 | brown fat cell differentiation |
| GO:0035556 | 0.00000 | 1.66794 | 95 | 145 | 2571 | intracellular signal transduction |
| GO:0060255 | 0.00000 | 1.49239 | 199 | 264 | 5386 | regulation of macromolecule metabolic process |
| GO:0007507 | 0.00000 | 2.40070 | 23 | 50 | 611 | heart development |
| GO:0031346 | 0.00000 | 2.66257 | 17 | 41 | 454 | positive regulation of cell projection organization |
| GO:0010556 | 0.00000 | 1.59652 | 120 | 174 | 3242 | regulation of macromolecule biosynthetic process |
| GO:0060840 | 0.00000 | 5.35241 | 4 | 17 | 101 | artery development |
| GO:0045834 | 0.00000 | 4.28375 | 6 | 21 | 151 | positive regulation of lipid metabolic process |
| GO:0048878 | 0.00000 | 1.97863 | 43 | 78 | 1152 | chemical homeostasis |
| GO:0050808 | 0.00000 | 2.71372 | 16 | 39 | 424 | synapse organization |
| GO:2001141 | 0.00000 | 1.63463 | 102 | 152 | 2750 | regulation of RNA biosynthetic process |
| GO:0048638 | 0.00000 | 2.78914 | 15 | 37 | 392 | regulation of developmental growth |
| GO:0010632 | 0.00000 | 3.54660 | 8 | 26 | 221 | regulation of epithelial cell migration |
| GO:0001936 | 0.00000 | 4.65879 | 5 | 19 | 127 | regulation of endothelial cell proliferation |
| GO:1902679 | 0.00000 | 1.96900 | 43 | 78 | 1157 | negative regulation of RNA biosynthetic process |
| GO:0050680 | 0.00000 | 4.41647 | 5 | 20 | 140 | negative regulation of epithelial cell proliferation |
| GO:0010594 | 0.00000 | 4.21847 | 6 | 21 | 153 | regulation of endothelial cell migration |
| GO:0071695 | 0.00000 | 3.88943 | 7 | 23 | 180 | anatomical structure maturation |
| GO:0006355 | 0.00000 | 1.63081 | 101 | 151 | 2736 | regulation of transcription, DNA-templated |
| GO:1903506 | 0.00000 | 1.62654 | 101 | 151 | 2742 | regulation of nucleic acid-templated transcription |
| GO:2000112 | 0.00000 | 1.58780 | 117 | 169 | 3156 | regulation of cellular macromolecule biosynthetic process |
| GO:0048732 | 0.00000 | 2.58598 | 17 | 41 | 466 | gland development |
| GO:0090066 | 0.00000 | 2.43298 | 21 | 46 | 554 | regulation of anatomical structure size |
| GO:0060536 | 0.00000 | 13.13807 | 1 | 9 | 27 | cartilage morphogenesis |
| GO:0001837 | 0.00000 | 4.53227 | 5 | 19 | 130 | epithelial to mesenchymal transition |
| GO:0010557 | 0.00000 | 1.77079 | 65 | 106 | 1752 | positive regulation of macromolecule biosynthetic process |
| GO:0061061 | 0.00000 | 2.27097 | 25 | 53 | 682 | muscle structure development |
| GO:0030279 | 0.00000 | 5.42010 | 3 | 16 | 94 | negative regulation of ossification |
| GO:0048709 | 0.00000 | 5.42010 | 3 | 16 | 94 | oligodendrocyte differentiation |
| GO:0006915 | 0.00000 | 1.74804 | 69 | 111 | 1860 | apoptotic process |
| GO:0016310 | 0.00000 | 1.69804 | 79 | 124 | 2144 | phosphorylation |
| GO:0003151 | 0.00000 | 5.82431 | 3 | 15 | 83 | outflow tract morphogenesis |
| GO:0070887 | 0.00000 | 1.60302 | 109 | 159 | 2933 | cellular response to chemical stimulus |
| GO:0048844 | 0.00000 | 6.26037 | 3 | 14 | 73 | artery morphogenesis |
| GO:0045892 | 0.00000 | 1.94696 | 43 | 77 | 1153 | negative regulation of transcription, DNA-templated |
| GO:0050790 | 0.00000 | 1.75642 | 66 | 107 | 1782 | regulation of catalytic activity |
| GO:1903507 | 0.00000 | 1.94128 | 43 | 77 | 1156 | negative regulation of nucleic acid-templated transcription |
| GO:0003413 | 0.00000 | 12.44604 | 1 | 9 | 28 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0014706 | 0.00000 | 2.61017 | 16 | 39 | 439 | striated muscle tissue development |
| GO:0003417 | 0.00000 | 10.11448 | 1 | 10 | 36 | growth plate cartilage development |
| GO:0022604 | 0.00000 | 2.47493 | 19 | 43 | 509 | regulation of cell morphogenesis |
| GO:0012501 | 0.00000 | 1.72645 | 70 | 112 | 1898 | programmed cell death |
| GO:0030324 | 0.00000 | 3.45980 | 8 | 25 | 217 | lung development |
| GO:0055114 | 0.00000 | 2.04041 | 35 | 66 | 942 | oxidation-reduction process |
| GO:0060560 | 0.00000 | 3.18489 | 10 | 28 | 262 | developmental growth involved in morphogenesis |
| GO:0003281 | 0.00000 | 5.57746 | 3 | 15 | 86 | ventricular septum development |
| GO:0048640 | 0.00000 | 4.57873 | 5 | 18 | 122 | negative regulation of developmental growth |
| GO:0003206 | 0.00000 | 4.13895 | 5 | 20 | 148 | cardiac chamber morphogenesis |
| GO:0045778 | 0.00000 | 5.15478 | 4 | 16 | 98 | positive regulation of ossification |
| GO:0010562 | 0.00000 | 1.94745 | 41 | 74 | 1106 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00000 | 1.94745 | 41 | 74 | 1106 | positive regulation of phosphate metabolic process |
| GO:0060541 | 0.00000 | 3.23502 | 9 | 27 | 249 | respiratory system development |
| GO:0002053 | 0.00000 | 9.73943 | 1 | 10 | 37 | positive regulation of mesenchymal cell proliferation |
| GO:0031324 | 0.00000 | 1.64069 | 89 | 134 | 2397 | negative regulation of cellular metabolic process |
| GO:0030323 | 0.00000 | 3.40611 | 8 | 25 | 220 | respiratory tube development |
| GO:0061138 | 0.00000 | 3.40611 | 8 | 25 | 220 | morphogenesis of a branching epithelium |
| GO:2000027 | 0.00000 | 3.50129 | 8 | 24 | 206 | regulation of animal organ morphogenesis |
| GO:0030308 | 0.00000 | 3.61131 | 7 | 23 | 192 | negative regulation of cell growth |
| GO:0043583 | 0.00000 | 3.27530 | 9 | 26 | 237 | ear development |
| GO:0045880 | 0.00000 | 9.39118 | 1 | 10 | 38 | positive regulation of smoothened signaling pathway |
| GO:0007219 | 0.00000 | 3.71588 | 7 | 22 | 179 | Notch signaling pathway |
| GO:0003179 | 0.00000 | 8.04126 | 2 | 11 | 47 | heart valve morphogenesis |
| GO:0003197 | 0.00000 | 8.04126 | 2 | 11 | 47 | endocardial cushion development |
| GO:0015711 | 0.00000 | 2.64976 | 15 | 36 | 399 | organic anion transport |
| GO:0003205 | 0.00000 | 3.56875 | 7 | 23 | 194 | cardiac chamber development |
| GO:0042981 | 0.00000 | 1.79100 | 56 | 93 | 1512 | regulation of apoptotic process |
| GO:0032774 | 0.00000 | 1.58329 | 105 | 153 | 2844 | RNA biosynthetic process |
| GO:0044283 | 0.00000 | 2.28230 | 23 | 48 | 613 | small molecule biosynthetic process |
| GO:0044057 | 0.00000 | 2.32515 | 21 | 46 | 577 | regulation of system process |
| GO:0050679 | 0.00000 | 3.54784 | 7 | 23 | 195 | positive regulation of epithelial cell proliferation |
| GO:0014031 | 0.00000 | 5.27905 | 3 | 15 | 90 | mesenchymal cell development |
| GO:0000122 | 0.00000 | 2.07132 | 31 | 60 | 842 | negative regulation of transcription by RNA polymerase II |
| GO:0045165 | 0.00000 | 3.06569 | 10 | 28 | 271 | cell fate commitment |
| GO:0048754 | 0.00000 | 3.62291 | 7 | 22 | 183 | branching morphogenesis of an epithelial tube |
| GO:0031399 | 0.00000 | 1.72744 | 64 | 103 | 1737 | regulation of protein modification process |
| GO:0006631 | 0.00000 | 2.69228 | 14 | 34 | 371 | fatty acid metabolic process |
| GO:0045893 | 0.00000 | 1.78150 | 56 | 92 | 1502 | positive regulation of transcription, DNA-templated |
| GO:0003198 | 0.00000 | 18.35674 | 1 | 7 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0003007 | 0.00000 | 3.02789 | 10 | 28 | 274 | heart morphogenesis |
| GO:0010596 | 0.00000 | 7.61735 | 2 | 11 | 49 | negative regulation of endothelial cell migration |
| GO:0014033 | 0.00000 | 5.14147 | 3 | 15 | 92 | neural crest cell differentiation |
| GO:1901362 | 0.00000 | 1.52738 | 127 | 178 | 3444 | organic cyclic compound biosynthetic process |
| GO:1903508 | 0.00000 | 1.77746 | 56 | 92 | 1505 | positive regulation of nucleic acid-templated transcription |
| GO:0010941 | 0.00000 | 1.73564 | 62 | 100 | 1677 | regulation of cell death |
| GO:1902680 | 0.00000 | 1.77612 | 56 | 92 | 1506 | positive regulation of RNA biosynthetic process |
| GO:0014013 | 0.00000 | 4.05474 | 5 | 19 | 143 | regulation of gliogenesis |
| GO:0006633 | 0.00000 | 4.25015 | 5 | 18 | 130 | fatty acid biosynthetic process |
| GO:0019216 | 0.00000 | 2.81875 | 12 | 31 | 324 | regulation of lipid metabolic process |
| GO:0006357 | 0.00000 | 1.68234 | 72 | 112 | 1941 | regulation of transcription by RNA polymerase II |
| GO:0043067 | 0.00000 | 1.76574 | 57 | 93 | 1531 | regulation of programmed cell death |
| GO:0060562 | 0.00000 | 2.66021 | 14 | 34 | 375 | epithelial tube morphogenesis |
| GO:1990138 | 0.00000 | 3.55616 | 7 | 22 | 186 | neuron projection extension |
| GO:0051253 | 0.00000 | 1.85030 | 46 | 79 | 1239 | negative regulation of RNA metabolic process |
| GO:0006351 | 0.00000 | 1.56878 | 105 | 151 | 2826 | transcription, DNA-templated |
| GO:0032787 | 0.00000 | 2.32149 | 20 | 44 | 552 | monocarboxylic acid metabolic process |
| GO:0030029 | 0.00000 | 2.13785 | 27 | 53 | 720 | actin filament-based process |
| GO:0030856 | 0.00000 | 3.99003 | 5 | 19 | 145 | regulation of epithelial cell differentiation |
| GO:0048771 | 0.00000 | 3.53445 | 7 | 22 | 187 | tissue remodeling |
| GO:0043269 | 0.00000 | 2.14798 | 26 | 52 | 703 | regulation of ion transport |
| GO:0010876 | 0.00000 | 2.68264 | 13 | 33 | 361 | lipid localization |
| GO:0051046 | 0.00000 | 2.01488 | 32 | 61 | 878 | regulation of secretion |
| GO:0097659 | 0.00000 | 1.56479 | 105 | 151 | 2832 | nucleic acid-templated transcription |
| GO:0045668 | 0.00000 | 6.44879 | 2 | 12 | 61 | negative regulation of osteoblast differentiation |
| GO:0019219 | 0.00000 | 1.52879 | 121 | 170 | 3276 | regulation of nucleobase-containing compound metabolic process |
| GO:0006812 | 0.00000 | 1.90588 | 40 | 71 | 1080 | cation transport |
| GO:0006468 | 0.00000 | 1.69602 | 67 | 105 | 1801 | protein phosphorylation |
| GO:0045686 | 0.00000 | 9.85091 | 1 | 9 | 33 | negative regulation of glial cell differentiation |
| GO:0001932 | 0.00000 | 1.78702 | 52 | 86 | 1396 | regulation of protein phosphorylation |
| GO:0003229 | 0.00000 | 6.31953 | 2 | 12 | 62 | ventricular cardiac muscle tissue development |
| GO:0060042 | 0.00000 | 6.31953 | 2 | 12 | 62 | retina morphogenesis in camera-type eye |
| GO:0006937 | 0.00000 | 3.89671 | 5 | 19 | 148 | regulation of muscle contraction |
| GO:0048469 | 0.00000 | 3.45017 | 7 | 22 | 191 | cell maturation |
| GO:0051252 | 0.00000 | 1.54395 | 110 | 157 | 2985 | regulation of RNA metabolic process |
| GO:0007417 | 0.00000 | 2.01821 | 31 | 59 | 847 | central nervous system development |
| GO:0048588 | 0.00000 | 3.05585 | 9 | 26 | 252 | developmental cell growth |
| GO:0050896 | 0.00000 | 1.37758 | 348 | 413 | 9397 | response to stimulus |
| GO:0010769 | 0.00000 | 2.73363 | 12 | 31 | 333 | regulation of cell morphogenesis involved in differentiation |
| GO:0062012 | 0.00000 | 2.73363 | 12 | 31 | 333 | regulation of small molecule metabolic process |
| GO:0048738 | 0.00000 | 3.04225 | 9 | 26 | 253 | cardiac muscle tissue development |
| GO:0003203 | 0.00000 | 9.45645 | 1 | 9 | 34 | endocardial cushion morphogenesis |
| GO:0097164 | 0.00000 | 3.67642 | 6 | 20 | 164 | ammonium ion metabolic process |
| GO:0008202 | 0.00000 | 2.88549 | 11 | 28 | 286 | steroid metabolic process |
| GO:0009892 | 0.00000 | 1.55485 | 103 | 148 | 2787 | negative regulation of metabolic process |
| GO:0001658 | 0.00000 | 6.07593 | 2 | 12 | 64 | branching involved in ureteric bud morphogenesis |
| GO:0051172 | 0.00000 | 1.61248 | 82 | 123 | 2222 | negative regulation of nitrogen compound metabolic process |
| GO:0016049 | 0.00000 | 2.32349 | 19 | 41 | 513 | cell growth |
| GO:0002063 | 0.00000 | 7.73183 | 2 | 10 | 44 | chondrocyte development |
| GO:0090184 | 0.00000 | 7.73183 | 2 | 10 | 44 | positive regulation of kidney development |
| GO:0006820 | 0.00000 | 2.29364 | 20 | 42 | 532 | anion transport |
| GO:0048659 | 0.00000 | 3.60091 | 6 | 20 | 167 | smooth muscle cell proliferation |
| GO:0006869 | 0.00000 | 2.72454 | 12 | 30 | 323 | lipid transport |
| GO:0051246 | 0.00000 | 1.55865 | 98 | 141 | 2642 | regulation of protein metabolic process |
| GO:0009792 | 0.00000 | 2.01981 | 30 | 56 | 802 | embryo development ending in birth or egg hatching |
| GO:0050922 | 0.00000 | 6.57686 | 2 | 11 | 55 | negative regulation of chemotaxis |
| GO:0007160 | 0.00000 | 3.31190 | 7 | 22 | 198 | cell-matrix adhesion |
| GO:0043009 | 0.00000 | 2.02907 | 29 | 55 | 784 | chordate embryonic development |
| GO:0019438 | 0.00000 | 1.50177 | 123 | 170 | 3324 | aromatic compound biosynthetic process |
| GO:0006644 | 0.00000 | 2.64482 | 13 | 31 | 343 | phospholipid metabolic process |
| GO:0048736 | 0.00000 | 3.29304 | 7 | 22 | 199 | appendage development |
| GO:0060173 | 0.00000 | 3.29304 | 7 | 22 | 199 | limb development |
| GO:0098742 | 0.00000 | 3.29304 | 7 | 22 | 199 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0046394 | 0.00001 | 2.63625 | 13 | 31 | 344 | carboxylic acid biosynthetic process |
| GO:0070167 | 0.00001 | 4.85632 | 3 | 14 | 90 | regulation of biomineral tissue development |
| GO:0051254 | 0.00001 | 1.70203 | 59 | 94 | 1599 | positive regulation of RNA metabolic process |
| GO:0045934 | 0.00001 | 1.76080 | 50 | 83 | 1363 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0016053 | 0.00001 | 2.62773 | 13 | 31 | 345 | organic acid biosynthetic process |
| GO:1902531 | 0.00001 | 1.68268 | 62 | 98 | 1687 | regulation of intracellular signal transduction |
| GO:0046942 | 0.00001 | 2.78709 | 11 | 28 | 295 | carboxylic acid transport |
| GO:0034762 | 0.00001 | 2.25135 | 20 | 42 | 541 | regulation of transmembrane transport |
| GO:0044093 | 0.00001 | 1.74555 | 52 | 85 | 1408 | positive regulation of molecular function |
| GO:0015849 | 0.00001 | 2.77657 | 11 | 28 | 296 | organic acid transport |
| GO:0009605 | 0.00001 | 1.57029 | 90 | 131 | 2429 | response to external stimulus |
| GO:0045913 | 0.00001 | 5.18888 | 3 | 13 | 79 | positive regulation of carbohydrate metabolic process |
| GO:0048864 | 0.00001 | 4.79304 | 3 | 14 | 91 | stem cell development |
| GO:0006366 | 0.00001 | 1.62415 | 74 | 112 | 2001 | transcription by RNA polymerase II |
| GO:0003170 | 0.00001 | 6.29034 | 2 | 11 | 57 | heart valve development |
| GO:0062013 | 0.00001 | 3.77553 | 5 | 18 | 144 | positive regulation of small molecule metabolic process |
| GO:0045446 | 0.00001 | 4.44585 | 4 | 15 | 104 | endothelial cell differentiation |
| GO:0010633 | 0.00001 | 5.64092 | 3 | 12 | 68 | negative regulation of epithelial cell migration |
| GO:0034654 | 0.00001 | 1.49651 | 120 | 166 | 3250 | nucleobase-containing compound biosynthetic process |
| GO:0044271 | 0.00001 | 1.45919 | 145 | 194 | 3918 | cellular nitrogen compound biosynthetic process |
| GO:0001958 | 0.00001 | 9.99687 | 1 | 8 | 29 | endochondral ossification |
| GO:0036075 | 0.00001 | 9.99687 | 1 | 8 | 29 | replacement ossification |
| GO:0046533 | 0.00001 | 32.71199 | 0 | 5 | 9 | negative regulation of photoreceptor cell differentiation |
| GO:0003002 | 0.00001 | 2.53543 | 14 | 32 | 368 | regionalization |
| GO:0090183 | 0.00001 | 6.15623 | 2 | 11 | 58 | regulation of kidney development |
| GO:0090263 | 0.00001 | 4.67128 | 3 | 14 | 93 | positive regulation of canonical Wnt signaling pathway |
| GO:0010810 | 0.00001 | 3.18421 | 8 | 22 | 205 | regulation of cell-substrate adhesion |
| GO:0051247 | 0.00001 | 1.68165 | 60 | 94 | 1616 | positive regulation of protein metabolic process |
| GO:0023061 | 0.00001 | 2.25917 | 19 | 40 | 513 | signal release |
| GO:0048839 | 0.00001 | 3.16677 | 8 | 22 | 206 | inner ear development |
| GO:0010770 | 0.00001 | 3.39179 | 7 | 20 | 176 | positive regulation of cell morphogenesis involved in differentiation |
| GO:0003006 | 0.00001 | 1.99253 | 29 | 54 | 782 | developmental process involved in reproduction |
| GO:0018130 | 0.00001 | 1.48475 | 123 | 168 | 3313 | heterocycle biosynthetic process |
| GO:0019752 | 0.00001 | 1.92682 | 33 | 59 | 883 | carboxylic acid metabolic process |
| GO:0022414 | 0.00001 | 1.71455 | 54 | 86 | 1448 | reproductive process |
| GO:0003231 | 0.00001 | 3.65871 | 5 | 18 | 148 | cardiac ventricle development |
| GO:0003418 | 0.00001 | 12.23509 | 1 | 7 | 22 | growth plate cartilage chondrocyte differentiation |
| GO:0000003 | 0.00001 | 1.71321 | 54 | 86 | 1449 | reproduction |
| GO:0043065 | 0.00001 | 2.13178 | 23 | 45 | 610 | positive regulation of apoptotic process |
| GO:0010817 | 0.00001 | 2.21779 | 20 | 41 | 535 | regulation of hormone levels |
| GO:0032940 | 0.00001 | 1.85058 | 38 | 66 | 1028 | secretion by cell |
| GO:0120162 | 0.00001 | 4.55553 | 4 | 14 | 95 | positive regulation of cold-induced thermogenesis |
| GO:0030879 | 0.00001 | 3.46423 | 6 | 19 | 164 | mammary gland development |
| GO:0045935 | 0.00001 | 1.63637 | 66 | 101 | 1784 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0014014 | 0.00001 | 6.57029 | 2 | 10 | 50 | negative regulation of gliogenesis |
| GO:0043068 | 0.00001 | 2.10880 | 23 | 45 | 616 | positive regulation of programmed cell death |
| GO:0031327 | 0.00001 | 1.70442 | 53 | 85 | 1438 | negative regulation of cellular biosynthetic process |
| GO:2000113 | 0.00001 | 1.72683 | 50 | 81 | 1352 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0071702 | 0.00001 | 1.54417 | 90 | 130 | 2444 | organic substance transport |
| GO:0044260 | 0.00001 | 1.36445 | 258 | 315 | 6974 | cellular macromolecule metabolic process |
| GO:0016525 | 0.00001 | 4.16394 | 4 | 15 | 110 | negative regulation of angiogenesis |
| GO:0042327 | 0.00001 | 1.83265 | 38 | 66 | 1037 | positive regulation of phosphorylation |
| GO:0030177 | 0.00001 | 3.90925 | 5 | 16 | 124 | positive regulation of Wnt signaling pathway |
| GO:0008589 | 0.00001 | 4.75520 | 3 | 13 | 85 | regulation of smoothened signaling pathway |
| GO:0014032 | 0.00001 | 4.75520 | 3 | 13 | 85 | neural crest cell development |
| GO:0055085 | 0.00001 | 1.75093 | 46 | 76 | 1250 | transmembrane transport |
| GO:0048568 | 0.00001 | 2.25278 | 18 | 38 | 488 | embryonic organ development |
| GO:0090101 | 0.00001 | 4.12038 | 4 | 15 | 111 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:1905330 | 0.00001 | 4.12038 | 4 | 15 | 111 | regulation of morphogenesis of an epithelium |
| GO:0016126 | 0.00001 | 6.40976 | 2 | 10 | 51 | sterol biosynthetic process |
| GO:0060412 | 0.00001 | 6.40976 | 2 | 10 | 51 | ventricular septum morphogenesis |
| GO:0003012 | 0.00001 | 2.44667 | 14 | 32 | 380 | muscle system process |
| GO:1901615 | 0.00002 | 2.30661 | 17 | 36 | 452 | organic hydroxy compound metabolic process |
| GO:0090288 | 0.00002 | 3.67899 | 5 | 17 | 139 | negative regulation of cellular response to growth factor stimulus |
| GO:0032268 | 0.00002 | 1.53676 | 91 | 130 | 2454 | regulation of cellular protein metabolic process |
| GO:0045685 | 0.00002 | 4.68985 | 3 | 13 | 86 | regulation of glial cell differentiation |
| GO:0010558 | 0.00002 | 1.70621 | 51 | 82 | 1384 | negative regulation of macromolecule biosynthetic process |
| GO:0090257 | 0.00002 | 2.92903 | 9 | 23 | 231 | regulation of muscle system process |
| GO:0007517 | 0.00002 | 2.35149 | 16 | 34 | 419 | muscle organ development |
| GO:0030514 | 0.00002 | 6.25686 | 2 | 10 | 52 | negative regulation of BMP signaling pathway |
| GO:0045599 | 0.00002 | 6.25686 | 2 | 10 | 52 | negative regulation of fat cell differentiation |
| GO:0003407 | 0.00002 | 5.56304 | 2 | 11 | 63 | neural retina development |
| GO:0001656 | 0.00002 | 4.62626 | 3 | 13 | 87 | metanephros development |
| GO:0007169 | 0.00002 | 2.17909 | 20 | 40 | 530 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:2000181 | 0.00002 | 4.03593 | 4 | 15 | 113 | negative regulation of blood vessel morphogenesis |
| GO:0003181 | 0.00002 | 10.79470 | 1 | 7 | 24 | atrioventricular valve morphogenesis |
| GO:0003272 | 0.00002 | 10.79470 | 1 | 7 | 24 | endocardial cushion formation |
| GO:0072330 | 0.00002 | 2.83941 | 9 | 24 | 248 | monocarboxylic acid biosynthetic process |
| GO:0030500 | 0.00002 | 5.01258 | 3 | 12 | 75 | regulation of bone mineralization |
| GO:0071310 | 0.00002 | 1.53877 | 88 | 126 | 2372 | cellular response to organic substance |
| GO:0002040 | 0.00002 | 3.99498 | 4 | 15 | 114 | sprouting angiogenesis |
| GO:0006082 | 0.00002 | 1.84985 | 35 | 61 | 948 | organic acid metabolic process |
| GO:0061383 | 0.00002 | 6.11108 | 2 | 10 | 53 | trabecula morphogenesis |
| GO:0044092 | 0.00002 | 1.82924 | 37 | 63 | 990 | negative regulation of molecular function |
| GO:0003422 | 0.00002 | 14.28657 | 1 | 6 | 17 | growth plate cartilage morphogenesis |
| GO:0001505 | 0.00002 | 2.43119 | 14 | 31 | 370 | regulation of neurotransmitter levels |
| GO:0010628 | 0.00002 | 1.58900 | 71 | 106 | 1925 | positive regulation of gene expression |
| GO:0031401 | 0.00002 | 1.74587 | 44 | 73 | 1202 | positive regulation of protein modification process |
| GO:0007610 | 0.00002 | 1.98825 | 26 | 49 | 709 | behavior |
| GO:0001709 | 0.00002 | 6.95047 | 2 | 9 | 43 | cell fate determination |
| GO:0001938 | 0.00002 | 4.50412 | 3 | 13 | 89 | positive regulation of endothelial cell proliferation |
| GO:1901564 | 0.00002 | 1.36402 | 227 | 280 | 6130 | organonitrogen compound metabolic process |
| GO:0007389 | 0.00002 | 2.25144 | 17 | 36 | 462 | pattern specification process |
| GO:0010942 | 0.00002 | 2.01218 | 25 | 47 | 672 | positive regulation of cell death |
| GO:0061213 | 0.00002 | 10.19454 | 1 | 7 | 25 | positive regulation of mesonephros development |
| GO:2000050 | 0.00002 | 10.19454 | 1 | 7 | 25 | regulation of non-canonical Wnt signaling pathway |
| GO:0003158 | 0.00003 | 3.91552 | 4 | 15 | 116 | endothelium development |
| GO:0016125 | 0.00003 | 3.70250 | 5 | 16 | 130 | sterol metabolic process |
| GO:0046532 | 0.00003 | 21.80604 | 0 | 5 | 11 | regulation of photoreceptor cell differentiation |
| GO:0038031 | 0.00003 | 52.28271 | 0 | 4 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:0048708 | 0.00003 | 4.78409 | 3 | 12 | 78 | astrocyte differentiation |
| GO:0032270 | 0.00003 | 1.65374 | 56 | 87 | 1513 | positive regulation of cellular protein metabolic process |
| GO:0010605 | 0.00003 | 1.50870 | 94 | 132 | 2533 | negative regulation of macromolecule metabolic process |
| GO:0015850 | 0.00003 | 2.81953 | 9 | 23 | 239 | organic hydroxy compound transport |
| GO:0010033 | 0.00003 | 1.46934 | 111 | 152 | 3005 | response to organic substance |
| GO:0033043 | 0.00003 | 1.72654 | 45 | 73 | 1214 | regulation of organelle organization |
| GO:0009890 | 0.00003 | 1.65740 | 55 | 85 | 1474 | negative regulation of biosynthetic process |
| GO:0003018 | 0.00003 | 3.07406 | 7 | 20 | 192 | vascular process in circulatory system |
| GO:0030036 | 0.00003 | 2.02151 | 24 | 45 | 640 | actin cytoskeleton organization |
| GO:1903530 | 0.00003 | 1.90450 | 30 | 53 | 799 | regulation of secretion by cell |
| GO:0048660 | 0.00003 | 3.30092 | 6 | 18 | 162 | regulation of smooth muscle cell proliferation |
| GO:0007015 | 0.00003 | 2.33742 | 15 | 32 | 396 | actin filament organization |
| GO:0043436 | 0.00003 | 1.83200 | 34 | 59 | 924 | oxoacid metabolic process |
| GO:0044262 | 0.00004 | 2.65018 | 10 | 25 | 275 | cellular carbohydrate metabolic process |
| GO:0045807 | 0.00004 | 3.27801 | 6 | 18 | 163 | positive regulation of endocytosis |
| GO:1901617 | 0.00004 | 2.92309 | 8 | 21 | 211 | organic hydroxy compound biosynthetic process |
| GO:0048713 | 0.00004 | 6.38606 | 2 | 9 | 46 | regulation of oligodendrocyte differentiation |
| GO:0045669 | 0.00004 | 4.98621 | 3 | 11 | 69 | positive regulation of osteoblast differentiation |
| GO:0003171 | 0.00004 | 9.17427 | 1 | 7 | 27 | atrioventricular valve development |
| GO:0001701 | 0.00004 | 2.15658 | 18 | 37 | 494 | in utero embryonic development |
| GO:0003183 | 0.00004 | 18.69006 | 0 | 5 | 12 | mitral valve morphogenesis |
| GO:0048570 | 0.00004 | 18.69006 | 0 | 5 | 12 | notochord morphogenesis |
| GO:0006939 | 0.00005 | 3.92322 | 4 | 14 | 108 | smooth muscle contraction |
| GO:0032835 | 0.00005 | 5.47328 | 2 | 10 | 58 | glomerulus development |
| GO:0120163 | 0.00005 | 6.21773 | 2 | 9 | 47 | negative regulation of cold-induced thermogenesis |
| GO:0006936 | 0.00005 | 2.59763 | 10 | 25 | 280 | muscle contraction |
| GO:0006597 | 0.00005 | Inf | 0 | 3 | 3 | spermine biosynthetic process |
| GO:0030513 | 0.00005 | 7.23652 | 1 | 8 | 37 | positive regulation of BMP signaling pathway |
| GO:0048846 | 0.00005 | 7.23652 | 1 | 8 | 37 | axon extension involved in axon guidance |
| GO:1902284 | 0.00005 | 7.23652 | 1 | 8 | 37 | neuron projection extension involved in neuron projection guidance |
| GO:0050880 | 0.00005 | 3.16803 | 6 | 18 | 168 | regulation of blood vessel size |
| GO:0009059 | 0.00006 | 1.39917 | 149 | 193 | 4028 | macromolecule biosynthetic process |
| GO:1903522 | 0.00006 | 2.77144 | 9 | 22 | 232 | regulation of blood circulation |
| GO:0001755 | 0.00006 | 5.36134 | 2 | 10 | 59 | neural crest cell migration |
| GO:0060037 | 0.00006 | 8.73701 | 1 | 7 | 28 | pharyngeal system development |
| GO:0061217 | 0.00006 | 8.73701 | 1 | 7 | 28 | regulation of mesonephros development |
| GO:0061005 | 0.00006 | 6.05803 | 2 | 9 | 48 | cell differentiation involved in kidney development |
| GO:0007010 | 0.00006 | 1.67736 | 47 | 75 | 1281 | cytoskeleton organization |
| GO:0007416 | 0.00006 | 3.14691 | 6 | 18 | 169 | synapse assembly |
| GO:0035150 | 0.00006 | 3.14691 | 6 | 18 | 169 | regulation of tube size |
| GO:0008215 | 0.00006 | 34.85358 | 0 | 4 | 7 | spermine metabolic process |
| GO:0038030 | 0.00006 | 34.85358 | 0 | 4 | 7 | non-canonical Wnt signaling pathway via MAPK cascade |
| GO:0060322 | 0.00006 | 1.94771 | 25 | 46 | 677 | head development |
| GO:1901343 | 0.00006 | 3.59371 | 5 | 15 | 125 | negative regulation of vasculature development |
| GO:0034220 | 0.00006 | 1.83106 | 32 | 55 | 860 | ion transmembrane transport |
| GO:0050801 | 0.00006 | 1.86367 | 30 | 52 | 799 | ion homeostasis |
| GO:0072079 | 0.00006 | 11.22365 | 1 | 6 | 20 | nephron tubule formation |
| GO:0006807 | 0.00006 | 1.31327 | 325 | 379 | 8771 | nitrogen compound metabolic process |
| GO:0010977 | 0.00007 | 3.10549 | 6 | 18 | 171 | negative regulation of neuron projection development |
| GO:0030001 | 0.00007 | 1.84557 | 30 | 53 | 822 | metal ion transport |
| GO:0003174 | 0.00007 | 16.35307 | 0 | 5 | 13 | mitral valve development |
| GO:0035296 | 0.00007 | 3.22657 | 6 | 17 | 156 | regulation of tube diameter |
| GO:0097746 | 0.00007 | 3.22657 | 6 | 17 | 156 | regulation of blood vessel diameter |
| GO:0060627 | 0.00007 | 2.05759 | 20 | 39 | 544 | regulation of vesicle-mediated transport |
| GO:0003148 | 0.00007 | 8.33950 | 1 | 7 | 29 | outflow tract septum morphogenesis |
| GO:1905314 | 0.00007 | 8.33950 | 1 | 7 | 29 | semi-lunar valve development |
| GO:0006109 | 0.00007 | 3.08519 | 6 | 18 | 172 | regulation of carbohydrate metabolic process |
| GO:0008016 | 0.00007 | 3.08519 | 6 | 18 | 172 | regulation of heart contraction |
| GO:0051145 | 0.00007 | 4.66368 | 3 | 11 | 73 | smooth muscle cell differentiation |
| GO:0005975 | 0.00007 | 2.07376 | 19 | 38 | 526 | carbohydrate metabolic process |
| GO:0045600 | 0.00007 | 5.15063 | 2 | 10 | 61 | positive regulation of fat cell differentiation |
| GO:0033036 | 0.00007 | 1.45431 | 104 | 142 | 2821 | macromolecule localization |
| GO:0002065 | 0.00008 | 3.34808 | 5 | 16 | 142 | columnar/cuboidal epithelial cell differentiation |
| GO:0001558 | 0.00008 | 2.19818 | 16 | 33 | 432 | regulation of cell growth |
| GO:0051047 | 0.00008 | 2.09114 | 19 | 37 | 508 | positive regulation of secretion |
| GO:0009612 | 0.00008 | 3.06514 | 6 | 18 | 173 | response to mechanical stimulus |
| GO:0035107 | 0.00008 | 3.06514 | 6 | 18 | 173 | appendage morphogenesis |
| GO:0035108 | 0.00008 | 3.06514 | 6 | 18 | 173 | limb morphogenesis |
| GO:0042551 | 0.00008 | 5.76200 | 2 | 9 | 50 | neuron maturation |
| GO:0032970 | 0.00008 | 2.28822 | 14 | 30 | 378 | regulation of actin filament-based process |
| GO:0034645 | 0.00008 | 1.39201 | 146 | 188 | 3933 | cellular macromolecule biosynthetic process |
| GO:0006464 | 0.00008 | 1.41600 | 126 | 166 | 3400 | cellular protein modification process |
| GO:0036211 | 0.00008 | 1.41600 | 126 | 166 | 3400 | protein modification process |
| GO:0003433 | 0.00008 | 10.47494 | 1 | 6 | 21 | chondrocyte development involved in endochondral bone morphogenesis |
| GO:0010468 | 0.00009 | 1.39653 | 139 | 181 | 3768 | regulation of gene expression |
| GO:0060317 | 0.00009 | 7.97655 | 1 | 7 | 30 | cardiac epithelial to mesenchymal transition |
| GO:1902533 | 0.00009 | 1.74706 | 37 | 61 | 998 | positive regulation of intracellular signal transduction |
| GO:0060341 | 0.00009 | 1.77310 | 35 | 58 | 935 | regulation of cellular localization |
| GO:0045923 | 0.00009 | 6.55722 | 1 | 8 | 40 | positive regulation of fatty acid metabolic process |
| GO:0007163 | 0.00009 | 2.82557 | 8 | 20 | 207 | establishment or maintenance of cell polarity |
| GO:0060041 | 0.00010 | 3.13575 | 6 | 17 | 160 | retina development in camera-type eye |
| GO:0009880 | 0.00010 | 4.95583 | 2 | 10 | 63 | embryonic pattern specification |
| GO:0010676 | 0.00010 | 4.95583 | 2 | 10 | 63 | positive regulation of cellular carbohydrate metabolic process |
| GO:2000756 | 0.00010 | 4.95583 | 2 | 10 | 63 | regulation of peptidyl-lysine acetylation |
| GO:0042136 | 0.00010 | 3.84397 | 4 | 13 | 102 | neurotransmitter biosynthetic process |
| GO:0071371 | 0.00010 | 14.53541 | 1 | 5 | 14 | cellular response to gonadotropin stimulus |
| GO:0055074 | 0.00010 | 2.10557 | 18 | 35 | 477 | calcium ion homeostasis |
| GO:0002573 | 0.00010 | 2.79541 | 8 | 20 | 209 | myeloid leukocyte differentiation |
| GO:0048639 | 0.00010 | 2.79541 | 8 | 20 | 209 | positive regulation of developmental growth |
| GO:0022612 | 0.00010 | 3.24448 | 5 | 16 | 146 | gland morphogenesis |
| GO:0046890 | 0.00011 | 3.09222 | 6 | 17 | 162 | regulation of lipid biosynthetic process |
| GO:0003190 | 0.00012 | 26.13902 | 0 | 4 | 8 | atrioventricular valve formation |
| GO:0060907 | 0.00012 | 26.13902 | 0 | 4 | 8 | positive regulation of macrophage cytokine production |
| GO:0046889 | 0.00012 | 4.04590 | 3 | 12 | 90 | positive regulation of lipid biosynthetic process |
| GO:1901700 | 0.00012 | 1.58273 | 58 | 86 | 1554 | response to oxygen-containing compound |
| GO:0043066 | 0.00012 | 1.75229 | 35 | 58 | 945 | negative regulation of apoptotic process |
| GO:0061180 | 0.00012 | 4.38025 | 3 | 11 | 77 | mammary gland epithelium development |
| GO:0051338 | 0.00012 | 1.81095 | 30 | 52 | 820 | regulation of transferase activity |
| GO:0048593 | 0.00012 | 3.34886 | 5 | 15 | 133 | camera-type eye morphogenesis |
| GO:0001934 | 0.00013 | 1.73170 | 37 | 60 | 989 | positive regulation of protein phosphorylation |
| GO:0048562 | 0.00013 | 2.38290 | 12 | 26 | 315 | embryonic organ morphogenesis |
| GO:0048546 | 0.00013 | 5.36842 | 2 | 9 | 53 | digestive tract morphogenesis |
| GO:0055117 | 0.00013 | 4.77519 | 2 | 10 | 65 | regulation of cardiac muscle contraction |
| GO:0042493 | 0.00013 | 1.77385 | 33 | 55 | 885 | response to drug |
| GO:0044087 | 0.00013 | 1.75284 | 34 | 57 | 928 | regulation of cellular component biogenesis |
| GO:0042471 | 0.00013 | 3.32057 | 5 | 15 | 134 | ear morphogenesis |
| GO:0090190 | 0.00015 | 9.24177 | 1 | 6 | 23 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0003188 | 0.00015 | 13.08129 | 1 | 5 | 15 | heart valve formation |
| GO:0034698 | 0.00015 | 13.08129 | 1 | 5 | 15 | response to gonadotropin |
| GO:0048715 | 0.00015 | 13.08129 | 1 | 5 | 15 | negative regulation of oligodendrocyte differentiation |
| GO:0061430 | 0.00015 | 13.08129 | 1 | 5 | 15 | bone trabecula morphogenesis |
| GO:0071404 | 0.00015 | 13.08129 | 1 | 5 | 15 | cellular response to low-density lipoprotein particle stimulus |
| GO:1901213 | 0.00015 | 13.08129 | 1 | 5 | 15 | regulation of transcription from RNA polymerase II promoter involved in heart development |
| GO:0003208 | 0.00015 | 4.25104 | 3 | 11 | 79 | cardiac ventricle morphogenesis |
| GO:0006942 | 0.00015 | 4.25104 | 3 | 11 | 79 | regulation of striated muscle contraction |
| GO:0043279 | 0.00015 | 4.25104 | 3 | 11 | 79 | response to alkaloid |
| GO:0007420 | 0.00015 | 1.92296 | 23 | 42 | 624 | brain development |
| GO:0032102 | 0.00015 | 2.34994 | 12 | 26 | 319 | negative regulation of response to external stimulus |
| GO:0005996 | 0.00016 | 2.56192 | 9 | 22 | 249 | monosaccharide metabolic process |
| GO:0007369 | 0.00016 | 2.98848 | 6 | 17 | 167 | gastrulation |
| GO:0098657 | 0.00017 | 1.78447 | 31 | 52 | 831 | import into cell |
| GO:0060688 | 0.00017 | 4.60722 | 2 | 10 | 67 | regulation of morphogenesis of a branching structure |
| GO:0071560 | 0.00017 | 2.77072 | 7 | 19 | 200 | cellular response to transforming growth factor beta stimulus |
| GO:0048841 | 0.00017 | 7.05523 | 1 | 7 | 33 | regulation of axon extension involved in axon guidance |
| GO:0043412 | 0.00017 | 1.38539 | 132 | 171 | 3571 | macromolecule modification |
| GO:0035270 | 0.00017 | 3.23848 | 5 | 15 | 137 | endocrine system development |
| GO:0001890 | 0.00017 | 2.96855 | 6 | 17 | 168 | placenta development |
| GO:0099173 | 0.00017 | 2.86062 | 7 | 18 | 184 | postsynapse organization |
| GO:0034764 | 0.00017 | 2.68093 | 8 | 20 | 217 | positive regulation of transmembrane transport |
| GO:0060021 | 0.00018 | 3.84785 | 3 | 12 | 94 | roof of mouth development |
| GO:0031345 | 0.00018 | 2.75537 | 7 | 19 | 201 | negative regulation of cell projection organization |
| GO:0050770 | 0.00018 | 2.75537 | 7 | 19 | 201 | regulation of axonogenesis |
| GO:0043069 | 0.00019 | 1.71996 | 36 | 58 | 961 | negative regulation of programmed cell death |
| GO:0034765 | 0.00019 | 2.08628 | 17 | 33 | 453 | regulation of ion transmembrane transport |
| GO:1903532 | 0.00019 | 2.08628 | 17 | 33 | 453 | positive regulation of secretion by cell |
| GO:0006066 | 0.00019 | 2.41410 | 11 | 24 | 287 | alcohol metabolic process |
| GO:1902652 | 0.00019 | 3.38105 | 5 | 14 | 123 | secondary alcohol metabolic process |
| GO:1903670 | 0.00019 | 4.52759 | 3 | 10 | 68 | regulation of sprouting angiogenesis |
| GO:0033688 | 0.00019 | 8.72795 | 1 | 6 | 24 | regulation of osteoblast proliferation |
| GO:0042474 | 0.00019 | 8.72795 | 1 | 6 | 24 | middle ear morphogenesis |
| GO:0048799 | 0.00019 | 8.72795 | 1 | 6 | 24 | animal organ maturation |
| GO:0002683 | 0.00019 | 2.08123 | 17 | 33 | 454 | negative regulation of immune system process |
| GO:0019853 | 0.00020 | 78.33606 | 0 | 3 | 4 | L-ascorbic acid biosynthetic process |
| GO:0090100 | 0.00020 | 3.56256 | 4 | 13 | 109 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0043549 | 0.00020 | 1.83953 | 26 | 46 | 713 | regulation of kinase activity |
| GO:0060028 | 0.00020 | 20.91028 | 0 | 4 | 9 | convergent extension involved in axis elongation |
| GO:0071372 | 0.00020 | 20.91028 | 0 | 4 | 9 | cellular response to follicle-stimulating hormone stimulus |
| GO:0090269 | 0.00020 | 20.91028 | 0 | 4 | 9 | fibroblast growth factor production |
| GO:0090270 | 0.00020 | 20.91028 | 0 | 4 | 9 | regulation of fibroblast growth factor production |
| GO:0010811 | 0.00020 | 3.35016 | 5 | 14 | 124 | positive regulation of cell-substrate adhesion |
| GO:1902903 | 0.00021 | 2.26306 | 13 | 27 | 343 | regulation of supramolecular fiber organization |
| GO:0003209 | 0.00021 | 6.79363 | 1 | 7 | 34 | cardiac atrium morphogenesis |
| GO:0043270 | 0.00021 | 2.34605 | 11 | 25 | 307 | positive regulation of ion transport |
| GO:0045785 | 0.00021 | 2.15594 | 15 | 30 | 399 | positive regulation of cell adhesion |
| GO:0016051 | 0.00021 | 2.80946 | 7 | 18 | 187 | carbohydrate biosynthetic process |
| GO:0001886 | 0.00021 | 11.89155 | 1 | 5 | 16 | endothelial cell morphogenesis |
| GO:0003414 | 0.00021 | 11.89155 | 1 | 5 | 16 | chondrocyte morphogenesis involved in endochondral bone morphogenesis |
| GO:0003429 | 0.00021 | 11.89155 | 1 | 5 | 16 | growth plate cartilage chondrocyte morphogenesis |
| GO:0060026 | 0.00021 | 11.89155 | 1 | 5 | 16 | convergent extension |
| GO:0090171 | 0.00021 | 11.89155 | 1 | 5 | 16 | chondrocyte morphogenesis |
| GO:0098771 | 0.00022 | 1.81990 | 27 | 47 | 736 | inorganic ion homeostasis |
| GO:0070169 | 0.00022 | 5.66984 | 2 | 8 | 45 | positive regulation of biomineral tissue development |
| GO:0051336 | 0.00022 | 1.70813 | 36 | 58 | 967 | regulation of hydrolase activity |
| GO:0042692 | 0.00023 | 2.17750 | 14 | 29 | 382 | muscle cell differentiation |
| GO:0098900 | 0.00023 | 4.92017 | 2 | 9 | 57 | regulation of action potential |
| GO:0071559 | 0.00023 | 2.69563 | 8 | 19 | 205 | response to transforming growth factor beta |
| GO:0030903 | 0.00024 | 8.26821 | 1 | 6 | 25 | notochord development |
| GO:0006874 | 0.00025 | 2.05142 | 17 | 33 | 460 | cellular calcium ion homeostasis |
| GO:0060047 | 0.00025 | 2.68110 | 8 | 19 | 206 | heart contraction |
| GO:0051493 | 0.00025 | 1.98058 | 19 | 36 | 519 | regulation of cytoskeleton organization |
| GO:0007157 | 0.00025 | 5.52039 | 2 | 8 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0014015 | 0.00026 | 3.95898 | 3 | 11 | 84 | positive regulation of gliogenesis |
| GO:0021782 | 0.00027 | 3.66822 | 4 | 12 | 98 | glial cell development |
| GO:0110110 | 0.00027 | 3.66822 | 4 | 12 | 98 | positive regulation of animal organ morphogenesis |
| GO:0006816 | 0.00027 | 2.12087 | 15 | 30 | 405 | calcium ion transport |
| GO:0030326 | 0.00028 | 3.08585 | 5 | 15 | 143 | embryonic limb morphogenesis |
| GO:0035113 | 0.00028 | 3.08585 | 5 | 15 | 143 | embryonic appendage morphogenesis |
| GO:0010243 | 0.00029 | 1.74045 | 31 | 52 | 850 | response to organonitrogen compound |
| GO:0003180 | 0.00029 | 10.90010 | 1 | 5 | 17 | aortic valve morphogenesis |
| GO:0035988 | 0.00029 | 10.90010 | 1 | 5 | 17 | chondrocyte proliferation |
| GO:0040015 | 0.00029 | 10.90010 | 1 | 5 | 17 | negative regulation of multicellular organism growth |
| GO:0048875 | 0.00029 | 10.90010 | 1 | 5 | 17 | chemical homeostasis within a tissue |
| GO:0060644 | 0.00029 | 10.90010 | 1 | 5 | 17 | mammary gland epithelial cell differentiation |
| GO:1901863 | 0.00029 | 3.90531 | 3 | 11 | 85 | positive regulation of muscle tissue development |
| GO:0042310 | 0.00029 | 3.62589 | 4 | 12 | 99 | vasoconstriction |
| GO:1902106 | 0.00029 | 3.62589 | 4 | 12 | 99 | negative regulation of leukocyte differentiation |
| GO:0048015 | 0.00030 | 3.06179 | 5 | 15 | 144 | phosphatidylinositol-mediated signaling |
| GO:0001702 | 0.00030 | 6.32453 | 1 | 7 | 36 | gastrulation with mouth forming second |
| GO:0045197 | 0.00030 | 6.32453 | 1 | 7 | 36 | establishment or maintenance of epithelial cell apical/basal polarity |
| GO:0046326 | 0.00030 | 6.32453 | 1 | 7 | 36 | positive regulation of glucose import |
| GO:0046470 | 0.00030 | 6.32453 | 1 | 7 | 36 | phosphatidylcholine metabolic process |
| GO:0048710 | 0.00030 | 6.32453 | 1 | 7 | 36 | regulation of astrocyte differentiation |
| GO:0060045 | 0.00031 | 7.85445 | 1 | 6 | 26 | positive regulation of cardiac muscle cell proliferation |
| GO:0060219 | 0.00031 | 7.85445 | 1 | 6 | 26 | camera-type eye photoreceptor cell differentiation |
| GO:0090189 | 0.00031 | 7.85445 | 1 | 6 | 26 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0060548 | 0.00031 | 1.65237 | 39 | 62 | 1067 | negative regulation of cell death |
| GO:0010675 | 0.00032 | 3.03810 | 5 | 15 | 145 | regulation of cellular carbohydrate metabolic process |
| GO:0032354 | 0.00033 | 17.42445 | 0 | 4 | 10 | response to follicle-stimulating hormone |
| GO:0060038 | 0.00034 | 4.63012 | 2 | 9 | 60 | cardiac muscle cell proliferation |
| GO:0046513 | 0.00035 | 5.24390 | 2 | 8 | 48 | ceramide biosynthetic process |
| GO:0060043 | 0.00035 | 5.24390 | 2 | 8 | 48 | regulation of cardiac muscle cell proliferation |
| GO:0043170 | 0.00035 | 1.27567 | 309 | 357 | 8357 | macromolecule metabolic process |
| GO:0055017 | 0.00035 | 3.54410 | 4 | 12 | 101 | cardiac muscle tissue growth |
| GO:0072507 | 0.00036 | 1.96055 | 19 | 35 | 509 | divalent inorganic cation homeostasis |
| GO:0007215 | 0.00036 | 3.80220 | 3 | 11 | 87 | glutamate receptor signaling pathway |
| GO:0030501 | 0.00036 | 6.11344 | 1 | 7 | 37 | positive regulation of bone mineralization |
| GO:0035850 | 0.00036 | 6.11344 | 1 | 7 | 37 | epithelial cell differentiation involved in kidney development |
| GO:0071514 | 0.00036 | 6.11344 | 1 | 7 | 37 | genetic imprinting |
| GO:0086065 | 0.00036 | 6.11344 | 1 | 7 | 37 | cell communication involved in cardiac conduction |
| GO:0019538 | 0.00036 | 1.31176 | 195 | 237 | 5268 | protein metabolic process |
| GO:0050878 | 0.00036 | 2.21213 | 12 | 26 | 337 | regulation of body fluid levels |
| GO:0048017 | 0.00037 | 2.99180 | 5 | 15 | 147 | inositol lipid-mediated signaling |
| GO:0008217 | 0.00038 | 2.66632 | 7 | 18 | 196 | regulation of blood pressure |
| GO:0006898 | 0.00038 | 2.58354 | 8 | 19 | 213 | receptor-mediated endocytosis |
| GO:0003338 | 0.00038 | 7.48009 | 1 | 6 | 27 | metanephros morphogenesis |
| GO:0033687 | 0.00038 | 7.48009 | 1 | 6 | 27 | osteoblast proliferation |
| GO:0061311 | 0.00038 | 7.48009 | 1 | 6 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0010629 | 0.00038 | 1.49906 | 65 | 92 | 1748 | negative regulation of gene expression |
| GO:0006809 | 0.00038 | 4.10202 | 3 | 10 | 74 | nitric oxide biosynthetic process |
| GO:0030148 | 0.00038 | 4.10202 | 3 | 10 | 74 | sphingolipid biosynthetic process |
| GO:1901983 | 0.00038 | 4.10202 | 3 | 10 | 74 | regulation of protein acetylation |
| GO:0046486 | 0.00039 | 2.24135 | 12 | 25 | 320 | glycerolipid metabolic process |
| GO:0032535 | 0.00039 | 2.09892 | 15 | 29 | 395 | regulation of cellular component size |
| GO:0010002 | 0.00039 | 10.06118 | 1 | 5 | 18 | cardioblast differentiation |
| GO:0048712 | 0.00039 | 10.06118 | 1 | 5 | 18 | negative regulation of astrocyte differentiation |
| GO:0032870 | 0.00040 | 1.94796 | 19 | 35 | 512 | cellular response to hormone stimulus |
| GO:0003015 | 0.00040 | 2.57018 | 8 | 19 | 214 | heart process |
| GO:0022408 | 0.00042 | 2.73164 | 7 | 17 | 181 | negative regulation of cell-cell adhesion |
| GO:0043085 | 0.00042 | 1.64470 | 38 | 60 | 1036 | positive regulation of catalytic activity |
| GO:0048675 | 0.00042 | 3.09554 | 5 | 14 | 133 | axon extension |
| GO:1904018 | 0.00043 | 2.63646 | 7 | 18 | 198 | positive regulation of vasculature development |
| GO:0003230 | 0.00043 | 5.91597 | 1 | 7 | 38 | cardiac atrium development |
| GO:0086004 | 0.00043 | 5.91597 | 1 | 7 | 38 | regulation of cardiac muscle cell contraction |
| GO:1905332 | 0.00043 | 5.91597 | 1 | 7 | 38 | positive regulation of morphogenesis of an epithelium |
| GO:0001738 | 0.00043 | 4.03873 | 3 | 10 | 75 | morphogenesis of a polarized epithelium |
| GO:0010565 | 0.00043 | 3.25588 | 4 | 13 | 118 | regulation of cellular ketone metabolic process |
| GO:0071248 | 0.00043 | 2.94688 | 6 | 15 | 149 | cellular response to metal ion |
| GO:0046324 | 0.00044 | 4.45500 | 2 | 9 | 62 | regulation of glucose import |
| GO:0060393 | 0.00044 | 4.45500 | 2 | 9 | 62 | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0007548 | 0.00044 | 2.31075 | 11 | 23 | 286 | sex differentiation |
| GO:0008104 | 0.00044 | 1.41571 | 93 | 124 | 2504 | protein localization |
| GO:0060428 | 0.00046 | 4.99374 | 2 | 8 | 50 | lung epithelium development |
| GO:0046661 | 0.00046 | 2.92492 | 6 | 15 | 150 | male sex differentiation |
| GO:0008203 | 0.00047 | 3.22502 | 4 | 13 | 119 | cholesterol metabolic process |
| GO:0022607 | 0.00047 | 1.39779 | 101 | 133 | 2723 | cellular component assembly |
| GO:0030224 | 0.00047 | 7.13977 | 1 | 6 | 28 | monocyte differentiation |
| GO:0098698 | 0.00047 | 7.13977 | 1 | 6 | 28 | postsynaptic specialization assembly |
| GO:1903131 | 0.00047 | 7.13977 | 1 | 6 | 28 | mononuclear cell differentiation |
| GO:0003192 | 0.00048 | 39.16628 | 0 | 3 | 5 | mitral valve formation |
| GO:0008295 | 0.00048 | 39.16628 | 0 | 3 | 5 | spermidine biosynthetic process |
| GO:0006873 | 0.00049 | 1.82338 | 24 | 41 | 639 | cellular ion homeostasis |
| GO:0055082 | 0.00049 | 1.73586 | 29 | 48 | 785 | cellular chemical homeostasis |
| GO:0010563 | 0.00049 | 1.90397 | 20 | 36 | 538 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00049 | 1.90397 | 20 | 36 | 538 | negative regulation of phosphate metabolic process |
| GO:0022407 | 0.00050 | 2.09386 | 14 | 28 | 382 | regulation of cell-cell adhesion |
| GO:0097756 | 0.00051 | 3.39105 | 4 | 12 | 105 | negative regulation of blood vessel diameter |
| GO:0002043 | 0.00052 | 9.34211 | 1 | 5 | 19 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0003215 | 0.00052 | 9.34211 | 1 | 5 | 19 | cardiac right ventricle morphogenesis |
| GO:0098840 | 0.00052 | 9.34211 | 1 | 5 | 19 | protein transport along microtubule |
| GO:0099118 | 0.00052 | 9.34211 | 1 | 5 | 19 | microtubule-based protein transport |
| GO:0001974 | 0.00053 | 4.87739 | 2 | 8 | 51 | blood vessel remodeling |
| GO:0046209 | 0.00053 | 3.91782 | 3 | 10 | 77 | nitric oxide metabolic process |
| GO:0002027 | 0.00053 | 3.61144 | 3 | 11 | 91 | regulation of heart rate |
| GO:0006694 | 0.00053 | 2.88196 | 6 | 15 | 152 | steroid biosynthetic process |
| GO:0032412 | 0.00055 | 2.43164 | 9 | 20 | 237 | regulation of ion transmembrane transporter activity |
| GO:0097193 | 0.00056 | 2.26713 | 11 | 23 | 291 | intrinsic apoptotic signaling pathway |
| GO:0032409 | 0.00056 | 2.36874 | 9 | 21 | 255 | regulation of transporter activity |
| GO:0051129 | 0.00057 | 1.75659 | 27 | 45 | 727 | negative regulation of cellular component organization |
| GO:0061037 | 0.00058 | 6.82904 | 1 | 6 | 29 | negative regulation of cartilage development |
| GO:0009725 | 0.00058 | 1.77916 | 25 | 43 | 686 | response to hormone |
| GO:0001704 | 0.00059 | 3.56669 | 3 | 11 | 92 | formation of primary germ layer |
| GO:0060976 | 0.00059 | 3.86003 | 3 | 10 | 78 | coronary vasculature development |
| GO:1900077 | 0.00059 | 5.55693 | 1 | 7 | 40 | negative regulation of cellular response to insulin stimulus |
| GO:0072503 | 0.00060 | 1.94013 | 18 | 33 | 484 | cellular divalent inorganic cation homeostasis |
| GO:0042326 | 0.00061 | 1.98398 | 16 | 31 | 445 | negative regulation of phosphorylation |
| GO:0060389 | 0.00062 | 4.21578 | 2 | 9 | 65 | pathway-restricted SMAD protein phosphorylation |
| GO:0042391 | 0.00065 | 2.00134 | 16 | 30 | 427 | regulation of membrane potential |
| GO:0030516 | 0.00066 | 3.28464 | 4 | 12 | 108 | regulation of axon extension |
| GO:0003176 | 0.00067 | 8.71891 | 1 | 5 | 20 | aortic valve development |
| GO:0010842 | 0.00067 | 8.71891 | 1 | 5 | 20 | retina layer formation |
| GO:0070977 | 0.00067 | 8.71891 | 1 | 5 | 20 | bone maturation |
| GO:0072087 | 0.00067 | 8.71891 | 1 | 5 | 20 | renal vesicle development |
| GO:0072148 | 0.00067 | 8.71891 | 1 | 5 | 20 | epithelial cell fate commitment |
| GO:0048592 | 0.00068 | 2.70057 | 6 | 16 | 172 | eye morphogenesis |
| GO:0043086 | 0.00069 | 1.77543 | 25 | 42 | 671 | negative regulation of catalytic activity |
| GO:0030850 | 0.00069 | 4.66020 | 2 | 8 | 53 | prostate gland development |
| GO:0048662 | 0.00069 | 4.66020 | 2 | 8 | 53 | negative regulation of smooth muscle cell proliferation |
| GO:0055010 | 0.00069 | 4.66020 | 2 | 8 | 53 | ventricular cardiac muscle tissue morphogenesis |
| GO:0001937 | 0.00069 | 5.39325 | 2 | 7 | 41 | negative regulation of endothelial cell proliferation |
| GO:0055023 | 0.00069 | 5.39325 | 2 | 7 | 41 | positive regulation of cardiac muscle tissue growth |
| GO:0099084 | 0.00069 | 5.39325 | 2 | 7 | 41 | postsynaptic specialization organization |
| GO:0110111 | 0.00069 | 5.39325 | 2 | 7 | 41 | negative regulation of animal organ morphogenesis |
| GO:0098655 | 0.00071 | 1.77253 | 25 | 42 | 672 | cation transmembrane transport |
| GO:0007156 | 0.00071 | 3.25063 | 4 | 12 | 109 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:2000177 | 0.00071 | 3.25063 | 4 | 12 | 109 | regulation of neural precursor cell proliferation |
| GO:0060767 | 0.00073 | 13.06717 | 0 | 4 | 12 | epithelial cell proliferation involved in prostate gland development |
| GO:0046879 | 0.00073 | 2.10236 | 13 | 26 | 353 | hormone secretion |
| GO:1901652 | 0.00073 | 2.10236 | 13 | 26 | 353 | response to peptide |
| GO:0045944 | 0.00075 | 1.56747 | 44 | 66 | 1193 | positive regulation of transcription by RNA polymerase II |
| GO:0030099 | 0.00075 | 2.03541 | 15 | 28 | 392 | myeloid cell differentiation |
| GO:0051098 | 0.00075 | 2.03541 | 15 | 28 | 392 | regulation of binding |
| GO:0007224 | 0.00076 | 2.89950 | 5 | 14 | 141 | smoothened signaling pathway |
| GO:0060419 | 0.00077 | 3.21732 | 4 | 12 | 110 | heart growth |
| GO:0035065 | 0.00078 | 4.55869 | 2 | 8 | 54 | regulation of histone acetylation |
| GO:0055025 | 0.00078 | 4.55869 | 2 | 8 | 54 | positive regulation of cardiac muscle tissue development |
| GO:0070838 | 0.00079 | 1.95037 | 17 | 31 | 452 | divalent metal ion transport |
| GO:0008593 | 0.00080 | 3.69644 | 3 | 10 | 81 | regulation of Notch signaling pathway |
| GO:0010907 | 0.00081 | 5.23892 | 2 | 7 | 42 | positive regulation of glucose metabolic process |
| GO:0055065 | 0.00081 | 1.77159 | 24 | 41 | 656 | metal ion homeostasis |
| GO:1905952 | 0.00081 | 2.87672 | 5 | 14 | 142 | regulation of lipid localization |
| GO:0022898 | 0.00084 | 2.34434 | 9 | 20 | 245 | regulation of transmembrane transporter activity |
| GO:0043537 | 0.00084 | 6.28215 | 1 | 6 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0090162 | 0.00084 | 6.28215 | 1 | 6 | 31 | establishment of epithelial cell polarity |
| GO:0051641 | 0.00084 | 1.38931 | 93 | 123 | 2523 | cellular localization |
| GO:0072111 | 0.00085 | 8.17361 | 1 | 5 | 21 | cell proliferation involved in kidney development |
| GO:0101023 | 0.00085 | 8.17361 | 1 | 5 | 21 | vascular endothelial cell proliferation |
| GO:1905562 | 0.00085 | 8.17361 | 1 | 5 | 21 | regulation of vascular endothelial cell proliferation |
| GO:0050920 | 0.00085 | 2.47035 | 8 | 18 | 210 | regulation of chemotaxis |
| GO:0009952 | 0.00087 | 2.39650 | 8 | 19 | 228 | anterior/posterior pattern specification |
| GO:0019217 | 0.00088 | 3.64493 | 3 | 10 | 82 | regulation of fatty acid metabolic process |
| GO:2001057 | 0.00088 | 3.64493 | 3 | 10 | 82 | reactive nitrogen species metabolic process |
| GO:0072511 | 0.00088 | 1.93631 | 17 | 31 | 455 | divalent inorganic cation transport |
| GO:0042472 | 0.00091 | 3.15269 | 4 | 12 | 112 | inner ear morphogenesis |
| GO:0048644 | 0.00092 | 3.35858 | 4 | 11 | 97 | muscle organ morphogenesis |
| GO:0003402 | 0.00093 | 26.10968 | 0 | 3 | 6 | planar cell polarity pathway involved in axis elongation |
| GO:0034638 | 0.00093 | 26.10968 | 0 | 3 | 6 | phosphatidylcholine catabolic process |
| GO:0060842 | 0.00093 | 26.10968 | 0 | 3 | 6 | arterial endothelial cell differentiation |
| GO:0061304 | 0.00093 | 26.10968 | 0 | 3 | 6 | retinal blood vessel morphogenesis |
| GO:0061312 | 0.00093 | 26.10968 | 0 | 3 | 6 | BMP signaling pathway involved in heart development |
| GO:0072602 | 0.00093 | 26.10968 | 0 | 3 | 6 | interleukin-4 secretion |
| GO:0098961 | 0.00093 | 26.10968 | 0 | 3 | 6 | dendritic transport of ribonucleoprotein complex |
| GO:0098963 | 0.00093 | 26.10968 | 0 | 3 | 6 | dendritic transport of messenger ribonucleoprotein complex |
| GO:1905563 | 0.00093 | 26.10968 | 0 | 3 | 6 | negative regulation of vascular endothelial cell proliferation |
| GO:0006695 | 0.00093 | 5.09317 | 2 | 7 | 43 | cholesterol biosynthetic process |
| GO:0050974 | 0.00093 | 5.09317 | 2 | 7 | 43 | detection of mechanical stimulus involved in sensory perception |
| GO:0051592 | 0.00094 | 2.97143 | 5 | 13 | 128 | response to calcium ion |
| GO:0010827 | 0.00097 | 3.59484 | 3 | 10 | 83 | regulation of glucose transmembrane transport |
| GO:0034103 | 0.00097 | 3.59484 | 3 | 10 | 83 | regulation of tissue remodeling |
| GO:0032101 | 0.00099 | 1.71545 | 27 | 44 | 726 | regulation of response to external stimulus |
| GO:0050772 | 0.00100 | 3.31982 | 4 | 11 | 98 | positive regulation of axonogenesis |
| GO:0055024 | 0.00100 | 3.31982 | 4 | 11 | 98 | regulation of cardiac muscle tissue development |
| GO:0042133 | 0.00100 | 2.81046 | 5 | 14 | 145 | neurotransmitter metabolic process |
| GO:0019637 | 0.00101 | 1.62954 | 34 | 53 | 920 | organophosphate metabolic process |
| GO:0006596 | 0.00102 | 11.61475 | 0 | 4 | 13 | polyamine biosynthetic process |
| GO:0010935 | 0.00102 | 11.61475 | 0 | 4 | 13 | regulation of macrophage cytokine production |
| GO:0060394 | 0.00102 | 11.61475 | 0 | 4 | 13 | negative regulation of pathway-restricted SMAD protein phosphorylation |
| GO:2000052 | 0.00102 | 11.61475 | 0 | 4 | 13 | positive regulation of non-canonical Wnt signaling pathway |
| GO:0009914 | 0.00105 | 2.04521 | 13 | 26 | 362 | hormone transport |
| GO:0030258 | 0.00106 | 2.41949 | 8 | 18 | 214 | lipid modification |
| GO:0045844 | 0.00106 | 3.54610 | 3 | 10 | 84 | positive regulation of striated muscle tissue development |
| GO:0048636 | 0.00106 | 3.54610 | 3 | 10 | 84 | positive regulation of muscle organ development |
| GO:0031649 | 0.00107 | 7.69247 | 1 | 5 | 22 | heat generation |
| GO:0060749 | 0.00107 | 7.69247 | 1 | 5 | 22 | mammary gland alveolus development |
| GO:0061377 | 0.00107 | 7.69247 | 1 | 5 | 22 | mammary gland lobule development |
| GO:0072273 | 0.00107 | 7.69247 | 1 | 5 | 22 | metanephric nephron morphogenesis |
| GO:0035088 | 0.00108 | 4.95529 | 2 | 7 | 44 | establishment or maintenance of apical/basal cell polarity |
| GO:0060421 | 0.00108 | 4.95529 | 2 | 7 | 44 | positive regulation of heart growth |
| GO:0061245 | 0.00108 | 4.95529 | 2 | 7 | 44 | establishment or maintenance of bipolar cell polarity |
| GO:1902653 | 0.00108 | 4.95529 | 2 | 7 | 44 | secondary alcohol biosynthetic process |
| GO:0098660 | 0.00115 | 1.74967 | 24 | 40 | 647 | inorganic ion transmembrane transport |
| GO:0051100 | 0.00117 | 2.64843 | 6 | 15 | 164 | negative regulation of binding |
| GO:0045137 | 0.00118 | 2.39484 | 8 | 18 | 216 | development of primary sexual characteristics |
| GO:0019218 | 0.00118 | 3.24493 | 4 | 11 | 100 | regulation of steroid metabolic process |
| GO:0086091 | 0.00119 | 5.81629 | 1 | 6 | 33 | regulation of heart rate by cardiac conduction |
| GO:2000758 | 0.00119 | 5.81629 | 1 | 6 | 33 | positive regulation of peptidyl-lysine acetylation |
| GO:0046323 | 0.00119 | 3.80677 | 3 | 9 | 71 | glucose import |
| GO:1990778 | 0.00121 | 2.09162 | 12 | 24 | 327 | protein localization to cell periphery |
| GO:0071526 | 0.00123 | 4.82467 | 2 | 7 | 45 | semaphorin-plexin signaling pathway |
| GO:1902667 | 0.00123 | 4.82467 | 2 | 7 | 45 | regulation of axon guidance |
| GO:1903115 | 0.00123 | 4.82467 | 2 | 7 | 45 | regulation of actin filament-based movement |
| GO:0010906 | 0.00124 | 3.03089 | 4 | 12 | 116 | regulation of glucose metabolic process |
| GO:0050730 | 0.00124 | 2.26303 | 9 | 20 | 253 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0018108 | 0.00125 | 2.12271 | 11 | 23 | 309 | peptidyl-tyrosine phosphorylation |
| GO:0061337 | 0.00127 | 4.19324 | 2 | 8 | 58 | cardiac conduction |
| GO:0023014 | 0.00127 | 1.65227 | 30 | 48 | 821 | signal transduction by protein phosphorylation |
| GO:0006112 | 0.00127 | 3.45248 | 3 | 10 | 86 | energy reserve metabolic process |
| GO:0007009 | 0.00127 | 3.45248 | 3 | 10 | 86 | plasma membrane organization |
| GO:0010717 | 0.00127 | 3.45248 | 3 | 10 | 86 | regulation of epithelial to mesenchymal transition |
| GO:0006875 | 0.00130 | 1.79414 | 21 | 36 | 568 | cellular metal ion homeostasis |
| GO:0015718 | 0.00130 | 2.72670 | 6 | 14 | 149 | monocarboxylic acid transport |
| GO:0050773 | 0.00132 | 2.52144 | 7 | 16 | 183 | regulation of dendrite development |
| GO:0048645 | 0.00132 | 3.74618 | 3 | 9 | 72 | animal organ formation |
| GO:0055094 | 0.00132 | 7.26478 | 1 | 5 | 23 | response to lipoprotein particle |
| GO:0046928 | 0.00134 | 2.84698 | 5 | 13 | 133 | regulation of neurotransmitter secretion |
| GO:0055123 | 0.00134 | 2.84698 | 5 | 13 | 133 | digestive system development |
| GO:0003252 | 0.00137 | Inf | 0 | 2 | 2 | negative regulation of cell proliferation involved in heart valve morphogenesis |
| GO:0042986 | 0.00137 | Inf | 0 | 2 | 2 | positive regulation of amyloid precursor protein biosynthetic process |
| GO:0060031 | 0.00137 | Inf | 0 | 2 | 2 | mediolateral intercalation |
| GO:0060775 | 0.00137 | Inf | 0 | 2 | 2 | planar cell polarity pathway involved in gastrula mediolateral intercalation |
| GO:0060995 | 0.00137 | Inf | 0 | 2 | 2 | cell-cell signaling involved in kidney development |
| GO:0061289 | 0.00137 | Inf | 0 | 2 | 2 | Wnt signaling pathway involved in kidney development |
| GO:0061290 | 0.00137 | Inf | 0 | 2 | 2 | canonical Wnt signaling pathway involved in metanephric kidney development |
| GO:0072204 | 0.00137 | Inf | 0 | 2 | 2 | cell-cell signaling involved in metanephros development |
| GO:0098964 | 0.00137 | Inf | 0 | 2 | 2 | anterograde dendritic transport of messenger ribonucleoprotein complex |
| GO:1904933 | 0.00137 | Inf | 0 | 2 | 2 | regulation of cell proliferation in midbrain |
| GO:2000575 | 0.00137 | Inf | 0 | 2 | 2 | negative regulation of microtubule motor activity |
| GO:0043393 | 0.00138 | 2.29663 | 9 | 19 | 237 | regulation of protein binding |
| GO:0045198 | 0.00139 | 10.45280 | 1 | 4 | 14 | establishment of epithelial cell apical/basal polarity |
| GO:0090136 | 0.00139 | 10.45280 | 1 | 4 | 14 | epithelial cell-cell adhesion |
| GO:2000095 | 0.00139 | 10.45280 | 1 | 4 | 14 | regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:0061053 | 0.00139 | 3.17333 | 4 | 11 | 102 | somite development |
| GO:0000165 | 0.00139 | 1.65349 | 30 | 47 | 803 | MAPK cascade |
| GO:0099068 | 0.00140 | 5.60831 | 1 | 6 | 34 | postsynapse assembly |
| GO:0010828 | 0.00141 | 4.70075 | 2 | 7 | 46 | positive regulation of glucose transmembrane transport |
| GO:0010812 | 0.00142 | 4.11083 | 2 | 8 | 59 | negative regulation of cell-substrate adhesion |
| GO:0048286 | 0.00142 | 4.11083 | 2 | 8 | 59 | lung alveolus development |
| GO:0018212 | 0.00142 | 2.10039 | 12 | 23 | 312 | peptidyl-tyrosine modification |
| GO:0042593 | 0.00143 | 2.23396 | 9 | 20 | 256 | glucose homeostasis |
| GO:0033500 | 0.00150 | 2.22443 | 10 | 20 | 257 | carbohydrate homeostasis |
| GO:0050807 | 0.00150 | 2.22443 | 10 | 20 | 257 | regulation of synapse organization |
| GO:1900006 | 0.00151 | 3.13869 | 4 | 11 | 103 | positive regulation of dendrite development |
| GO:1903825 | 0.00151 | 3.13869 | 4 | 11 | 103 | organic acid transmembrane transport |
| GO:1905039 | 0.00151 | 3.13869 | 4 | 11 | 103 | carboxylic acid transmembrane transport |
| GO:0009798 | 0.00152 | 3.36365 | 3 | 10 | 88 | axis specification |
| GO:0060998 | 0.00152 | 3.36365 | 3 | 10 | 88 | regulation of dendritic spine development |
| GO:0009410 | 0.00153 | 2.33533 | 8 | 18 | 221 | response to xenobiotic stimulus |
| GO:0055080 | 0.00153 | 1.68460 | 27 | 43 | 721 | cation homeostasis |
| GO:0006665 | 0.00154 | 2.94551 | 4 | 12 | 119 | sphingolipid metabolic process |
| GO:0007269 | 0.00156 | 2.47661 | 7 | 16 | 186 | neurotransmitter secretion |
| GO:0099643 | 0.00156 | 2.47661 | 7 | 16 | 186 | signal release from synapse |
| GO:0006941 | 0.00158 | 2.66706 | 6 | 14 | 152 | striated muscle contraction |
| GO:0003057 | 0.00158 | 19.58139 | 0 | 3 | 7 | regulation of the force of heart contraction by chemical signal |
| GO:0003186 | 0.00158 | 19.58139 | 0 | 3 | 7 | tricuspid valve morphogenesis |
| GO:0019852 | 0.00158 | 19.58139 | 0 | 3 | 7 | L-ascorbic acid metabolic process |
| GO:0035864 | 0.00158 | 19.58139 | 0 | 3 | 7 | response to potassium ion |
| GO:0035865 | 0.00158 | 19.58139 | 0 | 3 | 7 | cellular response to potassium ion |
| GO:0048842 | 0.00158 | 19.58139 | 0 | 3 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0060385 | 0.00158 | 19.58139 | 0 | 3 | 7 | axonogenesis involved in innervation |
| GO:0060676 | 0.00158 | 19.58139 | 0 | 3 | 7 | ureteric bud formation |
| GO:0072282 | 0.00158 | 19.58139 | 0 | 3 | 7 | metanephric nephron tubule morphogenesis |
| GO:0002521 | 0.00159 | 1.78689 | 21 | 35 | 554 | leukocyte differentiation |
| GO:0031400 | 0.00159 | 1.78689 | 21 | 35 | 554 | negative regulation of protein modification process |
| GO:0060999 | 0.00159 | 4.03160 | 2 | 8 | 60 | positive regulation of dendritic spine development |
| GO:0042445 | 0.00159 | 2.39318 | 8 | 17 | 204 | hormone metabolic process |
| GO:0030100 | 0.00160 | 2.16302 | 10 | 21 | 277 | regulation of endocytosis |
| GO:0055021 | 0.00160 | 3.63059 | 3 | 9 | 74 | regulation of cardiac muscle tissue growth |
| GO:0060563 | 0.00160 | 3.63059 | 3 | 9 | 74 | neuroepithelial cell differentiation |
| GO:0050890 | 0.00161 | 2.07853 | 12 | 23 | 315 | cognition |
| GO:0010575 | 0.00162 | 6.88212 | 1 | 5 | 24 | positive regulation of vascular endothelial growth factor production |
| GO:0055083 | 0.00163 | 5.41468 | 1 | 6 | 35 | monovalent inorganic anion homeostasis |
| GO:0051051 | 0.00164 | 1.81664 | 19 | 33 | 514 | negative regulation of transport |
| GO:0097190 | 0.00165 | 1.75166 | 22 | 37 | 597 | apoptotic signaling pathway |
| GO:0034641 | 0.00166 | 1.26505 | 201 | 238 | 5435 | cellular nitrogen compound metabolic process |
| GO:0034446 | 0.00166 | 3.32092 | 3 | 10 | 89 | substrate adhesion-dependent cell spreading |
| GO:0051937 | 0.00166 | 3.32092 | 3 | 10 | 89 | catecholamine transport |
| GO:0060415 | 0.00166 | 3.32092 | 3 | 10 | 89 | muscle tissue morphogenesis |
| GO:0014065 | 0.00166 | 2.91811 | 4 | 12 | 120 | phosphatidylinositol 3-kinase signaling |
| GO:0048565 | 0.00166 | 2.91811 | 4 | 12 | 120 | digestive tract development |
| GO:0060048 | 0.00166 | 2.91811 | 4 | 12 | 120 | cardiac muscle contraction |
| GO:0090087 | 0.00166 | 1.67695 | 27 | 43 | 724 | regulation of peptide transport |
| GO:0002064 | 0.00167 | 2.25484 | 9 | 19 | 241 | epithelial cell development |
| GO:0060538 | 0.00168 | 2.38035 | 8 | 17 | 205 | skeletal muscle organ development |
| GO:0043408 | 0.00169 | 1.66504 | 28 | 44 | 746 | regulation of MAPK cascade |
| GO:0015672 | 0.00170 | 1.87159 | 17 | 30 | 454 | monovalent inorganic cation transport |
| GO:0048661 | 0.00176 | 3.07164 | 4 | 11 | 105 | positive regulation of smooth muscle cell proliferation |
| GO:0014855 | 0.00176 | 3.57542 | 3 | 9 | 75 | striated muscle cell proliferation |
| GO:0010171 | 0.00177 | 3.95535 | 2 | 8 | 61 | body morphogenesis |
| GO:0030858 | 0.00177 | 3.95535 | 2 | 8 | 61 | positive regulation of epithelial cell differentiation |
| GO:0070059 | 0.00177 | 3.95535 | 2 | 8 | 61 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:0014066 | 0.00181 | 3.27926 | 3 | 10 | 90 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0030097 | 0.00181 | 1.59671 | 33 | 51 | 901 | hemopoiesis |
| GO:0006897 | 0.00181 | 1.67914 | 26 | 42 | 706 | endocytosis |
| GO:0002762 | 0.00182 | 4.47105 | 2 | 7 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:0006684 | 0.00183 | 9.50212 | 1 | 4 | 15 | sphingomyelin metabolic process |
| GO:0010878 | 0.00183 | 9.50212 | 1 | 4 | 15 | cholesterol storage |
| GO:0010934 | 0.00183 | 9.50212 | 1 | 4 | 15 | macrophage cytokine production |
| GO:0031650 | 0.00183 | 9.50212 | 1 | 4 | 15 | regulation of heat generation |
| GO:0043129 | 0.00183 | 9.50212 | 1 | 4 | 15 | surfactant homeostasis |
| GO:0050872 | 0.00183 | 9.50212 | 1 | 4 | 15 | white fat cell differentiation |
| GO:0055062 | 0.00183 | 9.50212 | 1 | 4 | 15 | phosphate ion homeostasis |
| GO:0072505 | 0.00183 | 9.50212 | 1 | 4 | 15 | divalent inorganic anion homeostasis |
| GO:0072506 | 0.00183 | 9.50212 | 1 | 4 | 15 | trivalent inorganic anion homeostasis |
| GO:0060071 | 0.00190 | 5.23396 | 1 | 6 | 36 | Wnt signaling pathway, planar cell polarity pathway |
| GO:0002761 | 0.00191 | 2.86479 | 5 | 12 | 122 | regulation of myeloid leukocyte differentiation |
| GO:0005977 | 0.00193 | 3.52190 | 3 | 9 | 76 | glycogen metabolic process |
| GO:0006073 | 0.00193 | 3.52190 | 3 | 9 | 76 | cellular glucan metabolic process |
| GO:0044042 | 0.00193 | 3.52190 | 3 | 9 | 76 | glucan metabolic process |
| GO:0055008 | 0.00193 | 3.52190 | 3 | 9 | 76 | cardiac muscle tissue morphogenesis |
| GO:0071277 | 0.00193 | 3.52190 | 3 | 9 | 76 | cellular response to calcium ion |
| GO:0097479 | 0.00194 | 2.41924 | 7 | 16 | 190 | synaptic vesicle localization |
| GO:0014909 | 0.00196 | 3.23863 | 3 | 10 | 91 | smooth muscle cell migration |
| GO:0035904 | 0.00196 | 3.88193 | 2 | 8 | 62 | aorta development |
| GO:0050996 | 0.00197 | 6.53772 | 1 | 5 | 25 | positive regulation of lipid catabolic process |
| GO:0071402 | 0.00197 | 6.53772 | 1 | 5 | 25 | cellular response to lipoprotein particle stimulus |
| GO:1903671 | 0.00197 | 6.53772 | 1 | 5 | 25 | negative regulation of sprouting angiogenesis |
| GO:0030003 | 0.00202 | 1.71621 | 23 | 38 | 625 | cellular cation homeostasis |
| GO:0061387 | 0.00205 | 2.83886 | 5 | 12 | 123 | regulation of extent of cell growth |
| GO:0050803 | 0.00206 | 2.15993 | 10 | 20 | 264 | regulation of synapse structure or activity |
| GO:0051347 | 0.00206 | 1.77216 | 20 | 34 | 542 | positive regulation of transferase activity |
| GO:0032271 | 0.00206 | 2.33034 | 8 | 17 | 209 | regulation of protein polymerization |
| GO:0015980 | 0.00211 | 2.20468 | 9 | 19 | 246 | energy derivation by oxidation of organic compounds |
| GO:0019725 | 0.00213 | 1.58316 | 34 | 51 | 908 | cellular homeostasis |
| GO:0008544 | 0.00214 | 2.02923 | 12 | 23 | 322 | epidermis development |
| GO:0050866 | 0.00216 | 2.39153 | 7 | 16 | 192 | negative regulation of cell activation |
| GO:0045859 | 0.00218 | 1.69524 | 24 | 39 | 649 | regulation of protein kinase activity |
| GO:0006636 | 0.00220 | 5.06489 | 1 | 6 | 37 | unsaturated fatty acid biosynthetic process |
| GO:1901653 | 0.00225 | 2.14218 | 10 | 20 | 266 | cellular response to peptide |
| GO:0010634 | 0.00226 | 2.66808 | 5 | 13 | 141 | positive regulation of epithelial cell migration |
| GO:0071456 | 0.00231 | 3.16031 | 3 | 10 | 93 | cellular response to hypoxia |
| GO:1904062 | 0.00231 | 2.01556 | 12 | 23 | 324 | regulation of cation transmembrane transport |
| GO:0015918 | 0.00232 | 3.41951 | 3 | 9 | 78 | sterol transport |
| GO:0030301 | 0.00232 | 3.41951 | 3 | 9 | 78 | cholesterol transport |
| GO:0045927 | 0.00234 | 2.04977 | 11 | 22 | 305 | positive regulation of growth |
| GO:0031295 | 0.00236 | 6.22612 | 1 | 5 | 26 | T cell costimulation |
| GO:0098901 | 0.00236 | 6.22612 | 1 | 5 | 26 | regulation of cardiac muscle cell action potential |
| GO:2000311 | 0.00236 | 6.22612 | 1 | 5 | 26 | regulation of AMPA receptor activity |
| GO:0042640 | 0.00237 | 8.70989 | 1 | 4 | 16 | anagen |
| GO:0045603 | 0.00237 | 8.70989 | 1 | 4 | 16 | positive regulation of endothelial cell differentiation |
| GO:0099640 | 0.00237 | 8.70989 | 1 | 4 | 16 | axo-dendritic protein transport |
| GO:0140058 | 0.00237 | 8.70989 | 1 | 4 | 16 | neuron projection arborization |
| GO:0051480 | 0.00239 | 1.94655 | 13 | 25 | 364 | regulation of cytosolic calcium ion concentration |
| GO:1902904 | 0.00241 | 2.64728 | 5 | 13 | 142 | negative regulation of supramolecular fiber organization |
| GO:0044085 | 0.00243 | 1.32338 | 109 | 137 | 2940 | cellular component biogenesis |
| GO:1902105 | 0.00245 | 2.08077 | 11 | 21 | 287 | regulation of leukocyte differentiation |
| GO:0003175 | 0.00246 | 15.66441 | 0 | 3 | 8 | tricuspid valve development |
| GO:0042364 | 0.00246 | 15.66441 | 0 | 3 | 8 | water-soluble vitamin biosynthetic process |
| GO:0071447 | 0.00246 | 15.66441 | 0 | 3 | 8 | cellular response to hydroperoxide |
| GO:0072033 | 0.00246 | 15.66441 | 0 | 3 | 8 | renal vesicle formation |
| GO:0072201 | 0.00246 | 15.66441 | 0 | 3 | 8 | negative regulation of mesenchymal cell proliferation |
| GO:1903236 | 0.00246 | 15.66441 | 0 | 3 | 8 | regulation of leukocyte tethering or rolling |
| GO:0051588 | 0.00249 | 2.43447 | 7 | 15 | 177 | regulation of neurotransmitter transport |
| GO:0000578 | 0.00253 | 4.90640 | 1 | 6 | 38 | embryonic axis specification |
| GO:0090175 | 0.00253 | 4.90640 | 1 | 6 | 38 | regulation of establishment of planar polarity |
| GO:0007626 | 0.00253 | 2.16611 | 9 | 19 | 250 | locomotory behavior |
| GO:1901360 | 0.00257 | 1.25731 | 189 | 223 | 5097 | organic cyclic compound metabolic process |
| GO:0033674 | 0.00259 | 1.81484 | 17 | 30 | 467 | positive regulation of kinase activity |
| GO:0031018 | 0.00260 | 4.16565 | 2 | 7 | 51 | endocrine pancreas development |
| GO:0051954 | 0.00260 | 4.16565 | 2 | 7 | 51 | positive regulation of amine transport |
| GO:0061614 | 0.00260 | 4.16565 | 2 | 7 | 51 | pri-miRNA transcription by RNA polymerase II |
| GO:1901698 | 0.00264 | 1.55753 | 35 | 52 | 940 | response to nitrogen compound |
| GO:0002520 | 0.00265 | 1.53777 | 37 | 55 | 1007 | immune system development |
| GO:0007519 | 0.00266 | 2.33797 | 7 | 16 | 196 | skeletal muscle tissue development |
| GO:0006940 | 0.00266 | 3.67713 | 2 | 8 | 65 | regulation of smooth muscle contraction |
| GO:0007179 | 0.00270 | 2.50276 | 6 | 14 | 161 | transforming growth factor beta receptor signaling pathway |
| GO:0099537 | 0.00273 | 1.58424 | 32 | 48 | 853 | trans-synaptic signaling |
| GO:0032411 | 0.00274 | 2.88656 | 4 | 11 | 111 | positive regulation of transporter activity |
| GO:0043244 | 0.00274 | 2.88656 | 4 | 11 | 111 | regulation of protein complex disassembly |
| GO:0098739 | 0.00274 | 2.88656 | 4 | 11 | 111 | import across plasma membrane |
| GO:0046530 | 0.00276 | 3.32288 | 3 | 9 | 80 | photoreceptor cell differentiation |
| GO:0033561 | 0.00281 | 5.94285 | 1 | 5 | 27 | regulation of water loss via skin |
| GO:0048843 | 0.00281 | 5.94285 | 1 | 5 | 27 | negative regulation of axon extension involved in axon guidance |
| GO:0007159 | 0.00286 | 2.01373 | 11 | 22 | 310 | leukocyte cell-cell adhesion |
| GO:1903038 | 0.00286 | 2.71588 | 5 | 12 | 128 | negative regulation of leukocyte cell-cell adhesion |
| GO:0046627 | 0.00290 | 4.75750 | 1 | 6 | 39 | negative regulation of insulin receptor signaling pathway |
| GO:0035051 | 0.00292 | 2.38989 | 7 | 15 | 180 | cardiocyte differentiation |
| GO:0045766 | 0.00292 | 2.38989 | 7 | 15 | 180 | positive regulation of angiogenesis |
| GO:0045428 | 0.00293 | 3.61357 | 2 | 8 | 66 | regulation of nitric oxide biosynthetic process |
| GO:0061035 | 0.00293 | 3.61357 | 2 | 8 | 66 | regulation of cartilage development |
| GO:0001892 | 0.00294 | 2.85785 | 4 | 11 | 112 | embryonic placenta development |
| GO:0001942 | 0.00294 | 2.85785 | 4 | 11 | 112 | hair follicle development |
| GO:0048663 | 0.00301 | 3.27659 | 3 | 9 | 81 | neuron fate commitment |
| GO:0060420 | 0.00301 | 3.27659 | 3 | 9 | 81 | regulation of heart growth |
| GO:0002689 | 0.00301 | 8.03954 | 1 | 4 | 17 | negative regulation of leukocyte chemotaxis |
| GO:0016486 | 0.00301 | 8.03954 | 1 | 4 | 17 | peptide hormone processing |
| GO:0061081 | 0.00301 | 8.03954 | 1 | 4 | 17 | positive regulation of myeloid leukocyte cytokine production involved in immune response |
| GO:0099171 | 0.00301 | 8.03954 | 1 | 4 | 17 | presynaptic modulation of chemical synaptic transmission |
| GO:0048880 | 0.00307 | 1.88024 | 14 | 26 | 391 | sensory system development |
| GO:0043491 | 0.00308 | 2.37538 | 7 | 15 | 181 | protein kinase B signaling |
| GO:0032956 | 0.00314 | 1.96267 | 12 | 23 | 332 | regulation of actin cytoskeleton organization |
| GO:0010638 | 0.00317 | 1.70603 | 21 | 35 | 578 | positive regulation of organelle organization |
| GO:0070997 | 0.00317 | 1.87502 | 15 | 26 | 392 | neuron death |
| GO:0050906 | 0.00325 | 2.66961 | 5 | 12 | 130 | detection of stimulus involved in sensory perception |
| GO:0046883 | 0.00326 | 2.02677 | 11 | 21 | 294 | regulation of hormone secretion |
| GO:0099536 | 0.00327 | 1.56807 | 32 | 48 | 861 | synaptic signaling |
| GO:1901214 | 0.00328 | 1.92406 | 13 | 24 | 353 | regulation of neuron death |
| GO:0043523 | 0.00329 | 2.11070 | 9 | 19 | 256 | regulation of neuron apoptotic process |
| GO:0010719 | 0.00332 | 5.68421 | 1 | 5 | 28 | negative regulation of epithelial to mesenchymal transition |
| GO:0031294 | 0.00332 | 5.68421 | 1 | 5 | 28 | lymphocyte costimulation |
| GO:1902668 | 0.00332 | 5.68421 | 1 | 5 | 28 | negative regulation of axon guidance |
| GO:0098662 | 0.00333 | 1.68679 | 22 | 36 | 601 | inorganic cation transmembrane transport |
| GO:0006650 | 0.00335 | 2.21398 | 8 | 17 | 219 | glycerophospholipid metabolic process |
| GO:0098773 | 0.00337 | 2.80211 | 4 | 11 | 114 | skin epidermis development |
| GO:0060326 | 0.00339 | 2.01928 | 11 | 21 | 295 | cell chemotaxis |
| GO:0006091 | 0.00340 | 1.91814 | 13 | 24 | 354 | generation of precursor metabolites and energy |
| GO:0048534 | 0.00342 | 1.53590 | 35 | 52 | 952 | hematopoietic or lymphoid organ development |
| GO:0050804 | 0.00344 | 1.65814 | 24 | 38 | 645 | modulation of chemical synaptic transmission |
| GO:0099177 | 0.00353 | 1.65534 | 24 | 38 | 646 | regulation of trans-synaptic signaling |
| GO:0019915 | 0.00354 | 3.49280 | 3 | 8 | 68 | lipid storage |
| GO:0002791 | 0.00355 | 1.75458 | 18 | 31 | 498 | regulation of peptide secretion |
| GO:0003139 | 0.00359 | 13.05309 | 0 | 3 | 9 | secondary heart field specification |
| GO:0008216 | 0.00359 | 13.05309 | 0 | 3 | 9 | spermidine metabolic process |
| GO:0033689 | 0.00359 | 13.05309 | 0 | 3 | 9 | negative regulation of osteoblast proliferation |
| GO:0035878 | 0.00359 | 13.05309 | 0 | 3 | 9 | nail development |
| GO:0044539 | 0.00359 | 13.05309 | 0 | 3 | 9 | long-chain fatty acid import |
| GO:0060837 | 0.00359 | 13.05309 | 0 | 3 | 9 | blood vessel endothelial cell differentiation |
| GO:1902669 | 0.00359 | 13.05309 | 0 | 3 | 9 | positive regulation of axon guidance |
| GO:1903589 | 0.00359 | 13.05309 | 0 | 3 | 9 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:2000020 | 0.00359 | 13.05309 | 0 | 3 | 9 | positive regulation of male gonad development |
| GO:2000794 | 0.00359 | 13.05309 | 0 | 3 | 9 | regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0022404 | 0.00361 | 2.77504 | 4 | 11 | 115 | molting cycle process |
| GO:0022405 | 0.00361 | 2.77504 | 4 | 11 | 115 | hair cycle process |
| GO:0035272 | 0.00361 | 3.89923 | 2 | 7 | 54 | exocrine system development |
| GO:0035306 | 0.00361 | 3.89923 | 2 | 7 | 54 | positive regulation of dephosphorylation |
| GO:0086001 | 0.00361 | 3.89923 | 2 | 7 | 54 | cardiac muscle cell action potential |
| GO:0034440 | 0.00366 | 2.94646 | 4 | 10 | 99 | lipid oxidation |
| GO:0090276 | 0.00368 | 2.19207 | 8 | 17 | 221 | regulation of peptide hormone secretion |
| GO:0042303 | 0.00368 | 2.62488 | 5 | 12 | 132 | molting cycle |
| GO:0042633 | 0.00368 | 2.62488 | 5 | 12 | 132 | hair cycle |
| GO:0009611 | 0.00374 | 1.76537 | 18 | 30 | 479 | response to wounding |
| GO:0006595 | 0.00376 | 7.46495 | 1 | 4 | 18 | polyamine metabolic process |
| GO:0006688 | 0.00376 | 7.46495 | 1 | 4 | 18 | glycosphingolipid biosynthetic process |
| GO:0009309 | 0.00376 | 7.46495 | 1 | 4 | 18 | amine biosynthetic process |
| GO:0022010 | 0.00376 | 7.46495 | 1 | 4 | 18 | central nervous system myelination |
| GO:0030002 | 0.00376 | 7.46495 | 1 | 4 | 18 | cellular anion homeostasis |
| GO:0030320 | 0.00376 | 7.46495 | 1 | 4 | 18 | cellular monovalent inorganic anion homeostasis |
| GO:0032291 | 0.00376 | 7.46495 | 1 | 4 | 18 | axon ensheathment in central nervous system |
| GO:0035089 | 0.00376 | 7.46495 | 1 | 4 | 18 | establishment of apical/basal cell polarity |
| GO:0042401 | 0.00376 | 7.46495 | 1 | 4 | 18 | cellular biogenic amine biosynthetic process |
| GO:0046321 | 0.00376 | 7.46495 | 1 | 4 | 18 | positive regulation of fatty acid oxidation |
| GO:0060850 | 0.00376 | 7.46495 | 1 | 4 | 18 | regulation of transcription involved in cell fate commitment |
| GO:0072077 | 0.00376 | 7.46495 | 1 | 4 | 18 | renal vesicle morphogenesis |
| GO:0070509 | 0.00385 | 3.14510 | 3 | 9 | 84 | calcium ion import |
| GO:0050868 | 0.00386 | 2.74849 | 4 | 11 | 116 | negative regulation of T cell activation |
| GO:0051494 | 0.00387 | 2.49180 | 6 | 13 | 150 | negative regulation of cytoskeleton organization |
| GO:1903725 | 0.00388 | 3.43539 | 3 | 8 | 69 | regulation of phospholipid metabolic process |
| GO:0035066 | 0.00389 | 5.44712 | 1 | 5 | 29 | positive regulation of histone acetylation |
| GO:0043010 | 0.00391 | 1.92476 | 13 | 23 | 338 | camera-type eye development |
| GO:0002432 | 0.00400 | 52.16317 | 0 | 2 | 3 | granuloma formation |
| GO:0003213 | 0.00400 | 52.16317 | 0 | 2 | 3 | cardiac right atrium morphogenesis |
| GO:0003249 | 0.00400 | 52.16317 | 0 | 2 | 3 | cell proliferation involved in heart valve morphogenesis |
| GO:0003250 | 0.00400 | 52.16317 | 0 | 2 | 3 | regulation of cell proliferation involved in heart valve morphogenesis |
| GO:0033566 | 0.00400 | 52.16317 | 0 | 2 | 3 | gamma-tubulin complex localization |
| GO:0035880 | 0.00400 | 52.16317 | 0 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0055095 | 0.00400 | 52.16317 | 0 | 2 | 3 | lipoprotein particle mediated signaling |
| GO:0055096 | 0.00400 | 52.16317 | 0 | 2 | 3 | low-density lipoprotein particle mediated signaling |
| GO:0060300 | 0.00400 | 52.16317 | 0 | 2 | 3 | regulation of cytokine activity |
| GO:0061144 | 0.00400 | 52.16317 | 0 | 2 | 3 | alveolar secondary septum development |
| GO:0071603 | 0.00400 | 52.16317 | 0 | 2 | 3 | endothelial cell-cell adhesion |
| GO:0072034 | 0.00400 | 52.16317 | 0 | 2 | 3 | renal vesicle induction |
| GO:0110025 | 0.00400 | 52.16317 | 0 | 2 | 3 | DNA strand resection involved in replication fork processing |
| GO:1901610 | 0.00400 | 52.16317 | 0 | 2 | 3 | positive regulation of vesicle transport along microtubule |
| GO:1901951 | 0.00400 | 52.16317 | 0 | 2 | 3 | regulation of anterograde dense core granule transport |
| GO:1901953 | 0.00400 | 52.16317 | 0 | 2 | 3 | positive regulation of anterograde dense core granule transport |
| GO:1902731 | 0.00400 | 52.16317 | 0 | 2 | 3 | negative regulation of chondrocyte proliferation |
| GO:1904057 | 0.00400 | 52.16317 | 0 | 2 | 3 | negative regulation of sensory perception of pain |
| GO:1990523 | 0.00400 | 52.16317 | 0 | 2 | 3 | bone regeneration |
| GO:2000137 | 0.00400 | 52.16317 | 0 | 2 | 3 | negative regulation of cell proliferation involved in heart morphogenesis |
| GO:2000820 | 0.00400 | 52.16317 | 0 | 2 | 3 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
| GO:2001055 | 0.00400 | 52.16317 | 0 | 2 | 3 | positive regulation of mesenchymal cell apoptotic process |
| GO:0030042 | 0.00401 | 3.81782 | 2 | 7 | 55 | actin filament depolymerization |
| GO:0043254 | 0.00402 | 1.79435 | 16 | 28 | 440 | regulation of protein complex assembly |
| GO:0006836 | 0.00412 | 1.98265 | 11 | 21 | 300 | neurotransmitter transport |
| GO:0003073 | 0.00412 | 2.72244 | 4 | 11 | 117 | regulation of systemic arterial blood pressure |
| GO:0051963 | 0.00412 | 2.72244 | 4 | 11 | 117 | regulation of synapse assembly |
| GO:0099175 | 0.00412 | 2.72244 | 4 | 11 | 117 | regulation of postsynapse organization |
| GO:0001666 | 0.00413 | 2.22573 | 8 | 16 | 205 | response to hypoxia |
| GO:0009913 | 0.00413 | 2.22573 | 8 | 16 | 205 | epidermal cell differentiation |
| GO:0030010 | 0.00416 | 2.58162 | 5 | 12 | 134 | establishment of cell polarity |
| GO:0015908 | 0.00417 | 3.10358 | 3 | 9 | 85 | fatty acid transport |
| GO:0017015 | 0.00422 | 2.88145 | 4 | 10 | 101 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0005978 | 0.00424 | 4.36046 | 2 | 6 | 42 | glycogen biosynthetic process |
| GO:0009250 | 0.00424 | 4.36046 | 2 | 6 | 42 | glucan biosynthetic process |
| GO:0010883 | 0.00424 | 4.36046 | 2 | 6 | 42 | regulation of lipid storage |
| GO:0032881 | 0.00424 | 4.36046 | 2 | 6 | 42 | regulation of polysaccharide metabolic process |
| GO:0042220 | 0.00424 | 4.36046 | 2 | 6 | 42 | response to cocaine |
| GO:1901985 | 0.00424 | 4.36046 | 2 | 6 | 42 | positive regulation of protein acetylation |
| GO:0060996 | 0.00439 | 2.69687 | 4 | 11 | 118 | dendritic spine development |
| GO:0001933 | 0.00442 | 1.82432 | 15 | 26 | 402 | negative regulation of protein phosphorylation |
| GO:0001736 | 0.00444 | 3.73974 | 2 | 7 | 56 | establishment of planar polarity |
| GO:0001754 | 0.00444 | 3.73974 | 2 | 7 | 56 | eye photoreceptor cell differentiation |
| GO:0002067 | 0.00444 | 3.73974 | 2 | 7 | 56 | glandular epithelial cell differentiation |
| GO:0046622 | 0.00444 | 3.73974 | 2 | 7 | 56 | positive regulation of organ growth |
| GO:0072347 | 0.00444 | 3.73974 | 2 | 7 | 56 | response to anesthetic |
| GO:1901701 | 0.00449 | 1.46426 | 43 | 61 | 1170 | cellular response to oxygen-containing compound |
| GO:0097581 | 0.00451 | 3.06313 | 3 | 9 | 86 | lamellipodium organization |
| GO:1901879 | 0.00451 | 3.06313 | 3 | 9 | 86 | regulation of protein depolymerization |
| GO:0044267 | 0.00453 | 1.25036 | 166 | 197 | 4494 | cellular protein metabolic process |
| GO:0002021 | 0.00453 | 5.22901 | 1 | 5 | 30 | response to dietary excess |
| GO:0003309 | 0.00453 | 5.22901 | 1 | 5 | 30 | type B pancreatic cell differentiation |
| GO:0099560 | 0.00453 | 5.22901 | 1 | 5 | 30 | synaptic membrane adhesion |
| GO:0003014 | 0.00453 | 2.85000 | 4 | 10 | 102 | renal system process |
| GO:0051402 | 0.00453 | 2.00217 | 10 | 20 | 283 | neuron apoptotic process |
| GO:0016070 | 0.00454 | 1.27068 | 136 | 165 | 3688 | RNA metabolic process |
| GO:0018394 | 0.00458 | 2.43808 | 6 | 13 | 153 | peptidyl-lysine acetylation |
| GO:0010038 | 0.00459 | 2.04104 | 10 | 19 | 264 | response to metal ion |
| GO:0044242 | 0.00462 | 2.26535 | 7 | 15 | 189 | cellular lipid catabolic process |
| GO:0097755 | 0.00462 | 3.32603 | 3 | 8 | 71 | positive regulation of blood vessel diameter |
| GO:0030859 | 0.00463 | 6.96698 | 1 | 4 | 19 | polarized epithelial cell differentiation |
| GO:0043931 | 0.00463 | 6.96698 | 1 | 4 | 19 | ossification involved in bone maturation |
| GO:0070875 | 0.00463 | 6.96698 | 1 | 4 | 19 | positive regulation of glycogen metabolic process |
| GO:1904385 | 0.00463 | 6.96698 | 1 | 4 | 19 | cellular response to angiotensin |
| GO:1905331 | 0.00463 | 6.96698 | 1 | 4 | 19 | negative regulation of morphogenesis of an epithelium |
| GO:1990776 | 0.00463 | 6.96698 | 1 | 4 | 19 | response to angiotensin |
| GO:0016358 | 0.00471 | 1.99450 | 11 | 20 | 284 | dendrite development |
| GO:0019932 | 0.00478 | 1.79012 | 16 | 27 | 425 | second-messenger-mediated signaling |
| GO:0032880 | 0.00478 | 1.50122 | 37 | 53 | 991 | regulation of protein localization |
| GO:0043434 | 0.00479 | 1.95427 | 11 | 21 | 304 | response to peptide hormone |
| GO:1903707 | 0.00484 | 2.42068 | 6 | 13 | 154 | negative regulation of hemopoiesis |
| GO:0006006 | 0.00485 | 2.25231 | 7 | 15 | 190 | glucose metabolic process |
| GO:1903844 | 0.00485 | 2.81923 | 4 | 10 | 103 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0002695 | 0.00488 | 2.32736 | 6 | 14 | 172 | negative regulation of leukocyte activation |
| GO:0007164 | 0.00490 | 3.66478 | 2 | 7 | 57 | establishment of tissue polarity |
| GO:0015909 | 0.00490 | 3.66478 | 2 | 7 | 57 | long-chain fatty acid transport |
| GO:0051148 | 0.00490 | 3.66478 | 2 | 7 | 57 | negative regulation of muscle cell differentiation |
| GO:0007050 | 0.00497 | 2.51932 | 5 | 12 | 137 | cell cycle arrest |
| GO:0002934 | 0.00499 | 11.18786 | 0 | 3 | 10 | desmosome organization |
| GO:0051639 | 0.00499 | 11.18786 | 0 | 3 | 10 | actin filament network formation |
| GO:0060379 | 0.00499 | 11.18786 | 0 | 3 | 10 | cardiac muscle cell myoblast differentiation |
| GO:0061626 | 0.00499 | 11.18786 | 0 | 3 | 10 | pharyngeal arch artery morphogenesis |
| GO:0072173 | 0.00499 | 11.18786 | 0 | 3 | 10 | metanephric tubule morphogenesis |
| GO:0072203 | 0.00499 | 11.18786 | 0 | 3 | 10 | cell proliferation involved in metanephros development |
| GO:1902513 | 0.00499 | 11.18786 | 0 | 3 | 10 | regulation of organelle transport along microtubule |
| GO:2000574 | 0.00499 | 11.18786 | 0 | 3 | 10 | regulation of microtubule motor activity |
| GO:0042060 | 0.00500 | 1.88232 | 13 | 23 | 345 | wound healing |
| GO:0043588 | 0.00509 | 1.97932 | 11 | 20 | 286 | skin development |
| GO:0050900 | 0.00518 | 1.90636 | 12 | 22 | 326 | leukocyte migration |
| GO:0032414 | 0.00520 | 2.78911 | 4 | 10 | 104 | positive regulation of ion transmembrane transporter activity |
| GO:0010574 | 0.00524 | 5.02767 | 1 | 5 | 31 | regulation of vascular endothelial growth factor production |
| GO:0010922 | 0.00524 | 5.02767 | 1 | 5 | 31 | positive regulation of phosphatase activity |
| GO:0044030 | 0.00524 | 5.02767 | 1 | 5 | 31 | regulation of DNA methylation |
| GO:0001708 | 0.00525 | 2.98532 | 3 | 9 | 88 | cell fate specification |
| GO:0031016 | 0.00525 | 2.98532 | 3 | 9 | 88 | pancreas development |
| GO:0035914 | 0.00525 | 2.98532 | 3 | 9 | 88 | skeletal muscle cell differentiation |
| GO:0051223 | 0.00528 | 1.60067 | 25 | 39 | 684 | regulation of protein transport |
| GO:1902532 | 0.00529 | 1.70242 | 19 | 31 | 512 | negative regulation of intracellular signal transduction |
| GO:0001817 | 0.00535 | 1.62078 | 24 | 37 | 641 | regulation of cytokine production |
| GO:0050891 | 0.00537 | 4.13059 | 2 | 6 | 44 | multicellular organismal water homeostasis |
| GO:1903727 | 0.00537 | 4.13059 | 2 | 6 | 44 | positive regulation of phospholipid metabolic process |
| GO:0050982 | 0.00540 | 3.59276 | 2 | 7 | 58 | detection of mechanical stimulus |
| GO:0035148 | 0.00540 | 2.29806 | 6 | 14 | 174 | tube formation |
| GO:0001654 | 0.00543 | 1.81587 | 14 | 25 | 388 | eye development |
| GO:0150063 | 0.00543 | 1.81587 | 14 | 25 | 388 | visual system development |
| GO:0006814 | 0.00544 | 2.15667 | 8 | 16 | 211 | sodium ion transport |
| GO:0071375 | 0.00548 | 2.09860 | 9 | 17 | 230 | cellular response to peptide hormone stimulus |
| GO:0007422 | 0.00548 | 3.22340 | 3 | 8 | 73 | peripheral nervous system development |
| GO:0061097 | 0.00548 | 3.22340 | 3 | 8 | 73 | regulation of protein tyrosine kinase activity |
| GO:0002682 | 0.00555 | 1.40951 | 52 | 71 | 1414 | regulation of immune system process |
| GO:0014812 | 0.00556 | 2.75963 | 4 | 10 | 105 | muscle cell migration |
| GO:0032091 | 0.00556 | 2.75963 | 4 | 10 | 105 | negative regulation of protein binding |
| GO:1902803 | 0.00556 | 2.75963 | 4 | 10 | 105 | regulation of synaptic vesicle transport |
| GO:1904659 | 0.00556 | 2.75963 | 4 | 10 | 105 | glucose transmembrane transport |
| GO:0071705 | 0.00562 | 1.33879 | 77 | 99 | 2081 | nitrogen compound transport |
| GO:0009110 | 0.00562 | 6.53125 | 1 | 4 | 20 | vitamin biosynthetic process |
| GO:0061162 | 0.00562 | 6.53125 | 1 | 4 | 20 | establishment of monopolar cell polarity |
| GO:0061323 | 0.00562 | 6.53125 | 1 | 4 | 20 | cell proliferation involved in heart morphogenesis |
| GO:2000136 | 0.00562 | 6.53125 | 1 | 4 | 20 | regulation of cell proliferation involved in heart morphogenesis |
| GO:0046165 | 0.00564 | 2.59922 | 5 | 11 | 122 | alcohol biosynthetic process |
| GO:0060395 | 0.00565 | 2.94787 | 3 | 9 | 89 | SMAD protein signal transduction |
| GO:1901861 | 0.00568 | 2.28369 | 6 | 14 | 175 | regulation of muscle tissue development |
| GO:0008406 | 0.00569 | 2.14557 | 8 | 16 | 212 | gonad development |
| GO:0051258 | 0.00583 | 1.99171 | 10 | 19 | 270 | protein polymerization |
| GO:0007268 | 0.00592 | 1.52828 | 31 | 46 | 844 | chemical synaptic transmission |
| GO:0098916 | 0.00592 | 1.52828 | 31 | 46 | 844 | anterograde trans-synaptic signaling |
| GO:0015872 | 0.00594 | 3.52351 | 2 | 7 | 59 | dopamine transport |
| GO:0034394 | 0.00594 | 3.52351 | 2 | 7 | 59 | protein localization to cell surface |
| GO:0035264 | 0.00595 | 2.13458 | 8 | 16 | 213 | multicellular organism growth |
| GO:0050432 | 0.00595 | 3.17442 | 3 | 8 | 74 | catecholamine secretion |
| GO:1901880 | 0.00595 | 3.17442 | 3 | 8 | 74 | negative regulation of protein depolymerization |
| GO:0008064 | 0.00597 | 2.26949 | 7 | 14 | 176 | regulation of actin polymerization or depolymerization |
| GO:0030857 | 0.00600 | 4.02450 | 2 | 6 | 45 | negative regulation of epithelial cell differentiation |
| GO:0031952 | 0.00600 | 4.02450 | 2 | 6 | 45 | regulation of protein autophosphorylation |
| GO:0044848 | 0.00600 | 4.02450 | 2 | 6 | 45 | biological phase |
| GO:0002026 | 0.00602 | 4.84124 | 1 | 5 | 32 | regulation of the force of heart contraction |
| GO:0045879 | 0.00602 | 4.84124 | 1 | 5 | 32 | negative regulation of smoothened signaling pathway |
| GO:0060977 | 0.00602 | 4.84124 | 1 | 5 | 32 | coronary vasculature morphogenesis |
| GO:1903305 | 0.00627 | 2.25546 | 7 | 14 | 177 | regulation of regulated secretory pathway |
| GO:0051147 | 0.00631 | 2.33725 | 6 | 13 | 159 | regulation of muscle cell differentiation |
| GO:0008645 | 0.00634 | 2.70249 | 4 | 10 | 107 | hexose transmembrane transport |
| GO:0043467 | 0.00634 | 2.70249 | 4 | 10 | 107 | regulation of generation of precursor metabolites and energy |
| GO:0051346 | 0.00636 | 1.79079 | 15 | 25 | 393 | negative regulation of hydrolase activity |
| GO:0001816 | 0.00636 | 1.57089 | 26 | 40 | 714 | cytokine production |
| GO:0034763 | 0.00637 | 2.55299 | 5 | 11 | 124 | negative regulation of transmembrane transport |
| GO:0019229 | 0.00645 | 3.12690 | 3 | 8 | 75 | regulation of vasoconstriction |
| GO:1900076 | 0.00645 | 3.12690 | 3 | 8 | 75 | regulation of cellular response to insulin stimulus |
| GO:0086003 | 0.00651 | 3.45688 | 2 | 7 | 60 | cardiac muscle cell contraction |
| GO:0016042 | 0.00660 | 1.92796 | 11 | 20 | 293 | lipid catabolic process |
| GO:0110053 | 0.00667 | 2.00579 | 9 | 18 | 254 | regulation of actin filament organization |
| GO:0045161 | 0.00667 | 9.78894 | 0 | 3 | 11 | neuronal ion channel clustering |
| GO:0060346 | 0.00667 | 9.78894 | 0 | 3 | 11 | bone trabecula formation |
| GO:0060768 | 0.00667 | 9.78894 | 0 | 3 | 11 | regulation of epithelial cell proliferation involved in prostate gland development |
| GO:0072172 | 0.00667 | 9.78894 | 0 | 3 | 11 | mesonephric tubule formation |
| GO:0086016 | 0.00667 | 9.78894 | 0 | 3 | 11 | AV node cell action potential |
| GO:0086027 | 0.00667 | 9.78894 | 0 | 3 | 11 | AV node cell to bundle of His cell signaling |
| GO:0097264 | 0.00667 | 9.78894 | 0 | 3 | 11 | self proteolysis |
| GO:0098935 | 0.00667 | 9.78894 | 0 | 3 | 11 | dendritic transport |
| GO:1902805 | 0.00667 | 9.78894 | 0 | 3 | 11 | positive regulation of synaptic vesicle transport |
| GO:0003382 | 0.00669 | 3.92371 | 2 | 6 | 46 | epithelial cell morphogenesis |
| GO:0030517 | 0.00669 | 3.92371 | 2 | 6 | 46 | negative regulation of axon extension |
| GO:0006349 | 0.00674 | 6.14678 | 1 | 4 | 21 | regulation of gene expression by genetic imprinting |
| GO:0032331 | 0.00674 | 6.14678 | 1 | 4 | 21 | negative regulation of chondrocyte differentiation |
| GO:0046475 | 0.00674 | 6.14678 | 1 | 4 | 21 | glycerophospholipid catabolic process |
| GO:0061339 | 0.00674 | 6.14678 | 1 | 4 | 21 | establishment or maintenance of monopolar cell polarity |
| GO:0097107 | 0.00674 | 6.14678 | 1 | 4 | 21 | postsynaptic density assembly |
| GO:2000209 | 0.00674 | 6.14678 | 1 | 4 | 21 | regulation of anoikis |
| GO:0017157 | 0.00675 | 2.05000 | 9 | 17 | 235 | regulation of exocytosis |
| GO:0015844 | 0.00676 | 2.67479 | 4 | 10 | 108 | monoamine transport |
| GO:0010573 | 0.00689 | 4.66813 | 1 | 5 | 33 | vascular endothelial growth factor production |
| GO:0033598 | 0.00689 | 4.66813 | 1 | 5 | 33 | mammary gland epithelial cell proliferation |
| GO:0035883 | 0.00689 | 4.66813 | 1 | 5 | 33 | enteroendocrine cell differentiation |
| GO:0060740 | 0.00689 | 4.66813 | 1 | 5 | 33 | prostate gland epithelium morphogenesis |
| GO:0030832 | 0.00690 | 2.22792 | 7 | 14 | 179 | regulation of actin filament length |
| GO:0048489 | 0.00690 | 2.22792 | 7 | 14 | 179 | synaptic vesicle transport |
| GO:0050796 | 0.00690 | 2.22792 | 7 | 14 | 179 | regulation of insulin secretion |
| GO:0097480 | 0.00690 | 2.22792 | 7 | 14 | 179 | establishment of synaptic vesicle localization |
| GO:0006672 | 0.00698 | 3.08078 | 3 | 8 | 76 | ceramide metabolic process |
| GO:0006643 | 0.00699 | 2.30546 | 6 | 13 | 161 | membrane lipid metabolic process |
| GO:0030902 | 0.00699 | 2.30546 | 6 | 13 | 161 | hindbrain development |
| GO:0001570 | 0.00701 | 2.84094 | 3 | 9 | 92 | vasculogenesis |
| GO:0016192 | 0.00709 | 1.38928 | 54 | 72 | 1453 | vesicle-mediated transport |
| GO:0015914 | 0.00713 | 3.39271 | 2 | 7 | 61 | phospholipid transport |
| GO:0033627 | 0.00713 | 3.39271 | 2 | 7 | 61 | cell adhesion mediated by integrin |
| GO:0090398 | 0.00713 | 3.39271 | 2 | 7 | 61 | cellular senescence |
| GO:0097006 | 0.00713 | 3.39271 | 2 | 7 | 61 | regulation of plasma lipoprotein particle levels |
| GO:2000736 | 0.00713 | 3.39271 | 2 | 7 | 61 | regulation of stem cell differentiation |
| GO:0051101 | 0.00716 | 2.50836 | 5 | 11 | 126 | regulation of DNA binding |
| GO:0002376 | 0.00720 | 1.29503 | 96 | 119 | 2588 | immune system process |
| GO:0005976 | 0.00721 | 2.64765 | 4 | 10 | 109 | polysaccharide metabolic process |
| GO:0015749 | 0.00721 | 2.64765 | 4 | 10 | 109 | monosaccharide transmembrane transport |
| GO:0051668 | 0.00724 | 2.21440 | 7 | 14 | 180 | localization within membrane |
| GO:0033554 | 0.00730 | 1.35964 | 63 | 82 | 1692 | cellular response to stress |
| GO:0098693 | 0.00734 | 2.38497 | 5 | 12 | 144 | regulation of synaptic vesicle cycle |
| GO:0001960 | 0.00744 | 3.82784 | 2 | 6 | 47 | negative regulation of cytokine-mediated signaling pathway |
| GO:0014888 | 0.00744 | 3.82784 | 2 | 6 | 47 | striated muscle adaptation |
| GO:0006835 | 0.00754 | 3.03599 | 3 | 8 | 77 | dicarboxylic acid transport |
| GO:1903037 | 0.00759 | 1.93706 | 10 | 19 | 277 | regulation of leukocyte cell-cell adhesion |
| GO:0002790 | 0.00760 | 1.60300 | 23 | 35 | 612 | peptide secretion |
| GO:0071417 | 0.00760 | 1.64075 | 20 | 32 | 547 | cellular response to organonitrogen compound |
| GO:0034219 | 0.00767 | 2.62106 | 4 | 10 | 110 | carbohydrate transmembrane transport |
| GO:0019318 | 0.00770 | 2.07093 | 8 | 16 | 219 | hexose metabolic process |
| GO:0042552 | 0.00774 | 2.36693 | 5 | 12 | 145 | myelination |
| GO:0034599 | 0.00779 | 1.97200 | 10 | 18 | 258 | cellular response to oxidative stress |
| GO:0001997 | 0.00781 | 26.08042 | 0 | 2 | 4 | positive regulation of the force of heart contraction by epinephrine-norepinephrine |
| GO:0003099 | 0.00781 | 26.08042 | 0 | 2 | 4 | positive regulation of the force of heart contraction by chemical signal |
| GO:0003195 | 0.00781 | 26.08042 | 0 | 2 | 4 | tricuspid valve formation |
| GO:0003273 | 0.00781 | 26.08042 | 0 | 2 | 4 | cell migration involved in endocardial cushion formation |
| GO:0006682 | 0.00781 | 26.08042 | 0 | 2 | 4 | galactosylceramide biosynthetic process |
| GO:0007223 | 0.00781 | 26.08042 | 0 | 2 | 4 | Wnt signaling pathway, calcium modulating pathway |
| GO:0009092 | 0.00781 | 26.08042 | 0 | 2 | 4 | homoserine metabolic process |
| GO:0014826 | 0.00781 | 26.08042 | 0 | 2 | 4 | vein smooth muscle contraction |
| GO:0014916 | 0.00781 | 26.08042 | 0 | 2 | 4 | regulation of lung blood pressure |
| GO:0019346 | 0.00781 | 26.08042 | 0 | 2 | 4 | transsulfuration |
| GO:0019375 | 0.00781 | 26.08042 | 0 | 2 | 4 | galactolipid biosynthetic process |
| GO:0019482 | 0.00781 | 26.08042 | 0 | 2 | 4 | beta-alanine metabolic process |
| GO:0060018 | 0.00781 | 26.08042 | 0 | 2 | 4 | astrocyte fate commitment |
| GO:0060221 | 0.00781 | 26.08042 | 0 | 2 | 4 | retinal rod cell differentiation |
| GO:0060528 | 0.00781 | 26.08042 | 0 | 2 | 4 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development |
| GO:0060819 | 0.00781 | 26.08042 | 0 | 2 | 4 | inactivation of X chromosome by genetic imprinting |
| GO:0061209 | 0.00781 | 26.08042 | 0 | 2 | 4 | cell proliferation involved in mesonephros development |
| GO:0070814 | 0.00781 | 26.08042 | 0 | 2 | 4 | hydrogen sulfide biosynthetic process |
| GO:0072197 | 0.00781 | 26.08042 | 0 | 2 | 4 | ureter morphogenesis |
| GO:0072289 | 0.00781 | 26.08042 | 0 | 2 | 4 | metanephric nephron tubule formation |
| GO:0090074 | 0.00781 | 26.08042 | 0 | 2 | 4 | negative regulation of protein homodimerization activity |
| GO:0090154 | 0.00781 | 26.08042 | 0 | 2 | 4 | positive regulation of sphingolipid biosynthetic process |
| GO:0090271 | 0.00781 | 26.08042 | 0 | 2 | 4 | positive regulation of fibroblast growth factor production |
| GO:0090427 | 0.00781 | 26.08042 | 0 | 2 | 4 | activation of meiosis |
| GO:0098904 | 0.00781 | 26.08042 | 0 | 2 | 4 | regulation of AV node cell action potential |
| GO:1901608 | 0.00781 | 26.08042 | 0 | 2 | 4 | regulation of vesicle transport along microtubule |
| GO:1903860 | 0.00781 | 26.08042 | 0 | 2 | 4 | negative regulation of dendrite extension |
| GO:1903964 | 0.00781 | 26.08042 | 0 | 2 | 4 | monounsaturated fatty acid metabolic process |
| GO:1903966 | 0.00781 | 26.08042 | 0 | 2 | 4 | monounsaturated fatty acid biosynthetic process |
| GO:1904809 | 0.00781 | 26.08042 | 0 | 2 | 4 | regulation of dense core granule transport |
| GO:1904811 | 0.00781 | 26.08042 | 0 | 2 | 4 | positive regulation of dense core granule transport |
| GO:1905643 | 0.00781 | 26.08042 | 0 | 2 | 4 | positive regulation of DNA methylation |
| GO:2000304 | 0.00781 | 26.08042 | 0 | 2 | 4 | positive regulation of ceramide biosynthetic process |
| GO:2000793 | 0.00781 | 26.08042 | 0 | 2 | 4 | cell proliferation involved in heart valve development |
| GO:2001013 | 0.00781 | 26.08042 | 0 | 2 | 4 | epithelial cell proliferation involved in renal tubule morphogenesis |
| GO:0014003 | 0.00783 | 4.50696 | 1 | 5 | 34 | oligodendrocyte development |
| GO:0045746 | 0.00783 | 4.50696 | 1 | 5 | 34 | negative regulation of Notch signaling pathway |
| GO:0060512 | 0.00783 | 4.50696 | 1 | 5 | 34 | prostate gland morphogenesis |
| GO:0070873 | 0.00783 | 4.50696 | 1 | 5 | 34 | regulation of glycogen metabolic process |
| GO:0051648 | 0.00787 | 1.92949 | 10 | 19 | 278 | vesicle localization |
| GO:0098656 | 0.00795 | 2.18784 | 7 | 14 | 182 | anion transmembrane transport |
| GO:0010467 | 0.00795 | 1.22625 | 174 | 203 | 4707 | gene expression |
| GO:0003323 | 0.00800 | 5.80504 | 1 | 4 | 22 | type B pancreatic cell development |
| GO:0044851 | 0.00800 | 5.80504 | 1 | 4 | 22 | hair cycle phase |
| GO:0045723 | 0.00800 | 5.80504 | 1 | 4 | 22 | positive regulation of fatty acid biosynthetic process |
| GO:0085029 | 0.00800 | 5.80504 | 1 | 4 | 22 | extracellular matrix assembly |
| GO:0008154 | 0.00804 | 2.11806 | 7 | 15 | 201 | actin polymerization or depolymerization |
| GO:0031348 | 0.00804 | 2.11806 | 7 | 15 | 201 | negative regulation of defense response |
| GO:0001676 | 0.00804 | 2.77384 | 3 | 9 | 94 | long-chain fatty acid metabolic process |
| GO:0007200 | 0.00804 | 2.77384 | 3 | 9 | 94 | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0040014 | 0.00804 | 2.77384 | 3 | 9 | 94 | regulation of multicellular organism growth |
| GO:0009896 | 0.00812 | 1.75205 | 15 | 25 | 401 | positive regulation of catabolic process |
| GO:0045682 | 0.00814 | 2.99249 | 3 | 8 | 78 | regulation of epidermis development |
| GO:2000243 | 0.00814 | 2.99249 | 3 | 8 | 78 | positive regulation of reproductive process |
| GO:0042180 | 0.00832 | 2.17480 | 7 | 14 | 183 | cellular ketone metabolic process |
| GO:0030512 | 0.00849 | 3.27125 | 2 | 7 | 63 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:1903793 | 0.00849 | 3.27125 | 2 | 7 | 63 | positive regulation of anion transport |
| GO:0017158 | 0.00850 | 2.44426 | 5 | 11 | 129 | regulation of calcium ion-dependent exocytosis |
| GO:0045995 | 0.00850 | 2.44426 | 5 | 11 | 129 | regulation of embryonic development |
| GO:0043271 | 0.00852 | 2.24438 | 6 | 13 | 165 | negative regulation of ion transport |
| GO:0051250 | 0.00859 | 2.33166 | 5 | 12 | 147 | negative regulation of lymphocyte activation |
| GO:0010595 | 0.00860 | 2.74147 | 4 | 9 | 95 | positive regulation of endothelial cell migration |
| GO:0032386 | 0.00861 | 1.70292 | 16 | 27 | 445 | regulation of intracellular transport |
| GO:0006020 | 0.00865 | 8.70089 | 0 | 3 | 12 | inositol metabolic process |
| GO:0007440 | 0.00865 | 8.70089 | 0 | 3 | 12 | foregut morphogenesis |
| GO:0010889 | 0.00865 | 8.70089 | 0 | 3 | 12 | regulation of sequestering of triglyceride |
| GO:0051798 | 0.00865 | 8.70089 | 0 | 3 | 12 | positive regulation of hair follicle development |
| GO:0060430 | 0.00865 | 8.70089 | 0 | 3 | 12 | lung saccule development |
| GO:0060502 | 0.00865 | 8.70089 | 0 | 3 | 12 | epithelial cell proliferation involved in lung morphogenesis |
| GO:0061299 | 0.00865 | 8.70089 | 0 | 3 | 12 | retina vasculature morphogenesis in camera-type eye |
| GO:0070444 | 0.00865 | 8.70089 | 0 | 3 | 12 | oligodendrocyte progenitor proliferation |
| GO:0070445 | 0.00865 | 8.70089 | 0 | 3 | 12 | regulation of oligodendrocyte progenitor proliferation |
| GO:0072176 | 0.00865 | 8.70089 | 0 | 3 | 12 | nephric duct development |
| GO:0072697 | 0.00865 | 8.70089 | 0 | 3 | 12 | protein localization to cell cortex |
| GO:1901660 | 0.00865 | 8.70089 | 0 | 3 | 12 | calcium ion export |
| GO:1902287 | 0.00865 | 8.70089 | 0 | 3 | 12 | semaphorin-plexin signaling pathway involved in axon guidance |
| GO:1904994 | 0.00865 | 8.70089 | 0 | 3 | 12 | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0008286 | 0.00867 | 2.56943 | 4 | 10 | 112 | insulin receptor signaling pathway |
| GO:0046467 | 0.00867 | 2.56943 | 4 | 10 | 112 | membrane lipid biosynthetic process |
| GO:1903409 | 0.00867 | 2.56943 | 4 | 10 | 112 | reactive oxygen species biosynthetic process |
| GO:0030534 | 0.00871 | 2.16191 | 7 | 14 | 184 | adult behavior |
| GO:0051924 | 0.00872 | 1.94739 | 10 | 18 | 261 | regulation of calcium ion transport |
| GO:0051146 | 0.00877 | 1.87239 | 11 | 20 | 301 | striated muscle cell differentiation |
| GO:0021675 | 0.00877 | 2.95021 | 3 | 8 | 79 | nerve development |
| GO:0060113 | 0.00877 | 2.95021 | 3 | 8 | 79 | inner ear receptor cell differentiation |
| GO:0009954 | 0.00886 | 4.35653 | 1 | 5 | 35 | proximal/distal pattern formation |
| GO:0097106 | 0.00886 | 4.35653 | 1 | 5 | 35 | postsynaptic density organization |
| GO:1900026 | 0.00886 | 4.35653 | 1 | 5 | 35 | positive regulation of substrate adhesion-dependent cell spreading |
| GO:0034767 | 0.00894 | 2.22961 | 6 | 13 | 166 | positive regulation of ion transmembrane transport |
| GO:0051928 | 0.00898 | 2.42361 | 5 | 11 | 130 | positive regulation of calcium ion transport |
| GO:0061041 | 0.00898 | 2.42361 | 5 | 11 | 130 | regulation of wound healing |
| GO:0071453 | 0.00898 | 2.42361 | 5 | 11 | 130 | cellular response to oxygen levels |
| GO:0007272 | 0.00905 | 2.31441 | 5 | 12 | 148 | ensheathment of neurons |
| GO:0008366 | 0.00905 | 2.31441 | 5 | 12 | 148 | axon ensheathment |
| GO:0007611 | 0.00910 | 1.89980 | 10 | 19 | 282 | learning or memory |
| GO:0010761 | 0.00910 | 3.64947 | 2 | 6 | 49 | fibroblast migration |
| GO:0030104 | 0.00910 | 3.64947 | 2 | 6 | 49 | water homeostasis |
| GO:0031113 | 0.00910 | 3.64947 | 2 | 6 | 49 | regulation of microtubule polymerization |
| GO:0042491 | 0.00910 | 3.64947 | 2 | 6 | 49 | inner ear auditory receptor cell differentiation |
| GO:0031058 | 0.00919 | 2.70983 | 4 | 9 | 96 | positive regulation of histone modification |
| GO:0045921 | 0.00919 | 2.70983 | 4 | 9 | 96 | positive regulation of exocytosis |
| GO:0046849 | 0.00919 | 2.70983 | 4 | 9 | 96 | bone remodeling |
| GO:0001885 | 0.00923 | 3.21371 | 2 | 7 | 64 | endothelial cell development |
| GO:0090278 | 0.00923 | 3.21371 | 2 | 7 | 64 | negative regulation of peptide hormone secretion |
| GO:0016311 | 0.00930 | 1.77591 | 13 | 23 | 364 | dephosphorylation |
| GO:0023019 | 0.00941 | 5.49926 | 1 | 4 | 23 | signal transduction involved in regulation of gene expression |
| GO:0030539 | 0.00941 | 5.49926 | 1 | 4 | 23 | male genitalia development |
| GO:0031954 | 0.00941 | 5.49926 | 1 | 4 | 23 | positive regulation of protein autophosphorylation |
| GO:0061436 | 0.00941 | 5.49926 | 1 | 4 | 23 | establishment of skin barrier |
| GO:0010959 | 0.00968 | 1.72406 | 15 | 25 | 407 | regulation of metal ion transport |
| GO:0043534 | 0.00977 | 2.51980 | 4 | 10 | 114 | blood vessel endothelial cell migration |
| GO:2000278 | 0.00977 | 2.51980 | 4 | 10 | 114 | regulation of DNA biosynthetic process |
| GO:0019395 | 0.00980 | 2.67892 | 4 | 9 | 97 | fatty acid oxidation |
| GO:0003401 | 0.00999 | 4.21581 | 1 | 5 | 36 | axis elongation |
| GO:0032885 | 0.00999 | 4.21581 | 1 | 5 | 36 | regulation of polysaccharide biosynthetic process |
| GO:0045987 | 0.00999 | 4.21581 | 1 | 5 | 36 | positive regulation of smooth muscle contraction |
| GO:0050919 | 0.00999 | 4.21581 | 1 | 5 | 36 | negative chemotaxis |
| GO:0061384 | 0.00999 | 4.21581 | 1 | 5 | 36 | heart trabecula morphogenesis |
| GO:0046626 | 0.01002 | 3.15816 | 2 | 7 | 65 | regulation of insulin receptor signaling pathway |
| GO:0060425 | 0.01002 | 3.15816 | 2 | 7 | 65 | lung morphogenesis |
| GO:1903845 | 0.01002 | 3.15816 | 2 | 7 | 65 | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0008038 | 0.01003 | 3.56637 | 2 | 6 | 50 | neuron recognition |
| GO:0009948 | 0.01003 | 3.56637 | 2 | 6 | 50 | anterior/posterior axis specification |
| GO:0035137 | 0.01003 | 3.56637 | 2 | 6 | 50 | hindlimb morphogenesis |
| GO:0043392 | 0.01003 | 3.56637 | 2 | 6 | 50 | negative regulation of DNA binding |
| GO:0070542 | 0.01003 | 3.56637 | 2 | 6 | 50 | response to fatty acid |
| GO:1900024 | 0.01003 | 3.56637 | 2 | 6 | 50 | regulation of substrate adhesion-dependent cell spreading |
| GO:1900449 | 0.01003 | 3.56637 | 2 | 6 | 50 | regulation of glutamate receptor signaling pathway |
| GO:0006954 | 0.01006 | 1.55914 | 24 | 36 | 646 | inflammatory response |
| GO:0006725 | 0.01006 | 1.21427 | 182 | 210 | 4913 | cellular aromatic compound metabolic process |
| GO:0045321 | 0.01010 | 1.45299 | 36 | 50 | 962 | leukocyte activation |
| GO:0043242 | 0.01015 | 2.86912 | 3 | 8 | 81 | negative regulation of protein complex disassembly |
| GO:0045860 | 0.01023 | 1.69572 | 16 | 26 | 430 | positive regulation of protein kinase activity |
| GO:0070201 | 0.01035 | 1.52742 | 26 | 39 | 714 | regulation of establishment of protein localization |
| GO:0051261 | 0.01036 | 2.49569 | 4 | 10 | 115 | protein depolymerization |
| GO:0043255 | 0.01045 | 2.64870 | 4 | 9 | 98 | regulation of carbohydrate biosynthetic process |
| GO:0043624 | 0.01056 | 2.36370 | 5 | 11 | 133 | cellular protein complex disassembly |
| GO:0030072 | 0.01086 | 1.89995 | 10 | 18 | 267 | peptide hormone secretion |
| GO:0007492 | 0.01087 | 3.10450 | 2 | 7 | 66 | endoderm development |
| GO:0014068 | 0.01087 | 3.10450 | 2 | 7 | 66 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0055081 | 0.01087 | 3.10450 | 2 | 7 | 66 | anion homeostasis |
| GO:1903036 | 0.01087 | 3.10450 | 2 | 7 | 66 | positive regulation of response to wounding |
| GO:2000179 | 0.01087 | 3.10450 | 2 | 7 | 66 | positive regulation of neural precursor cell proliferation |
| GO:0042632 | 0.01089 | 2.83022 | 3 | 8 | 82 | cholesterol homeostasis |
| GO:0007351 | 0.01094 | 7.83046 | 0 | 3 | 13 | tripartite regional subdivision |
| GO:0008595 | 0.01094 | 7.83046 | 0 | 3 | 13 | anterior/posterior axis specification, embryo |
| GO:0010885 | 0.01094 | 7.83046 | 0 | 3 | 13 | regulation of cholesterol storage |
| GO:0014820 | 0.01094 | 7.83046 | 0 | 3 | 13 | tonic smooth muscle contraction |
| GO:0031223 | 0.01094 | 7.83046 | 0 | 3 | 13 | auditory behavior |
| GO:0042635 | 0.01094 | 7.83046 | 0 | 3 | 13 | positive regulation of hair cycle |
| GO:0048340 | 0.01094 | 7.83046 | 0 | 3 | 13 | paraxial mesoderm morphogenesis |
| GO:0060100 | 0.01094 | 7.83046 | 0 | 3 | 13 | positive regulation of phagocytosis, engulfment |
| GO:0072160 | 0.01094 | 7.83046 | 0 | 3 | 13 | nephron tubule epithelial cell differentiation |
| GO:0086067 | 0.01094 | 7.83046 | 0 | 3 | 13 | AV node cell to bundle of His cell communication |
| GO:0099159 | 0.01094 | 7.83046 | 0 | 3 | 13 | regulation of modification of postsynaptic structure |
| GO:1902285 | 0.01094 | 7.83046 | 0 | 3 | 13 | semaphorin-plexin signaling pathway involved in neuron projection guidance |
| GO:1903587 | 0.01094 | 7.83046 | 0 | 3 | 13 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:1905155 | 0.01094 | 7.83046 | 0 | 3 | 13 | positive regulation of membrane invagination |
| GO:2000018 | 0.01094 | 7.83046 | 0 | 3 | 13 | regulation of male gonad development |
| GO:2001212 | 0.01094 | 7.83046 | 0 | 3 | 13 | regulation of vasculogenesis |
| GO:0034104 | 0.01096 | 5.22407 | 1 | 4 | 24 | negative regulation of tissue remodeling |
| GO:0046685 | 0.01096 | 5.22407 | 1 | 4 | 24 | response to arsenic-containing substance |
| GO:0061003 | 0.01096 | 5.22407 | 1 | 4 | 24 | positive regulation of dendritic spine morphogenesis |
| GO:0044070 | 0.01097 | 2.47203 | 4 | 10 | 116 | regulation of anion transport |
| GO:0030834 | 0.01102 | 3.48696 | 2 | 6 | 51 | regulation of actin filament depolymerization |
| GO:0043618 | 0.01102 | 3.48696 | 2 | 6 | 51 | regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0045687 | 0.01102 | 3.48696 | 2 | 6 | 51 | positive regulation of glial cell differentiation |
| GO:0048806 | 0.01102 | 3.48696 | 2 | 6 | 51 | genitalia development |
| GO:0060761 | 0.01102 | 3.48696 | 2 | 6 | 51 | negative regulation of response to cytokine stimulus |
| GO:0001894 | 0.01108 | 1.98221 | 8 | 16 | 228 | tissue homeostasis |
| GO:0016485 | 0.01108 | 1.98221 | 8 | 16 | 228 | protein processing |
| GO:0001959 | 0.01113 | 2.61915 | 4 | 9 | 99 | regulation of cytokine-mediated signaling pathway |
| GO:0044264 | 0.01113 | 2.61915 | 4 | 9 | 99 | cellular polysaccharide metabolic process |
| GO:0050848 | 0.01113 | 2.61915 | 4 | 9 | 99 | regulation of calcium-mediated signaling |
| GO:0006692 | 0.01120 | 4.08388 | 1 | 5 | 37 | prostanoid metabolic process |
| GO:0006693 | 0.01120 | 4.08388 | 1 | 5 | 37 | prostaglandin metabolic process |
| GO:0045684 | 0.01120 | 4.08388 | 1 | 5 | 37 | positive regulation of epidermis development |
| GO:1905209 | 0.01120 | 4.08388 | 1 | 5 | 37 | positive regulation of cardiocyte differentiation |
| GO:0015893 | 0.01127 | 2.02998 | 8 | 15 | 209 | drug transport |
| GO:0019722 | 0.01127 | 2.02998 | 8 | 15 | 209 | calcium-mediated signaling |
| GO:0036294 | 0.01161 | 2.44882 | 4 | 10 | 117 | cellular response to decreased oxygen levels |
| GO:0055092 | 0.01167 | 2.79236 | 3 | 8 | 83 | sterol homeostasis |
| GO:0050865 | 0.01168 | 1.53201 | 25 | 37 | 675 | regulation of cell activation |
| GO:0006766 | 0.01176 | 3.05262 | 2 | 7 | 67 | vitamin metabolic process |
| GO:0050771 | 0.01176 | 3.05262 | 2 | 7 | 67 | negative regulation of axonogenesis |
| GO:1904888 | 0.01176 | 3.05262 | 2 | 7 | 67 | cranial skeletal system development |
| GO:0010035 | 0.01179 | 1.63999 | 18 | 28 | 478 | response to inorganic substance |
| GO:0016202 | 0.01182 | 2.14490 | 6 | 13 | 172 | regulation of striated muscle tissue development |
| GO:0033559 | 0.01184 | 2.59026 | 4 | 9 | 100 | unsaturated fatty acid metabolic process |
| GO:0071804 | 0.01185 | 2.07576 | 7 | 14 | 191 | cellular potassium ion transport |
| GO:0071805 | 0.01185 | 2.07576 | 7 | 14 | 191 | potassium ion transmembrane transport |
| GO:0036293 | 0.01197 | 1.96350 | 9 | 16 | 230 | response to decreased oxygen levels |
| GO:0051604 | 0.01200 | 1.84305 | 11 | 19 | 290 | protein maturation |
| GO:0001954 | 0.01207 | 3.41101 | 2 | 6 | 52 | positive regulation of cell-matrix adhesion |
| GO:0007528 | 0.01207 | 3.41101 | 2 | 6 | 52 | neuromuscular junction development |
| GO:0045604 | 0.01207 | 3.41101 | 2 | 6 | 52 | regulation of epidermal cell differentiation |
| GO:0045773 | 0.01207 | 3.41101 | 2 | 6 | 52 | positive regulation of axon extension |
| GO:1904705 | 0.01207 | 3.41101 | 2 | 6 | 52 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.01207 | 3.41101 | 2 | 6 | 52 | vascular smooth muscle cell proliferation |
| GO:0008584 | 0.01228 | 2.42603 | 4 | 10 | 118 | male gonad development |
| GO:0051952 | 0.01228 | 2.42603 | 4 | 10 | 118 | regulation of amine transport |
| GO:0017156 | 0.01236 | 2.13140 | 6 | 13 | 173 | calcium ion regulated exocytosis |
| GO:0061024 | 0.01237 | 1.49967 | 28 | 40 | 745 | membrane organization |
| GO:0014910 | 0.01249 | 2.75550 | 3 | 8 | 84 | regulation of smooth muscle cell migration |
| GO:0031110 | 0.01249 | 2.75550 | 3 | 8 | 84 | regulation of microtubule polymerization or depolymerization |
| GO:0070252 | 0.01249 | 2.75550 | 3 | 8 | 84 | actin-mediated cell contraction |
| GO:0002686 | 0.01252 | 3.95995 | 1 | 5 | 38 | negative regulation of leukocyte migration |
| GO:0042304 | 0.01252 | 3.95995 | 1 | 5 | 38 | regulation of fatty acid biosynthetic process |
| GO:0072210 | 0.01252 | 3.95995 | 1 | 5 | 38 | metanephric nephron development |
| GO:0097009 | 0.01252 | 3.95995 | 1 | 5 | 38 | energy homeostasis |
| GO:1901021 | 0.01252 | 3.95995 | 1 | 5 | 38 | positive regulation of calcium ion transmembrane transporter activity |
| GO:2000300 | 0.01259 | 2.56199 | 4 | 9 | 101 | regulation of synaptic vesicle exocytosis |
| GO:0006817 | 0.01268 | 4.97508 | 1 | 4 | 25 | phosphate ion transport |
| GO:0007413 | 0.01268 | 4.97508 | 1 | 4 | 25 | axonal fasciculation |
| GO:0010742 | 0.01268 | 4.97508 | 1 | 4 | 25 | macrophage derived foam cell differentiation |
| GO:0014821 | 0.01268 | 4.97508 | 1 | 4 | 25 | phasic smooth muscle contraction |
| GO:0014829 | 0.01268 | 4.97508 | 1 | 4 | 25 | vascular smooth muscle contraction |
| GO:0031100 | 0.01268 | 4.97508 | 1 | 4 | 25 | animal organ regeneration |
| GO:0044550 | 0.01268 | 4.97508 | 1 | 4 | 25 | secondary metabolite biosynthetic process |
| GO:0048148 | 0.01268 | 4.97508 | 1 | 4 | 25 | behavioral response to cocaine |
| GO:0048714 | 0.01268 | 4.97508 | 1 | 4 | 25 | positive regulation of oligodendrocyte differentiation |
| GO:0086019 | 0.01268 | 4.97508 | 1 | 4 | 25 | cell-cell signaling involved in cardiac conduction |
| GO:0106030 | 0.01268 | 4.97508 | 1 | 4 | 25 | neuron projection fasciculation |
| GO:1904861 | 0.01268 | 4.97508 | 1 | 4 | 25 | excitatory synapse assembly |
| GO:2000738 | 0.01268 | 4.97508 | 1 | 4 | 25 | positive regulation of stem cell differentiation |
| GO:0002904 | 0.01270 | 17.38617 | 0 | 2 | 5 | positive regulation of B cell apoptotic process |
| GO:0003096 | 0.01270 | 17.38617 | 0 | 2 | 5 | renal sodium ion transport |
| GO:0003164 | 0.01270 | 17.38617 | 0 | 2 | 5 | His-Purkinje system development |
| GO:0007354 | 0.01270 | 17.38617 | 0 | 2 | 5 | zygotic determination of anterior/posterior axis, embryo |
| GO:0007494 | 0.01270 | 17.38617 | 0 | 2 | 5 | midgut development |
| GO:0009403 | 0.01270 | 17.38617 | 0 | 2 | 5 | toxin biosynthetic process |
| GO:0010694 | 0.01270 | 17.38617 | 0 | 2 | 5 | positive regulation of alkaline phosphatase activity |
| GO:0010891 | 0.01270 | 17.38617 | 0 | 2 | 5 | negative regulation of sequestering of triglyceride |
| GO:0015727 | 0.01270 | 17.38617 | 0 | 2 | 5 | lactate transport |
| GO:0019344 | 0.01270 | 17.38617 | 0 | 2 | 5 | cysteine biosynthetic process |
| GO:0031632 | 0.01270 | 17.38617 | 0 | 2 | 5 | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0033564 | 0.01270 | 17.38617 | 0 | 2 | 5 | anterior/posterior axon guidance |
| GO:0035873 | 0.01270 | 17.38617 | 0 | 2 | 5 | lactate transmembrane transport |
| GO:0035879 | 0.01270 | 17.38617 | 0 | 2 | 5 | plasma membrane lactate transport |
| GO:0035898 | 0.01270 | 17.38617 | 0 | 2 | 5 | parathyroid hormone secretion |
| GO:0046476 | 0.01270 | 17.38617 | 0 | 2 | 5 | glycosylceramide biosynthetic process |
| GO:0046959 | 0.01270 | 17.38617 | 0 | 2 | 5 | habituation |
| GO:0048818 | 0.01270 | 17.38617 | 0 | 2 | 5 | positive regulation of hair follicle maturation |
| GO:0060398 | 0.01270 | 17.38617 | 0 | 2 | 5 | regulation of growth hormone receptor signaling pathway |
| GO:0060696 | 0.01270 | 17.38617 | 0 | 2 | 5 | regulation of phospholipid catabolic process |
| GO:0060948 | 0.01270 | 17.38617 | 0 | 2 | 5 | cardiac vascular smooth muscle cell development |
| GO:0070100 | 0.01270 | 17.38617 | 0 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
| GO:0070777 | 0.01270 | 17.38617 | 0 | 2 | 5 | D-aspartate transport |
| GO:0070779 | 0.01270 | 17.38617 | 0 | 2 | 5 | D-aspartate import across plasma membrane |
| GO:0071442 | 0.01270 | 17.38617 | 0 | 2 | 5 | positive regulation of histone H3-K14 acetylation |
| GO:0071557 | 0.01270 | 17.38617 | 0 | 2 | 5 | histone H3-K27 demethylation |
| GO:0071640 | 0.01270 | 17.38617 | 0 | 2 | 5 | regulation of macrophage inflammatory protein 1 alpha production |
| GO:0090272 | 0.01270 | 17.38617 | 0 | 2 | 5 | negative regulation of fibroblast growth factor production |
| GO:0097638 | 0.01270 | 17.38617 | 0 | 2 | 5 | L-arginine import across plasma membrane |
| GO:0099502 | 0.01270 | 17.38617 | 0 | 2 | 5 | calcium-dependent activation of synaptic vesicle fusion |
| GO:1903238 | 0.01270 | 17.38617 | 0 | 2 | 5 | positive regulation of leukocyte tethering or rolling |
| GO:1904502 | 0.01270 | 17.38617 | 0 | 2 | 5 | regulation of lipophagy |
| GO:1904504 | 0.01270 | 17.38617 | 0 | 2 | 5 | positive regulation of lipophagy |
| GO:2000324 | 0.01270 | 17.38617 | 0 | 2 | 5 | positive regulation of glucocorticoid receptor signaling pathway |
| GO:0002694 | 0.01288 | 1.53993 | 23 | 35 | 635 | regulation of leukocyte activation |
| GO:1903706 | 0.01290 | 1.69833 | 15 | 24 | 396 | regulation of hemopoiesis |
| GO:0050708 | 0.01291 | 1.64281 | 17 | 27 | 460 | regulation of protein secretion |
| GO:0006813 | 0.01291 | 1.94515 | 9 | 16 | 232 | potassium ion transport |
| GO:0022409 | 0.01291 | 1.94515 | 9 | 16 | 232 | positive regulation of cell-cell adhesion |
| GO:0046546 | 0.01298 | 2.40367 | 4 | 10 | 119 | development of primary male sexual characteristics |
| GO:0045620 | 0.01320 | 3.33828 | 2 | 6 | 53 | negative regulation of lymphocyte differentiation |
| GO:0090303 | 0.01320 | 3.33828 | 2 | 6 | 53 | positive regulation of wound healing |
| GO:0099172 | 0.01320 | 3.33828 | 2 | 6 | 53 | presynapse organization |
| GO:0034613 | 0.01324 | 1.33022 | 61 | 78 | 1639 | cellular protein localization |
| GO:0035418 | 0.01336 | 2.71959 | 3 | 8 | 85 | protein localization to synapse |
| GO:0042490 | 0.01336 | 2.71959 | 3 | 8 | 85 | mechanoreceptor differentiation |
| GO:0035249 | 0.01337 | 2.53432 | 4 | 9 | 102 | synaptic transmission, glutamatergic |
| GO:0043473 | 0.01337 | 2.53432 | 4 | 9 | 102 | pigmentation |
| GO:0050886 | 0.01337 | 2.53432 | 4 | 9 | 102 | endocrine process |
| GO:0097237 | 0.01338 | 2.18504 | 6 | 12 | 156 | cellular response to toxic substance |
| GO:0006534 | 0.01354 | 7.11828 | 1 | 3 | 14 | cysteine metabolic process |
| GO:0031000 | 0.01354 | 7.11828 | 1 | 3 | 14 | response to caffeine |
| GO:0031987 | 0.01354 | 7.11828 | 1 | 3 | 14 | locomotion involved in locomotory behavior |
| GO:0033631 | 0.01354 | 7.11828 | 1 | 3 | 14 | cell-cell adhesion mediated by integrin |
| GO:0034433 | 0.01354 | 7.11828 | 1 | 3 | 14 | steroid esterification |
| GO:0034434 | 0.01354 | 7.11828 | 1 | 3 | 14 | sterol esterification |
| GO:0034435 | 0.01354 | 7.11828 | 1 | 3 | 14 | cholesterol esterification |
| GO:0036270 | 0.01354 | 7.11828 | 1 | 3 | 14 | response to diuretic |
| GO:0042159 | 0.01354 | 7.11828 | 1 | 3 | 14 | lipoprotein catabolic process |
| GO:0042759 | 0.01354 | 7.11828 | 1 | 3 | 14 | long-chain fatty acid biosynthetic process |
| GO:0060396 | 0.01354 | 7.11828 | 1 | 3 | 14 | growth hormone receptor signaling pathway |
| GO:0071378 | 0.01354 | 7.11828 | 1 | 3 | 14 | cellular response to growth hormone stimulus |
| GO:1905941 | 0.01354 | 7.11828 | 1 | 3 | 14 | positive regulation of gonad development |
| GO:0048706 | 0.01367 | 2.27013 | 5 | 11 | 138 | embryonic skeletal system development |
| GO:0050728 | 0.01367 | 2.27013 | 5 | 11 | 138 | negative regulation of inflammatory response |
| GO:0046717 | 0.01371 | 2.38171 | 4 | 10 | 120 | acid secretion |
| GO:0051153 | 0.01371 | 2.38171 | 4 | 10 | 120 | regulation of striated muscle cell differentiation |
| GO:0006687 | 0.01393 | 3.84331 | 1 | 5 | 39 | glycosphingolipid metabolic process |
| GO:0009395 | 0.01393 | 3.84331 | 1 | 5 | 39 | phospholipid catabolic process |
| GO:0097484 | 0.01393 | 3.84331 | 1 | 5 | 39 | dendrite extension |
| GO:0008654 | 0.01402 | 2.16988 | 6 | 12 | 157 | phospholipid biosynthetic process |
| GO:0048634 | 0.01411 | 2.09189 | 7 | 13 | 176 | regulation of muscle organ development |
| GO:0035019 | 0.01440 | 3.26859 | 2 | 6 | 54 | somatic stem cell population maintenance |
| GO:0035315 | 0.01440 | 3.26859 | 2 | 6 | 54 | hair cell differentiation |
| GO:0048016 | 0.01440 | 3.26859 | 2 | 6 | 54 | inositol phosphate-mediated signaling |
| GO:0002089 | 0.01455 | 4.74873 | 1 | 4 | 26 | lens morphogenesis in camera-type eye |
| GO:0003299 | 0.01455 | 4.74873 | 1 | 4 | 26 | muscle hypertrophy in response to stress |
| GO:0014898 | 0.01455 | 4.74873 | 1 | 4 | 26 | cardiac muscle hypertrophy in response to stress |
| GO:0050901 | 0.01455 | 4.74873 | 1 | 4 | 26 | leukocyte tethering or rolling |
| GO:0060065 | 0.01455 | 4.74873 | 1 | 4 | 26 | uterus development |
| GO:0089718 | 0.01455 | 4.74873 | 1 | 4 | 26 | amino acid import across plasma membrane |
| GO:0090025 | 0.01455 | 4.74873 | 1 | 4 | 26 | regulation of monocyte chemotaxis |
| GO:0090077 | 0.01455 | 4.74873 | 1 | 4 | 26 | foam cell differentiation |
| GO:2000178 | 0.01455 | 4.74873 | 1 | 4 | 26 | negative regulation of neural precursor cell proliferation |
| GO:2001257 | 0.01468 | 2.15492 | 6 | 12 | 158 | regulation of cation channel activity |
| GO:0000271 | 0.01475 | 2.90686 | 3 | 7 | 70 | polysaccharide biosynthetic process |
| GO:0071241 | 0.01486 | 1.95867 | 8 | 15 | 216 | cellular response to inorganic substance |
| GO:0070727 | 0.01493 | 1.32202 | 61 | 78 | 1648 | cellular macromolecule localization |
| GO:0022600 | 0.01504 | 2.48075 | 4 | 9 | 104 | digestive system process |
| GO:0031333 | 0.01509 | 2.23473 | 5 | 11 | 140 | negative regulation of protein complex assembly |
| GO:0010921 | 0.01525 | 2.33897 | 5 | 10 | 122 | regulation of phosphatase activity |
| GO:0015837 | 0.01525 | 2.33897 | 5 | 10 | 122 | amine transport |
| GO:0030705 | 0.01536 | 2.14016 | 6 | 12 | 159 | cytoskeleton-dependent intracellular transport |
| GO:0061351 | 0.01537 | 2.06634 | 7 | 13 | 178 | neural precursor cell proliferation |
| GO:2001235 | 0.01537 | 2.06634 | 7 | 13 | 178 | positive regulation of apoptotic signaling pathway |
| GO:0001101 | 0.01538 | 1.71196 | 13 | 22 | 360 | response to acid chemical |
| GO:0021983 | 0.01545 | 3.73333 | 1 | 5 | 40 | pituitary gland development |
| GO:1905953 | 0.01545 | 3.73333 | 1 | 5 | 40 | negative regulation of lipid localization |
| GO:0052547 | 0.01565 | 1.66644 | 15 | 24 | 403 | regulation of peptidase activity |
| GO:0003044 | 0.01567 | 3.20174 | 2 | 6 | 55 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0072577 | 0.01567 | 3.20174 | 2 | 6 | 55 | endothelial cell apoptotic process |
| GO:0090304 | 0.01578 | 1.20962 | 155 | 180 | 4198 | nucleic acid metabolic process |
| GO:0006950 | 0.01579 | 1.22538 | 130 | 153 | 3512 | response to stress |
| GO:0097529 | 0.01581 | 1.99616 | 7 | 14 | 198 | myeloid leukocyte migration |
| GO:0019233 | 0.01584 | 2.21744 | 5 | 11 | 141 | sensory perception of pain |
| GO:0035637 | 0.01584 | 2.21744 | 5 | 11 | 141 | multicellular organismal signaling |
| GO:0055007 | 0.01584 | 2.21744 | 5 | 11 | 141 | cardiac muscle cell differentiation |
| GO:0050433 | 0.01585 | 2.86132 | 3 | 7 | 71 | regulation of catecholamine secretion |
| GO:0050810 | 0.01585 | 2.86132 | 3 | 7 | 71 | regulation of steroid biosynthetic process |
| GO:0030048 | 0.01592 | 2.45480 | 4 | 9 | 105 | actin filament-based movement |
| GO:0043123 | 0.01592 | 2.45480 | 4 | 9 | 105 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:1905269 | 0.01592 | 2.45480 | 4 | 9 | 105 | positive regulation of chromatin organization |
| GO:2000379 | 0.01592 | 2.45480 | 4 | 9 | 105 | positive regulation of reactive oxygen species metabolic process |
| GO:0051092 | 0.01607 | 2.31817 | 5 | 10 | 123 | positive regulation of NF-kappaB transcription factor activity |
| GO:0080134 | 0.01613 | 1.36424 | 46 | 61 | 1247 | regulation of response to stress |
| GO:0003128 | 0.01647 | 6.52480 | 1 | 3 | 15 | heart field specification |
| GO:0006677 | 0.01647 | 6.52480 | 1 | 3 | 15 | glycosylceramide metabolic process |
| GO:0014049 | 0.01647 | 6.52480 | 1 | 3 | 15 | positive regulation of glutamate secretion |
| GO:0030730 | 0.01647 | 6.52480 | 1 | 3 | 15 | sequestering of triglyceride |
| GO:0042953 | 0.01647 | 6.52480 | 1 | 3 | 15 | lipoprotein transport |
| GO:0044872 | 0.01647 | 6.52480 | 1 | 3 | 15 | lipoprotein localization |
| GO:0045655 | 0.01647 | 6.52480 | 1 | 3 | 15 | regulation of monocyte differentiation |
| GO:0071243 | 0.01647 | 6.52480 | 1 | 3 | 15 | cellular response to arsenic-containing substance |
| GO:0072189 | 0.01647 | 6.52480 | 1 | 3 | 15 | ureter development |
| GO:0098703 | 0.01647 | 6.52480 | 1 | 3 | 15 | calcium ion import across plasma membrane |
| GO:1901722 | 0.01647 | 6.52480 | 1 | 3 | 15 | regulation of cell proliferation involved in kidney development |
| GO:1902656 | 0.01647 | 6.52480 | 1 | 3 | 15 | calcium ion import into cytosol |
| GO:2000811 | 0.01647 | 6.52480 | 1 | 3 | 15 | negative regulation of anoikis |
| GO:0006996 | 0.01658 | 1.22379 | 129 | 152 | 3492 | organelle organization |
| GO:0002068 | 0.01659 | 4.54206 | 1 | 4 | 27 | glandular epithelial cell development |
| GO:0014887 | 0.01659 | 4.54206 | 1 | 4 | 27 | cardiac muscle adaptation |
| GO:0036003 | 0.01659 | 4.54206 | 1 | 4 | 27 | positive regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0045956 | 0.01659 | 4.54206 | 1 | 4 | 27 | positive regulation of calcium ion-dependent exocytosis |
| GO:0048745 | 0.01659 | 4.54206 | 1 | 4 | 27 | smooth muscle tissue development |
| GO:0051446 | 0.01659 | 4.54206 | 1 | 4 | 27 | positive regulation of meiotic cell cycle |
| GO:0060008 | 0.01659 | 4.54206 | 1 | 4 | 27 | Sertoli cell differentiation |
| GO:0060343 | 0.01659 | 4.54206 | 1 | 4 | 27 | trabecula formation |
| GO:0090103 | 0.01659 | 4.54206 | 1 | 4 | 27 | cochlea morphogenesis |
| GO:0008643 | 0.01661 | 2.20042 | 5 | 11 | 142 | carbohydrate transport |
| GO:0018393 | 0.01661 | 2.20042 | 5 | 11 | 142 | internal peptidyl-lysine acetylation |
| GO:0045216 | 0.01661 | 2.20042 | 5 | 11 | 142 | cell-cell junction organization |
| GO:0046483 | 0.01700 | 1.19555 | 179 | 205 | 4848 | heterocycle metabolic process |
| GO:0008543 | 0.01702 | 2.81717 | 3 | 7 | 72 | fibroblast growth factor receptor signaling pathway |
| GO:0043620 | 0.01702 | 3.13756 | 2 | 6 | 56 | regulation of DNA-templated transcription in response to stress |
| GO:0007431 | 0.01708 | 3.62947 | 2 | 5 | 41 | salivary gland development |
| GO:1903672 | 0.01708 | 3.62947 | 2 | 5 | 41 | positive regulation of sprouting angiogenesis |
| GO:0006139 | 0.01709 | 1.19730 | 175 | 200 | 4720 | nucleobase-containing compound metabolic process |
| GO:0051650 | 0.01716 | 1.83702 | 10 | 17 | 260 | establishment of vesicle localization |
| GO:0032869 | 0.01742 | 2.02917 | 7 | 13 | 181 | cellular response to insulin stimulus |
| GO:0048145 | 0.01782 | 2.40448 | 4 | 9 | 107 | regulation of fibroblast proliferation |
| GO:0032272 | 0.01824 | 2.77436 | 3 | 7 | 73 | negative regulation of protein polymerization |
| GO:2000573 | 0.01824 | 2.77436 | 3 | 7 | 73 | positive regulation of DNA biosynthetic process |
| GO:0006865 | 0.01825 | 2.16713 | 5 | 11 | 144 | amino acid transport |
| GO:0035303 | 0.01834 | 2.08309 | 6 | 12 | 163 | regulation of dephosphorylation |
| GO:1903034 | 0.01834 | 2.08309 | 6 | 12 | 163 | regulation of response to wounding |
| GO:0043535 | 0.01835 | 2.55319 | 3 | 8 | 90 | regulation of blood vessel endothelial cell migration |
| GO:0045123 | 0.01845 | 3.07591 | 2 | 6 | 57 | cellular extravasation |
| GO:0099601 | 0.01845 | 3.07591 | 2 | 6 | 57 | regulation of neurotransmitter receptor activity |
| GO:0001705 | 0.01858 | 13.03904 | 0 | 2 | 6 | ectoderm formation |
| GO:0006686 | 0.01858 | 13.03904 | 0 | 2 | 6 | sphingomyelin biosynthetic process |
| GO:0008228 | 0.01858 | 13.03904 | 0 | 2 | 6 | opsonization |
| GO:0010701 | 0.01858 | 13.03904 | 0 | 2 | 6 | positive regulation of norepinephrine secretion |
| GO:0014043 | 0.01858 | 13.03904 | 0 | 2 | 6 | negative regulation of neuron maturation |
| GO:0035860 | 0.01858 | 13.03904 | 0 | 2 | 6 | glial cell-derived neurotrophic factor receptor signaling pathway |
| GO:0038007 | 0.01858 | 13.03904 | 0 | 2 | 6 | netrin-activated signaling pathway |
| GO:0045162 | 0.01858 | 13.03904 | 0 | 2 | 6 | clustering of voltage-gated sodium channels |
| GO:0045650 | 0.01858 | 13.03904 | 0 | 2 | 6 | negative regulation of macrophage differentiation |
| GO:0051891 | 0.01858 | 13.03904 | 0 | 2 | 6 | positive regulation of cardioblast differentiation |
| GO:0060331 | 0.01858 | 13.03904 | 0 | 2 | 6 | negative regulation of response to interferon-gamma |
| GO:0060336 | 0.01858 | 13.03904 | 0 | 2 | 6 | negative regulation of interferon-gamma-mediated signaling pathway |
| GO:0061218 | 0.01858 | 13.03904 | 0 | 2 | 6 | negative regulation of mesonephros development |
| GO:0061724 | 0.01858 | 13.03904 | 0 | 2 | 6 | lipophagy |
| GO:0070099 | 0.01858 | 13.03904 | 0 | 2 | 6 | regulation of chemokine-mediated signaling pathway |
| GO:0070447 | 0.01858 | 13.03904 | 0 | 2 | 6 | positive regulation of oligodendrocyte progenitor proliferation |
| GO:0070813 | 0.01858 | 13.03904 | 0 | 2 | 6 | hydrogen sulfide metabolic process |
| GO:0071608 | 0.01858 | 13.03904 | 0 | 2 | 6 | macrophage inflammatory protein-1 alpha production |
| GO:0071895 | 0.01858 | 13.03904 | 0 | 2 | 6 | odontoblast differentiation |
| GO:0072174 | 0.01858 | 13.03904 | 0 | 2 | 6 | metanephric tubule formation |
| GO:0072177 | 0.01858 | 13.03904 | 0 | 2 | 6 | mesonephric duct development |
| GO:0090027 | 0.01858 | 13.03904 | 0 | 2 | 6 | negative regulation of monocyte chemotaxis |
| GO:0098937 | 0.01858 | 13.03904 | 0 | 2 | 6 | anterograde dendritic transport |
| GO:0099566 | 0.01858 | 13.03904 | 0 | 2 | 6 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:1903400 | 0.01858 | 13.03904 | 0 | 2 | 6 | L-arginine transmembrane transport |
| GO:1903826 | 0.01858 | 13.03904 | 0 | 2 | 6 | arginine transmembrane transport |
| GO:1904428 | 0.01858 | 13.03904 | 0 | 2 | 6 | negative regulation of tubulin deacetylation |
| GO:1904778 | 0.01858 | 13.03904 | 0 | 2 | 6 | positive regulation of protein localization to cell cortex |
| GO:1905203 | 0.01858 | 13.03904 | 0 | 2 | 6 | regulation of connective tissue replacement |
| GO:1990822 | 0.01858 | 13.03904 | 0 | 2 | 6 | basic amino acid transmembrane transport |
| GO:0001945 | 0.01881 | 4.35261 | 1 | 4 | 28 | lymph vessel development |
| GO:0005979 | 0.01881 | 4.35261 | 1 | 4 | 28 | regulation of glycogen biosynthetic process |
| GO:0008045 | 0.01881 | 4.35261 | 1 | 4 | 28 | motor neuron axon guidance |
| GO:0010962 | 0.01881 | 4.35261 | 1 | 4 | 28 | regulation of glucan biosynthetic process |
| GO:0031116 | 0.01881 | 4.35261 | 1 | 4 | 28 | positive regulation of microtubule polymerization |
| GO:0033137 | 0.01881 | 4.35261 | 1 | 4 | 28 | negative regulation of peptidyl-serine phosphorylation |
| GO:0060039 | 0.01881 | 4.35261 | 1 | 4 | 28 | pericardium development |
| GO:0060384 | 0.01881 | 4.35261 | 1 | 4 | 28 | innervation |
| GO:0060445 | 0.01881 | 4.35261 | 1 | 4 | 28 | branching involved in salivary gland morphogenesis |
| GO:0061082 | 0.01881 | 4.35261 | 1 | 4 | 28 | myeloid leukocyte cytokine production |
| GO:0061298 | 0.01881 | 4.35261 | 1 | 4 | 28 | retina vasculature development in camera-type eye |
| GO:1903859 | 0.01881 | 4.35261 | 1 | 4 | 28 | regulation of dendrite extension |
| GO:0030835 | 0.01881 | 3.53122 | 2 | 5 | 42 | negative regulation of actin filament depolymerization |
| GO:2000826 | 0.01881 | 3.53122 | 2 | 5 | 42 | regulation of heart morphogenesis |
| GO:0006473 | 0.01891 | 2.00512 | 7 | 13 | 183 | protein acetylation |
| GO:0072659 | 0.01897 | 1.81437 | 10 | 17 | 263 | protein localization to plasma membrane |
| GO:0006475 | 0.01912 | 2.15086 | 5 | 11 | 145 | internal protein amino acid acetylation |
| GO:0014070 | 0.01929 | 1.45826 | 28 | 39 | 745 | response to organic cyclic compound |
| GO:0048609 | 0.01935 | 1.43080 | 31 | 43 | 837 | multicellular organismal reproductive process |
| GO:0010660 | 0.01949 | 2.52231 | 3 | 8 | 91 | regulation of muscle cell apoptotic process |
| GO:0051966 | 0.01953 | 2.73283 | 3 | 7 | 74 | regulation of synaptic transmission, glutamatergic |
| GO:0010469 | 0.01967 | 2.23851 | 5 | 10 | 127 | regulation of signaling receptor activity |
| GO:0002467 | 0.01973 | 6.02262 | 1 | 3 | 16 | germinal center formation |
| GO:0003161 | 0.01973 | 6.02262 | 1 | 3 | 16 | cardiac conduction system development |
| GO:0003222 | 0.01973 | 6.02262 | 1 | 3 | 16 | ventricular trabecula myocardium morphogenesis |
| GO:0007638 | 0.01973 | 6.02262 | 1 | 3 | 16 | mechanosensory behavior |
| GO:0008272 | 0.01973 | 6.02262 | 1 | 3 | 16 | sulfate transport |
| GO:0051127 | 0.01973 | 6.02262 | 1 | 3 | 16 | positive regulation of actin nucleation |
| GO:0051151 | 0.01973 | 6.02262 | 1 | 3 | 16 | negative regulation of smooth muscle cell differentiation |
| GO:0060099 | 0.01973 | 6.02262 | 1 | 3 | 16 | regulation of phagocytosis, engulfment |
| GO:0060979 | 0.01973 | 6.02262 | 1 | 3 | 16 | vasculogenesis involved in coronary vascular morphogenesis |
| GO:0071498 | 0.01973 | 6.02262 | 1 | 3 | 16 | cellular response to fluid shear stress |
| GO:1903779 | 0.01973 | 6.02262 | 1 | 3 | 16 | regulation of cardiac conduction |
| GO:2001053 | 0.01973 | 6.02262 | 1 | 3 | 16 | regulation of mesenchymal cell apoptotic process |
| GO:0051640 | 0.01980 | 1.51691 | 22 | 32 | 588 | organelle localization |
| GO:0032147 | 0.01986 | 1.84177 | 9 | 16 | 244 | activation of protein kinase activity |
| GO:0048144 | 0.01986 | 2.35618 | 4 | 9 | 109 | fibroblast proliferation |
| GO:0070371 | 0.01995 | 1.68794 | 13 | 21 | 348 | ERK1 and ERK2 cascade |
| GO:0002011 | 0.01995 | 3.01662 | 2 | 6 | 58 | morphogenesis of an epithelial sheet |
| GO:0006576 | 0.02066 | 3.43813 | 2 | 5 | 43 | cellular biogenic amine metabolic process |
| GO:0033344 | 0.02066 | 3.43813 | 2 | 5 | 43 | cholesterol efflux |
| GO:0086002 | 0.02066 | 3.43813 | 2 | 5 | 43 | cardiac muscle cell action potential involved in contraction |
| GO:1902893 | 0.02066 | 3.43813 | 2 | 5 | 43 | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0051099 | 0.02070 | 1.92239 | 8 | 14 | 205 | positive regulation of binding |
| GO:2001242 | 0.02084 | 2.04224 | 6 | 12 | 166 | regulation of intrinsic apoptotic signaling pathway |
| GO:0002718 | 0.02087 | 2.69252 | 3 | 7 | 75 | regulation of cytokine production involved in immune response |
| GO:0070373 | 0.02087 | 2.69252 | 3 | 7 | 75 | negative regulation of ERK1 and ERK2 cascade |
| GO:0046660 | 0.02093 | 2.11904 | 5 | 11 | 147 | female sex differentiation |
| GO:0002688 | 0.02095 | 2.33275 | 4 | 9 | 110 | regulation of leukocyte chemotaxis |
| GO:0060759 | 0.02095 | 2.33275 | 4 | 9 | 110 | regulation of response to cytokine stimulus |
| GO:0051248 | 0.02110 | 1.37588 | 39 | 52 | 1052 | negative regulation of protein metabolic process |
| GO:0030031 | 0.02114 | 1.55525 | 19 | 28 | 502 | cell projection assembly |
| GO:0051345 | 0.02114 | 1.55525 | 19 | 28 | 502 | positive regulation of hydrolase activity |
| GO:0002691 | 0.02119 | 4.17832 | 1 | 4 | 29 | regulation of cellular extravasation |
| GO:0048820 | 0.02119 | 4.17832 | 1 | 4 | 29 | hair follicle maturation |
| GO:0060914 | 0.02119 | 4.17832 | 1 | 4 | 29 | heart formation |
| GO:0061756 | 0.02119 | 4.17832 | 1 | 4 | 29 | leukocyte adhesion to vascular endothelial cell |
| GO:0071709 | 0.02119 | 4.17832 | 1 | 4 | 29 | membrane assembly |
| GO:0008361 | 0.02149 | 1.91230 | 8 | 14 | 206 | regulation of cell size |
| GO:0030837 | 0.02154 | 2.95957 | 2 | 6 | 59 | negative regulation of actin filament polymerization |
| GO:0031122 | 0.02154 | 2.95957 | 2 | 6 | 59 | cytoplasmic microtubule organization |
| GO:0046850 | 0.02154 | 2.95957 | 2 | 6 | 59 | regulation of bone remodeling |
| GO:0060324 | 0.02154 | 2.95957 | 2 | 6 | 59 | face development |
| GO:0060986 | 0.02154 | 2.95957 | 2 | 6 | 59 | endocrine hormone secretion |
| GO:0071156 | 0.02154 | 2.95957 | 2 | 6 | 59 | regulation of cell cycle arrest |
| GO:1903307 | 0.02154 | 2.95957 | 2 | 6 | 59 | positive regulation of regulated secretory pathway |
| GO:0042886 | 0.02176 | 1.28782 | 66 | 82 | 1775 | amide transport |
| GO:0019221 | 0.02182 | 1.69501 | 12 | 20 | 330 | cytokine-mediated signaling pathway |
| GO:0046888 | 0.02192 | 2.46275 | 3 | 8 | 93 | negative regulation of hormone secretion |
| GO:0001952 | 0.02208 | 2.30977 | 4 | 9 | 111 | regulation of cell-matrix adhesion |
| GO:0030193 | 0.02228 | 2.65338 | 3 | 7 | 76 | regulation of blood coagulation |
| GO:0042116 | 0.02228 | 2.65338 | 3 | 7 | 76 | macrophage activation |
| GO:0046785 | 0.02228 | 2.65338 | 3 | 7 | 76 | microtubule polymerization |
| GO:0051965 | 0.02228 | 2.65338 | 3 | 7 | 76 | positive regulation of synapse assembly |
| GO:1904427 | 0.02228 | 2.65338 | 3 | 7 | 76 | positive regulation of calcium ion transmembrane transport |
| GO:0070588 | 0.02231 | 1.77783 | 10 | 17 | 268 | calcium ion transmembrane transport |
| GO:0051235 | 0.02252 | 1.71483 | 11 | 19 | 310 | maintenance of location |
| GO:0045581 | 0.02262 | 3.34983 | 2 | 5 | 44 | negative regulation of T cell differentiation |
| GO:0090279 | 0.02262 | 3.34983 | 2 | 5 | 44 | regulation of calcium ion import |
| GO:0034330 | 0.02272 | 1.80969 | 9 | 16 | 248 | cell junction organization |
| GO:0050731 | 0.02302 | 1.94739 | 7 | 13 | 188 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0014911 | 0.02321 | 2.90463 | 2 | 6 | 60 | positive regulation of smooth muscle cell migration |
| GO:0051926 | 0.02321 | 2.90463 | 2 | 6 | 60 | negative regulation of calcium ion transport |
| GO:1905207 | 0.02321 | 2.90463 | 2 | 6 | 60 | regulation of cardiocyte differentiation |
| GO:0045445 | 0.02321 | 2.43400 | 3 | 8 | 94 | myoblast differentiation |
| GO:0003184 | 0.02331 | 5.59218 | 1 | 3 | 17 | pulmonary valve morphogenesis |
| GO:0007350 | 0.02331 | 5.59218 | 1 | 3 | 17 | blastoderm segmentation |
| GO:0009070 | 0.02331 | 5.59218 | 1 | 3 | 17 | serine family amino acid biosynthetic process |
| GO:0010880 | 0.02331 | 5.59218 | 1 | 3 | 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| GO:0010888 | 0.02331 | 5.59218 | 1 | 3 | 17 | negative regulation of lipid storage |
| GO:0015701 | 0.02331 | 5.59218 | 1 | 3 | 17 | bicarbonate transport |
| GO:0032780 | 0.02331 | 5.59218 | 1 | 3 | 17 | negative regulation of ATPase activity |
| GO:0036120 | 0.02331 | 5.59218 | 1 | 3 | 17 | cellular response to platelet-derived growth factor stimulus |
| GO:0042074 | 0.02331 | 5.59218 | 1 | 3 | 17 | cell migration involved in gastrulation |
| GO:0045019 | 0.02331 | 5.59218 | 1 | 3 | 17 | negative regulation of nitric oxide biosynthetic process |
| GO:0045725 | 0.02331 | 5.59218 | 1 | 3 | 17 | positive regulation of glycogen biosynthetic process |
| GO:0045836 | 0.02331 | 5.59218 | 1 | 3 | 17 | positive regulation of meiotic nuclear division |
| GO:0060413 | 0.02331 | 5.59218 | 1 | 3 | 17 | atrial septum morphogenesis |
| GO:0060416 | 0.02331 | 5.59218 | 1 | 3 | 17 | response to growth hormone |
| GO:0072234 | 0.02331 | 5.59218 | 1 | 3 | 17 | metanephric nephron tubule development |
| GO:0097091 | 0.02331 | 5.59218 | 1 | 3 | 17 | synaptic vesicle clustering |
| GO:0097152 | 0.02331 | 5.59218 | 1 | 3 | 17 | mesenchymal cell apoptotic process |
| GO:1904406 | 0.02331 | 5.59218 | 1 | 3 | 17 | negative regulation of nitric oxide metabolic process |
| GO:1905153 | 0.02331 | 5.59218 | 1 | 3 | 17 | regulation of membrane invagination |
| GO:1905244 | 0.02331 | 5.59218 | 1 | 3 | 17 | regulation of modification of synaptic structure |
| GO:2000696 | 0.02331 | 5.59218 | 1 | 3 | 17 | regulation of epithelial cell differentiation involved in kidney development |
| GO:0032504 | 0.02346 | 1.41053 | 31 | 43 | 848 | multicellular organism reproduction |
| GO:0015833 | 0.02350 | 1.28442 | 65 | 81 | 1757 | peptide transport |
| GO:0000038 | 0.02376 | 4.01743 | 1 | 4 | 30 | very long-chain fatty acid metabolic process |
| GO:0014002 | 0.02376 | 4.01743 | 1 | 4 | 30 | astrocyte development |
| GO:0022011 | 0.02376 | 4.01743 | 1 | 4 | 30 | myelination in peripheral nervous system |
| GO:0032292 | 0.02376 | 4.01743 | 1 | 4 | 30 | peripheral nervous system axon ensheathment |
| GO:0035767 | 0.02376 | 4.01743 | 1 | 4 | 30 | endothelial cell chemotaxis |
| GO:0043090 | 0.02376 | 4.01743 | 1 | 4 | 30 | amino acid import |
| GO:0044062 | 0.02376 | 4.01743 | 1 | 4 | 30 | regulation of excretion |
| GO:0099633 | 0.02376 | 4.01743 | 1 | 4 | 30 | protein localization to postsynaptic specialization membrane |
| GO:0099645 | 0.02376 | 4.01743 | 1 | 4 | 30 | neurotransmitter receptor localization to postsynaptic specialization membrane |
| GO:0043525 | 0.02376 | 2.61536 | 3 | 7 | 77 | positive regulation of neuron apoptotic process |
| GO:1900046 | 0.02376 | 2.61536 | 3 | 7 | 77 | regulation of hemostasis |
| GO:0048511 | 0.02376 | 1.76361 | 10 | 17 | 270 | rhythmic process |
| GO:0032269 | 0.02376 | 1.37801 | 37 | 49 | 989 | negative regulation of cellular protein metabolic process |
| GO:0050954 | 0.02388 | 1.73104 | 11 | 18 | 291 | sensory perception of mechanical stimulus |
| GO:1904064 | 0.02389 | 2.07303 | 6 | 11 | 150 | positive regulation of cation transmembrane transport |
| GO:0045055 | 0.02426 | 1.79406 | 9 | 16 | 250 | regulated exocytosis |
| GO:0007589 | 0.02447 | 2.26515 | 4 | 9 | 113 | body fluid secretion |
| GO:1901216 | 0.02447 | 2.26515 | 4 | 9 | 113 | positive regulation of neuron death |
| GO:0043409 | 0.02455 | 1.99018 | 6 | 12 | 170 | negative regulation of MAPK cascade |
| GO:0002793 | 0.02457 | 1.69710 | 12 | 19 | 313 | positive regulation of peptide secretion |
| GO:0014046 | 0.02469 | 3.26594 | 2 | 5 | 45 | dopamine secretion |
| GO:0014059 | 0.02469 | 3.26594 | 2 | 5 | 45 | regulation of dopamine secretion |
| GO:0060323 | 0.02469 | 3.26594 | 2 | 5 | 45 | head morphogenesis |
| GO:1902743 | 0.02469 | 3.26594 | 2 | 5 | 45 | regulation of lamellipodium organization |
| GO:0006979 | 0.02473 | 1.60804 | 15 | 23 | 399 | response to oxidative stress |
| GO:0031056 | 0.02494 | 2.05813 | 6 | 11 | 151 | regulation of histone modification |
| GO:0019748 | 0.02496 | 2.85169 | 2 | 6 | 61 | secondary metabolic process |
| GO:0001508 | 0.02497 | 2.14629 | 5 | 10 | 132 | action potential |
| GO:0009855 | 0.02497 | 2.14629 | 5 | 10 | 132 | determination of bilateral symmetry |
| GO:0050805 | 0.02530 | 2.57841 | 3 | 7 | 78 | negative regulation of synaptic transmission |
| GO:0002158 | 0.02538 | 10.43077 | 0 | 2 | 7 | osteoclast proliferation |
| GO:0003256 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
| GO:0003321 | 0.02538 | 10.43077 | 0 | 2 | 7 | positive regulation of blood pressure by epinephrine-norepinephrine |
| GO:0006108 | 0.02538 | 10.43077 | 0 | 2 | 7 | malate metabolic process |
| GO:0006681 | 0.02538 | 10.43077 | 0 | 2 | 7 | galactosylceramide metabolic process |
| GO:0010881 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion |
| GO:0010886 | 0.02538 | 10.43077 | 0 | 2 | 7 | positive regulation of cholesterol storage |
| GO:0015822 | 0.02538 | 10.43077 | 0 | 2 | 7 | ornithine transport |
| GO:0019367 | 0.02538 | 10.43077 | 0 | 2 | 7 | fatty acid elongation, saturated fatty acid |
| GO:0019368 | 0.02538 | 10.43077 | 0 | 2 | 7 | fatty acid elongation, unsaturated fatty acid |
| GO:0032808 | 0.02538 | 10.43077 | 0 | 2 | 7 | lacrimal gland development |
| GO:0033278 | 0.02538 | 10.43077 | 0 | 2 | 7 | cell proliferation in midbrain |
| GO:0033629 | 0.02538 | 10.43077 | 0 | 2 | 7 | negative regulation of cell adhesion mediated by integrin |
| GO:0034379 | 0.02538 | 10.43077 | 0 | 2 | 7 | very-low-density lipoprotein particle assembly |
| GO:0034625 | 0.02538 | 10.43077 | 0 | 2 | 7 | fatty acid elongation, monounsaturated fatty acid |
| GO:0034626 | 0.02538 | 10.43077 | 0 | 2 | 7 | fatty acid elongation, polyunsaturated fatty acid |
| GO:0035931 | 0.02538 | 10.43077 | 0 | 2 | 7 | mineralocorticoid secretion |
| GO:0035932 | 0.02538 | 10.43077 | 0 | 2 | 7 | aldosterone secretion |
| GO:0038203 | 0.02538 | 10.43077 | 0 | 2 | 7 | TORC2 signaling |
| GO:0042297 | 0.02538 | 10.43077 | 0 | 2 | 7 | vocal learning |
| GO:0042940 | 0.02538 | 10.43077 | 0 | 2 | 7 | D-amino acid transport |
| GO:0045656 | 0.02538 | 10.43077 | 0 | 2 | 7 | negative regulation of monocyte differentiation |
| GO:0060017 | 0.02538 | 10.43077 | 0 | 2 | 7 | parathyroid gland development |
| GO:0060029 | 0.02538 | 10.43077 | 0 | 2 | 7 | convergent extension involved in organogenesis |
| GO:0060054 | 0.02538 | 10.43077 | 0 | 2 | 7 | positive regulation of epithelial cell proliferation involved in wound healing |
| GO:0060501 | 0.02538 | 10.43077 | 0 | 2 | 7 | positive regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0060770 | 0.02538 | 10.43077 | 0 | 2 | 7 | negative regulation of epithelial cell proliferation involved in prostate gland development |
| GO:0061314 | 0.02538 | 10.43077 | 0 | 2 | 7 | Notch signaling involved in heart development |
| GO:0071440 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of histone H3-K14 acetylation |
| GO:0071676 | 0.02538 | 10.43077 | 0 | 2 | 7 | negative regulation of mononuclear cell migration |
| GO:0086042 | 0.02538 | 10.43077 | 0 | 2 | 7 | cardiac muscle cell-cardiac muscle cell adhesion |
| GO:0086064 | 0.02538 | 10.43077 | 0 | 2 | 7 | cell communication by electrical coupling involved in cardiac conduction |
| GO:0098596 | 0.02538 | 10.43077 | 0 | 2 | 7 | imitative learning |
| GO:0150011 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of neuron projection arborization |
| GO:0150012 | 0.02538 | 10.43077 | 0 | 2 | 7 | positive regulation of neuron projection arborization |
| GO:1900084 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of peptidyl-tyrosine autophosphorylation |
| GO:1903352 | 0.02538 | 10.43077 | 0 | 2 | 7 | L-ornithine transmembrane transport |
| GO:1904776 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of protein localization to cell cortex |
| GO:1990034 | 0.02538 | 10.43077 | 0 | 2 | 7 | calcium ion export across plasma membrane |
| GO:1990048 | 0.02538 | 10.43077 | 0 | 2 | 7 | anterograde neuronal dense core vesicle transport |
| GO:2000096 | 0.02538 | 10.43077 | 0 | 2 | 7 | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:2000653 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of genetic imprinting |
| GO:2000855 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of mineralocorticoid secretion |
| GO:2000858 | 0.02538 | 10.43077 | 0 | 2 | 7 | regulation of aldosterone secretion |
| GO:2001016 | 0.02538 | 10.43077 | 0 | 2 | 7 | positive regulation of skeletal muscle cell differentiation |
| GO:0016567 | 0.02545 | 1.50458 | 21 | 30 | 555 | protein ubiquitination |
| GO:0016570 | 0.02548 | 1.58551 | 16 | 24 | 422 | histone modification |
| GO:1901699 | 0.02593 | 1.48137 | 22 | 32 | 601 | cellular response to nitrogen compound |
| GO:0010657 | 0.02595 | 2.37847 | 4 | 8 | 96 | muscle cell apoptotic process |
| GO:1903426 | 0.02595 | 2.37847 | 4 | 8 | 96 | regulation of reactive oxygen species biosynthetic process |
| GO:0120031 | 0.02601 | 1.53765 | 18 | 27 | 489 | plasma membrane bounded cell projection assembly |
| GO:0051896 | 0.02602 | 2.04344 | 6 | 11 | 152 | regulation of protein kinase B signaling |
| GO:0051222 | 0.02611 | 1.58147 | 16 | 24 | 423 | positive regulation of protein transport |
| GO:0009799 | 0.02614 | 2.12874 | 5 | 10 | 133 | specification of symmetry |
| GO:0031099 | 0.02614 | 2.12874 | 5 | 10 | 133 | regeneration |
| GO:0045786 | 0.02614 | 1.56537 | 16 | 25 | 445 | negative regulation of cell cycle |
| GO:0034629 | 0.02650 | 3.86847 | 1 | 4 | 31 | cellular protein-containing complex localization |
| GO:0043243 | 0.02650 | 3.86847 | 1 | 4 | 31 | positive regulation of protein complex disassembly |
| GO:0043276 | 0.02650 | 3.86847 | 1 | 4 | 31 | anoikis |
| GO:0045616 | 0.02650 | 3.86847 | 1 | 4 | 31 | regulation of keratinocyte differentiation |
| GO:0045662 | 0.02650 | 3.86847 | 1 | 4 | 31 | negative regulation of myoblast differentiation |
| GO:0001775 | 0.02653 | 1.35459 | 39 | 52 | 1067 | cell activation |
| GO:0048813 | 0.02658 | 1.96512 | 6 | 12 | 172 | dendrite morphogenesis |
| GO:0032868 | 0.02666 | 1.85385 | 8 | 14 | 212 | response to insulin |
| GO:0045637 | 0.02666 | 1.85385 | 8 | 14 | 212 | regulation of myeloid cell differentiation |
| GO:0007204 | 0.02676 | 1.67973 | 12 | 19 | 316 | positive regulation of cytosolic calcium ion concentration |
| GO:1902905 | 0.02677 | 1.90353 | 7 | 13 | 192 | positive regulation of supramolecular fiber organization |
| GO:0006801 | 0.02680 | 2.80064 | 2 | 6 | 62 | superoxide metabolic process |
| GO:0021772 | 0.02689 | 3.18614 | 2 | 5 | 46 | olfactory bulb development |
| GO:0090102 | 0.02689 | 3.18614 | 2 | 5 | 46 | cochlea development |
| GO:0015748 | 0.02690 | 2.54248 | 3 | 7 | 79 | organophosphate ester transport |
| GO:0046364 | 0.02690 | 2.54248 | 3 | 7 | 79 | monosaccharide biosynthetic process |
| GO:0046620 | 0.02703 | 2.22221 | 4 | 9 | 115 | regulation of organ growth |
| GO:0009628 | 0.02708 | 1.36095 | 38 | 50 | 1021 | response to abiotic stimulus |
| GO:0001838 | 0.02714 | 2.02896 | 6 | 11 | 153 | embryonic epithelial tube formation |
| GO:0002076 | 0.02722 | 5.21914 | 1 | 3 | 18 | osteoblast development |
| GO:0005980 | 0.02722 | 5.21914 | 1 | 3 | 18 | glycogen catabolic process |
| GO:0009251 | 0.02722 | 5.21914 | 1 | 3 | 18 | glucan catabolic process |
| GO:0010996 | 0.02722 | 5.21914 | 1 | 3 | 18 | response to auditory stimulus |
| GO:0014072 | 0.02722 | 5.21914 | 1 | 3 | 18 | response to isoquinoline alkaloid |
| GO:0030952 | 0.02722 | 5.21914 | 1 | 3 | 18 | establishment or maintenance of cytoskeleton polarity |
| GO:0034111 | 0.02722 | 5.21914 | 1 | 3 | 18 | negative regulation of homotypic cell-cell adhesion |
| GO:0036119 | 0.02722 | 5.21914 | 1 | 3 | 18 | response to platelet-derived growth factor |
| GO:0042219 | 0.02722 | 5.21914 | 1 | 3 | 18 | cellular modified amino acid catabolic process |
| GO:0048268 | 0.02722 | 5.21914 | 1 | 3 | 18 | clathrin coat assembly |
| GO:0048791 | 0.02722 | 5.21914 | 1 | 3 | 18 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0050910 | 0.02722 | 5.21914 | 1 | 3 | 18 | detection of mechanical stimulus involved in sensory perception of sound |
| GO:0060841 | 0.02722 | 5.21914 | 1 | 3 | 18 | venous blood vessel development |
| GO:0060947 | 0.02722 | 5.21914 | 1 | 3 | 18 | cardiac vascular smooth muscle cell differentiation |
| GO:0099150 | 0.02722 | 5.21914 | 1 | 3 | 18 | regulation of postsynaptic specialization assembly |
| GO:0150052 | 0.02722 | 5.21914 | 1 | 3 | 18 | regulation of postsynapse assembly |
| GO:1904706 | 0.02722 | 5.21914 | 1 | 3 | 18 | negative regulation of vascular smooth muscle cell proliferation |
| GO:2000678 | 0.02722 | 5.21914 | 1 | 3 | 18 | negative regulation of transcription regulatory region DNA binding |
| GO:0055088 | 0.02735 | 2.11148 | 5 | 10 | 134 | lipid homeostasis |
| GO:0001819 | 0.02739 | 1.57343 | 16 | 24 | 425 | positive regulation of cytokine production |
| GO:0006641 | 0.02740 | 2.35164 | 4 | 8 | 97 | triglyceride metabolic process |
| GO:0034766 | 0.02740 | 2.35164 | 4 | 8 | 97 | negative regulation of ion transmembrane transport |
| GO:0050863 | 0.02768 | 1.69952 | 11 | 18 | 296 | regulation of T cell activation |
| GO:0046434 | 0.02777 | 1.89287 | 7 | 13 | 193 | organophosphate catabolic process |
| GO:0018193 | 0.02825 | 1.34483 | 41 | 53 | 1095 | peptidyl-amino acid modification |
| GO:0050727 | 0.02830 | 1.66834 | 12 | 19 | 318 | regulation of inflammatory response |
| GO:0046545 | 0.02838 | 2.20135 | 4 | 9 | 116 | development of primary female sexual characteristics |
| GO:0035050 | 0.02858 | 2.50754 | 3 | 7 | 80 | embryonic heart tube development |
| GO:0050818 | 0.02858 | 2.50754 | 3 | 7 | 80 | regulation of coagulation |
| GO:0033692 | 0.02873 | 2.75139 | 2 | 6 | 63 | cellular polysaccharide biosynthetic process |
| GO:0046777 | 0.02909 | 1.78798 | 9 | 15 | 235 | protein autophosphorylation |
| GO:0043470 | 0.02920 | 3.11014 | 2 | 5 | 47 | regulation of carbohydrate catabolic process |
| GO:0045429 | 0.02920 | 3.11014 | 2 | 5 | 47 | positive regulation of nitric oxide biosynthetic process |
| GO:0060612 | 0.02920 | 3.11014 | 2 | 5 | 47 | adipose tissue development |
| GO:0099054 | 0.02920 | 3.11014 | 2 | 5 | 47 | presynapse assembly |
| GO:1904407 | 0.02920 | 3.11014 | 2 | 5 | 47 | positive regulation of nitric oxide metabolic process |
| GO:0031112 | 0.02943 | 3.73014 | 1 | 4 | 32 | positive regulation of microtubule polymerization or depolymerization |
| GO:0040036 | 0.02943 | 3.73014 | 1 | 4 | 32 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0060487 | 0.02943 | 3.73014 | 1 | 4 | 32 | lung epithelial cell differentiation |
| GO:0043122 | 0.02948 | 2.00060 | 6 | 11 | 155 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0051090 | 0.03003 | 1.59225 | 14 | 22 | 385 | regulation of DNA-binding transcription factor activity |
| GO:0072657 | 0.03007 | 1.50337 | 19 | 28 | 518 | protein localization to membrane |
| GO:0010771 | 0.03047 | 2.29975 | 4 | 8 | 99 | negative regulation of cell morphogenesis involved in differentiation |
| GO:0030073 | 0.03059 | 1.81681 | 8 | 14 | 216 | insulin secretion |
| GO:0030833 | 0.03070 | 1.98671 | 6 | 11 | 156 | regulation of actin filament polymerization |
| GO:0050766 | 0.03075 | 2.70383 | 2 | 6 | 64 | positive regulation of phagocytosis |
| GO:2001244 | 0.03075 | 2.70383 | 2 | 6 | 64 | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0002274 | 0.03094 | 1.86159 | 7 | 13 | 196 | myeloid leukocyte activation |
| GO:0016573 | 0.03121 | 2.06132 | 5 | 10 | 137 | histone acetylation |
| GO:0031109 | 0.03122 | 2.16076 | 4 | 9 | 118 | microtubule polymerization or depolymerization |
| GO:0007635 | 0.03145 | 4.89272 | 1 | 3 | 19 | chemosensory behavior |
| GO:0010763 | 0.03145 | 4.89272 | 1 | 3 | 19 | positive regulation of fibroblast migration |
| GO:0010766 | 0.03145 | 4.89272 | 1 | 3 | 19 | negative regulation of sodium ion transport |
| GO:0014808 | 0.03145 | 4.89272 | 1 | 3 | 19 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| GO:0015740 | 0.03145 | 4.89272 | 1 | 3 | 19 | C4-dicarboxylate transport |
| GO:0033194 | 0.03145 | 4.89272 | 1 | 3 | 19 | response to hydroperoxide |
| GO:0040037 | 0.03145 | 4.89272 | 1 | 3 | 19 | negative regulation of fibroblast growth factor receptor signaling pathway |
| GO:0060231 | 0.03145 | 4.89272 | 1 | 3 | 19 | mesenchymal to epithelial transition |
| GO:0060338 | 0.03145 | 4.89272 | 1 | 3 | 19 | regulation of type I interferon-mediated signaling pathway |
| GO:1900409 | 0.03145 | 4.89272 | 1 | 3 | 19 | positive regulation of cellular response to oxidative stress |
| GO:1905276 | 0.03145 | 4.89272 | 1 | 3 | 19 | regulation of epithelial tube formation |
| GO:0002720 | 0.03164 | 3.03767 | 2 | 5 | 48 | positive regulation of cytokine production involved in immune response |
| GO:0021988 | 0.03164 | 3.03767 | 2 | 5 | 48 | olfactory lobe development |
| GO:0032330 | 0.03164 | 3.03767 | 2 | 5 | 48 | regulation of chondrocyte differentiation |
| GO:0046189 | 0.03164 | 3.03767 | 2 | 5 | 48 | phenol-containing compound biosynthetic process |
| GO:0071675 | 0.03164 | 3.03767 | 2 | 5 | 48 | regulation of mononuclear cell migration |
| GO:0007565 | 0.03196 | 1.97301 | 6 | 11 | 157 | female pregnancy |
| GO:0001706 | 0.03254 | 3.60135 | 1 | 4 | 33 | endoderm formation |
| GO:0014044 | 0.03254 | 3.60135 | 1 | 4 | 33 | Schwann cell development |
| GO:0060479 | 0.03254 | 3.60135 | 1 | 4 | 33 | lung cell differentiation |
| GO:0071634 | 0.03254 | 3.60135 | 1 | 4 | 33 | regulation of transforming growth factor beta production |
| GO:0071827 | 0.03254 | 3.60135 | 1 | 4 | 33 | plasma lipoprotein particle organization |
| GO:0090322 | 0.03254 | 3.60135 | 1 | 4 | 33 | regulation of superoxide metabolic process |
| GO:0006855 | 0.03285 | 2.65788 | 2 | 6 | 65 | drug transmembrane transport |
| GO:0060997 | 0.03285 | 2.65788 | 2 | 6 | 65 | dendritic spine morphogenesis |
| GO:0001993 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
| GO:0005981 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of glycogen catabolic process |
| GO:0007442 | 0.03302 | 8.69192 | 0 | 2 | 8 | hindgut morphogenesis |
| GO:0009912 | 0.03302 | 8.69192 | 0 | 2 | 8 | auditory receptor cell fate commitment |
| GO:0019374 | 0.03302 | 8.69192 | 0 | 2 | 8 | galactolipid metabolic process |
| GO:0030643 | 0.03302 | 8.69192 | 0 | 2 | 8 | cellular phosphate ion homeostasis |
| GO:0032287 | 0.03302 | 8.69192 | 0 | 2 | 8 | peripheral nervous system myelin maintenance |
| GO:0032906 | 0.03302 | 8.69192 | 0 | 2 | 8 | transforming growth factor beta2 production |
| GO:0032909 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of transforming growth factor beta2 production |
| GO:0042045 | 0.03302 | 8.69192 | 0 | 2 | 8 | epithelial fluid transport |
| GO:0045654 | 0.03302 | 8.69192 | 0 | 2 | 8 | positive regulation of megakaryocyte differentiation |
| GO:0046958 | 0.03302 | 8.69192 | 0 | 2 | 8 | nonassociative learning |
| GO:0051340 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of ligase activity |
| GO:0051890 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of cardioblast differentiation |
| GO:0060027 | 0.03302 | 8.69192 | 0 | 2 | 8 | convergent extension involved in gastrulation |
| GO:0060120 | 0.03302 | 8.69192 | 0 | 2 | 8 | inner ear receptor cell fate commitment |
| GO:0060363 | 0.03302 | 8.69192 | 0 | 2 | 8 | cranial suture morphogenesis |
| GO:0060836 | 0.03302 | 8.69192 | 0 | 2 | 8 | lymphatic endothelial cell differentiation |
| GO:0071649 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of chemokine (C-C motif) ligand 5 production |
| GO:0072501 | 0.03302 | 8.69192 | 0 | 2 | 8 | cellular divalent inorganic anion homeostasis |
| GO:0072502 | 0.03302 | 8.69192 | 0 | 2 | 8 | cellular trivalent inorganic anion homeostasis |
| GO:1900454 | 0.03302 | 8.69192 | 0 | 2 | 8 | positive regulation of long-term synaptic depression |
| GO:1901201 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of extracellular matrix assembly |
| GO:1901857 | 0.03302 | 8.69192 | 0 | 2 | 8 | positive regulation of cellular respiration |
| GO:1904996 | 0.03302 | 8.69192 | 0 | 2 | 8 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:1905274 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of modification of postsynaptic actin cytoskeleton |
| GO:2000303 | 0.03302 | 8.69192 | 0 | 2 | 8 | regulation of ceramide biosynthetic process |
| GO:2000543 | 0.03302 | 8.69192 | 0 | 2 | 8 | positive regulation of gastrulation |
| GO:2000617 | 0.03302 | 8.69192 | 0 | 2 | 8 | positive regulation of histone H3-K9 acetylation |
| GO:0016569 | 0.03303 | 1.54210 | 16 | 24 | 433 | covalent chromatin modification |
| GO:0009306 | 0.03385 | 1.46456 | 21 | 30 | 569 | protein secretion |
| GO:0007613 | 0.03400 | 2.02918 | 5 | 10 | 139 | memory |
| GO:0006639 | 0.03426 | 2.12164 | 4 | 9 | 120 | acylglycerol metabolic process |
| GO:0007586 | 0.03426 | 2.12164 | 4 | 9 | 120 | digestion |
| GO:0001764 | 0.03465 | 1.88216 | 7 | 12 | 179 | neuron migration |
| GO:0048332 | 0.03505 | 2.61347 | 2 | 6 | 66 | mesoderm morphogenesis |
| GO:1904377 | 0.03505 | 2.61347 | 2 | 6 | 66 | positive regulation of protein localization to cell periphery |
| GO:0090068 | 0.03519 | 1.74004 | 9 | 15 | 241 | positive regulation of cell cycle process |
| GO:0034101 | 0.03545 | 2.01348 | 5 | 10 | 140 | erythrocyte homeostasis |
| GO:0006887 | 0.03556 | 1.57996 | 14 | 21 | 370 | exocytosis |
| GO:0016572 | 0.03583 | 3.48115 | 1 | 4 | 34 | histone phosphorylation |
| GO:0035116 | 0.03583 | 3.48115 | 1 | 4 | 34 | embryonic hindlimb morphogenesis |
| GO:0046320 | 0.03583 | 3.48115 | 1 | 4 | 34 | regulation of fatty acid oxidation |
| GO:2000108 | 0.03583 | 3.48115 | 1 | 4 | 34 | positive regulation of leukocyte apoptotic process |
| GO:0046887 | 0.03594 | 1.93303 | 6 | 11 | 160 | positive regulation of hormone secretion |
| GO:0072175 | 0.03594 | 1.93303 | 6 | 11 | 160 | epithelial tube formation |
| GO:0042475 | 0.03598 | 2.37685 | 3 | 7 | 84 | odontogenesis of dentin-containing tooth |
| GO:0003177 | 0.03601 | 4.60471 | 1 | 3 | 20 | pulmonary valve development |
| GO:0032148 | 0.03601 | 4.60471 | 1 | 3 | 20 | activation of protein kinase B activity |
| GO:0033605 | 0.03601 | 4.60471 | 1 | 3 | 20 | positive regulation of catecholamine secretion |
| GO:0042573 | 0.03601 | 4.60471 | 1 | 3 | 20 | retinoic acid metabolic process |
| GO:0044247 | 0.03601 | 4.60471 | 1 | 3 | 20 | cellular polysaccharide catabolic process |
| GO:0045649 | 0.03601 | 4.60471 | 1 | 3 | 20 | regulation of macrophage differentiation |
| GO:0045986 | 0.03601 | 4.60471 | 1 | 3 | 20 | negative regulation of smooth muscle contraction |
| GO:0048557 | 0.03601 | 4.60471 | 1 | 3 | 20 | embryonic digestive tract morphogenesis |
| GO:0050966 | 0.03601 | 4.60471 | 1 | 3 | 20 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0070633 | 0.03601 | 4.60471 | 1 | 3 | 20 | transepithelial transport |
| GO:0072170 | 0.03601 | 4.60471 | 1 | 3 | 20 | metanephric tubule development |
| GO:0072243 | 0.03601 | 4.60471 | 1 | 3 | 20 | metanephric nephron epithelium development |
| GO:1903514 | 0.03601 | 4.60471 | 1 | 3 | 20 | release of sequestered calcium ion into cytosol by endoplasmic reticulum |
| GO:2000114 | 0.03601 | 4.60471 | 1 | 3 | 20 | regulation of establishment of cell polarity |
| GO:0043268 | 0.03689 | 2.90240 | 2 | 5 | 50 | positive regulation of potassium ion transport |
| GO:0048701 | 0.03689 | 2.90240 | 2 | 5 | 50 | embryonic cranial skeleton morphogenesis |
| GO:0050715 | 0.03695 | 1.99802 | 5 | 10 | 141 | positive regulation of cytokine secretion |
| GO:0000085 | 0.03701 | Inf | 0 | 1 | 1 | mitotic G2 phase |
| GO:0001715 | 0.03701 | Inf | 0 | 1 | 1 | ectodermal cell fate specification |
| GO:0001987 | 0.03701 | Inf | 0 | 1 | 1 | vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure |
| GO:0002174 | 0.03701 | Inf | 0 | 1 | 1 | mammary stem cell proliferation |
| GO:0002785 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of antimicrobial peptide production |
| GO:0002787 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of antibacterial peptide production |
| GO:0003017 | 0.03701 | Inf | 0 | 1 | 1 | lymph circulation |
| GO:0003059 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of the force of heart contraction by epinephrine |
| GO:0003138 | 0.03701 | Inf | 0 | 1 | 1 | primary heart field specification |
| GO:0003172 | 0.03701 | Inf | 0 | 1 | 1 | sinoatrial valve development |
| GO:0003178 | 0.03701 | Inf | 0 | 1 | 1 | coronary sinus valve development |
| GO:0003182 | 0.03701 | Inf | 0 | 1 | 1 | coronary sinus valve morphogenesis |
| GO:0003185 | 0.03701 | Inf | 0 | 1 | 1 | sinoatrial valve morphogenesis |
| GO:0003270 | 0.03701 | Inf | 0 | 1 | 1 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation |
| GO:0003421 | 0.03701 | Inf | 0 | 1 | 1 | growth plate cartilage axis specification |
| GO:0006147 | 0.03701 | Inf | 0 | 1 | 1 | guanine catabolic process |
| GO:0006535 | 0.03701 | Inf | 0 | 1 | 1 | cysteine biosynthetic process from serine |
| GO:0007225 | 0.03701 | Inf | 0 | 1 | 1 | patched ligand maturation |
| GO:0007497 | 0.03701 | Inf | 0 | 1 | 1 | posterior midgut development |
| GO:0007634 | 0.03701 | Inf | 0 | 1 | 1 | optokinetic behavior |
| GO:0008057 | 0.03701 | Inf | 0 | 1 | 1 | eye pigment granule organization |
| GO:0008348 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of antimicrobial humoral response |
| GO:0009447 | 0.03701 | Inf | 0 | 1 | 1 | putrescine catabolic process |
| GO:0009956 | 0.03701 | Inf | 0 | 1 | 1 | radial pattern formation |
| GO:0010157 | 0.03701 | Inf | 0 | 1 | 1 | response to chlorate |
| GO:0010335 | 0.03701 | Inf | 0 | 1 | 1 | response to non-ionic osmotic stress |
| GO:0010849 | 0.03701 | Inf | 0 | 1 | 1 | regulation of proton-transporting ATPase activity, rotational mechanism |
| GO:0010967 | 0.03701 | Inf | 0 | 1 | 1 | regulation of polyamine biosynthetic process |
| GO:0014861 | 0.03701 | Inf | 0 | 1 | 1 | regulation of skeletal muscle contraction via regulation of action potential |
| GO:0016024 | 0.03701 | Inf | 0 | 1 | 1 | CDP-diacylglycerol biosynthetic process |
| GO:0016131 | 0.03701 | Inf | 0 | 1 | 1 | brassinosteroid metabolic process |
| GO:0016132 | 0.03701 | Inf | 0 | 1 | 1 | brassinosteroid biosynthetic process |
| GO:0019483 | 0.03701 | Inf | 0 | 1 | 1 | beta-alanine biosynthetic process |
| GO:0019484 | 0.03701 | Inf | 0 | 1 | 1 | beta-alanine catabolic process |
| GO:0030704 | 0.03701 | Inf | 0 | 1 | 1 | vitelline membrane formation |
| GO:0031651 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of heat generation |
| GO:0032599 | 0.03701 | Inf | 0 | 1 | 1 | protein transport out of membrane raft |
| GO:0032600 | 0.03701 | Inf | 0 | 1 | 1 | chemokine receptor transport out of membrane raft |
| GO:0032913 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of transforming growth factor beta3 production |
| GO:0033396 | 0.03701 | Inf | 0 | 1 | 1 | beta-alanine biosynthetic process via 3-ureidopropionate |
| GO:0033606 | 0.03701 | Inf | 0 | 1 | 1 | chemokine receptor transport within lipid bilayer |
| GO:0034102 | 0.03701 | Inf | 0 | 1 | 1 | erythrocyte clearance |
| GO:0034106 | 0.03701 | Inf | 0 | 1 | 1 | regulation of erythrocyte clearance |
| GO:0034107 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte clearance |
| GO:0034119 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte aggregation |
| GO:0034640 | 0.03701 | Inf | 0 | 1 | 1 | establishment of mitochondrion localization by microtubule attachment |
| GO:0035638 | 0.03701 | Inf | 0 | 1 | 1 | signal maturation |
| GO:0035645 | 0.03701 | Inf | 0 | 1 | 1 | enteric smooth muscle cell differentiation |
| GO:0035921 | 0.03701 | Inf | 0 | 1 | 1 | desmosome disassembly |
| GO:0036149 | 0.03701 | Inf | 0 | 1 | 1 | phosphatidylinositol acyl-chain remodeling |
| GO:0036275 | 0.03701 | Inf | 0 | 1 | 1 | response to 5-fluorouracil |
| GO:0036290 | 0.03701 | Inf | 0 | 1 | 1 | protein trans-autophosphorylation |
| GO:0036309 | 0.03701 | Inf | 0 | 1 | 1 | protein localization to M-band |
| GO:0036316 | 0.03701 | Inf | 0 | 1 | 1 | SREBP-SCAP complex retention in endoplasmic reticulum |
| GO:0036335 | 0.03701 | Inf | 0 | 1 | 1 | intestinal stem cell homeostasis |
| GO:0036371 | 0.03701 | Inf | 0 | 1 | 1 | protein localization to T-tubule |
| GO:0036517 | 0.03701 | Inf | 0 | 1 | 1 | chemoattraction of serotonergic neuron axon |
| GO:0038098 | 0.03701 | Inf | 0 | 1 | 1 | sequestering of BMP from receptor via BMP binding |
| GO:0038133 | 0.03701 | Inf | 0 | 1 | 1 | ERBB2-ERBB3 signaling pathway |
| GO:0038172 | 0.03701 | Inf | 0 | 1 | 1 | interleukin-33-mediated signaling pathway |
| GO:0042103 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of T cell homeostatic proliferation |
| GO:0042665 | 0.03701 | Inf | 0 | 1 | 1 | regulation of ectodermal cell fate specification |
| GO:0042666 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of ectodermal cell fate specification |
| GO:0043990 | 0.03701 | Inf | 0 | 1 | 1 | histone H2A-S1 phosphorylation |
| GO:0044333 | 0.03701 | Inf | 0 | 1 | 1 | Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:0044722 | 0.03701 | Inf | 0 | 1 | 1 | renal phosphate excretion |
| GO:0045175 | 0.03701 | Inf | 0 | 1 | 1 | basal protein localization |
| GO:0046014 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of T cell homeostatic proliferation |
| GO:0046722 | 0.03701 | Inf | 0 | 1 | 1 | lactic acid secretion |
| GO:0048074 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of eye pigmentation |
| GO:0048086 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of developmental pigmentation |
| GO:0048174 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of short-term neuronal synaptic plasticity |
| GO:0050894 | 0.03701 | Inf | 0 | 1 | 1 | determination of affect |
| GO:0051319 | 0.03701 | Inf | 0 | 1 | 1 | G2 phase |
| GO:0051352 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of ligase activity |
| GO:0051417 | 0.03701 | Inf | 0 | 1 | 1 | microtubule nucleation by spindle pole body |
| GO:0051638 | 0.03701 | Inf | 0 | 1 | 1 | barbed-end actin filament uncapping |
| GO:0051780 | 0.03701 | Inf | 0 | 1 | 1 | behavioral response to nutrient |
| GO:0060183 | 0.03701 | Inf | 0 | 1 | 1 | apelin receptor signaling pathway |
| GO:0060464 | 0.03701 | Inf | 0 | 1 | 1 | lung lobe formation |
| GO:0060517 | 0.03701 | Inf | 0 | 1 | 1 | epithelial cell proliferation involved in prostatic bud elongation |
| GO:0060540 | 0.03701 | Inf | 0 | 1 | 1 | diaphragm morphogenesis |
| GO:0060784 | 0.03701 | Inf | 0 | 1 | 1 | regulation of cell proliferation involved in tissue homeostasis |
| GO:0060843 | 0.03701 | Inf | 0 | 1 | 1 | venous endothelial cell differentiation |
| GO:0061301 | 0.03701 | Inf | 0 | 1 | 1 | cerebellum vasculature morphogenesis |
| GO:0061682 | 0.03701 | Inf | 0 | 1 | 1 | seminal vesicle morphogenesis |
| GO:0061782 | 0.03701 | Inf | 0 | 1 | 1 | vesicle fusion with vesicle |
| GO:0061885 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of mini excitatory postsynaptic potential |
| GO:0061889 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of astrocyte activation |
| GO:0061986 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of transcription by glucose |
| GO:0061987 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of transcription from RNA polymerase II promoter by glucose |
| GO:0070054 | 0.03701 | Inf | 0 | 1 | 1 | mRNA splicing, via endonucleolytic cleavage and ligation |
| GO:0070367 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0070543 | 0.03701 | Inf | 0 | 1 | 1 | response to linoleic acid |
| GO:0071324 | 0.03701 | Inf | 0 | 1 | 1 | cellular response to disaccharide stimulus |
| GO:0071329 | 0.03701 | Inf | 0 | 1 | 1 | cellular response to sucrose stimulus |
| GO:0071471 | 0.03701 | Inf | 0 | 1 | 1 | cellular response to non-ionic osmotic stress |
| GO:0072139 | 0.03701 | Inf | 0 | 1 | 1 | glomerular parietal epithelial cell differentiation |
| GO:0072428 | 0.03701 | Inf | 0 | 1 | 1 | signal transduction involved in intra-S DNA damage checkpoint |
| GO:0072702 | 0.03701 | Inf | 0 | 1 | 1 | response to methyl methanesulfonate |
| GO:0072703 | 0.03701 | Inf | 0 | 1 | 1 | cellular response to methyl methanesulfonate |
| GO:0086072 | 0.03701 | Inf | 0 | 1 | 1 | AV node cell-bundle of His cell adhesion involved in cell communication |
| GO:0086100 | 0.03701 | Inf | 0 | 1 | 1 | endothelin receptor signaling pathway |
| GO:0090095 | 0.03701 | Inf | 0 | 1 | 1 | regulation of metanephric cap mesenchymal cell proliferation |
| GO:0090096 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of metanephric cap mesenchymal cell proliferation |
| GO:0090119 | 0.03701 | Inf | 0 | 1 | 1 | vesicle-mediated cholesterol transport |
| GO:0090275 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of somatostatin secretion |
| GO:0090291 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of osteoclast proliferation |
| GO:0097056 | 0.03701 | Inf | 0 | 1 | 1 | selenocysteinyl-tRNA(Sec) biosynthetic process |
| GO:0097291 | 0.03701 | Inf | 0 | 1 | 1 | renal phosphate ion absorption |
| GO:0097640 | 0.03701 | Inf | 0 | 1 | 1 | L-ornithine import across plasma membrane |
| GO:0098746 | 0.03701 | Inf | 0 | 1 | 1 | fast, calcium ion-dependent exocytosis of neurotransmitter |
| GO:0099098 | 0.03701 | Inf | 0 | 1 | 1 | microtubule polymerization based movement |
| GO:0099161 | 0.03701 | Inf | 0 | 1 | 1 | regulation of presynaptic dense core granule exocytosis |
| GO:0100001 | 0.03701 | Inf | 0 | 1 | 1 | regulation of skeletal muscle contraction by action potential |
| GO:0106016 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of inflammatory response to wounding |
| GO:0106088 | 0.03701 | Inf | 0 | 1 | 1 | regulation of cell adhesion involved in sprouting angiogenesis |
| GO:0106089 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of cell adhesion involved in sprouting angiogenesis |
| GO:0110026 | 0.03701 | Inf | 0 | 1 | 1 | regulation of DNA strand resection involved in replication fork processing |
| GO:0110113 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of lipid transporter activity |
| GO:0120077 | 0.03701 | Inf | 0 | 1 | 1 | angiogenic sprout fusion |
| GO:0120078 | 0.03701 | Inf | 0 | 1 | 1 | cell adhesion involved in sprouting angiogenesis |
| GO:0140075 | 0.03701 | Inf | 0 | 1 | 1 | regulation of lipoprotein transport |
| GO:0140077 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of lipoprotein transport |
| GO:0150024 | 0.03701 | Inf | 0 | 1 | 1 | oxidised low-density lipoprotein particle clearance |
| GO:1900085 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of peptidyl-tyrosine autophosphorylation |
| GO:1900161 | 0.03701 | Inf | 0 | 1 | 1 | regulation of phospholipid scramblase activity |
| GO:1900163 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of phospholipid scramblase activity |
| GO:1900387 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter |
| GO:1901229 | 0.03701 | Inf | 0 | 1 | 1 | regulation of non-canonical Wnt signaling pathway via JNK cascade |
| GO:1901231 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of non-canonical Wnt signaling pathway via JNK cascade |
| GO:1901232 | 0.03701 | Inf | 0 | 1 | 1 | regulation of convergent extension involved in axis elongation |
| GO:1901233 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of convergent extension involved in axis elongation |
| GO:1901304 | 0.03701 | Inf | 0 | 1 | 1 | regulation of spermidine biosynthetic process |
| GO:1901307 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of spermidine biosynthetic process |
| GO:1901627 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of postsynaptic membrane organization |
| GO:1901954 | 0.03701 | Inf | 0 | 1 | 1 | regulation of retrograde dense core granule transport |
| GO:1901956 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of retrograde dense core granule transport |
| GO:1902161 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of cyclic nucleotide-gated ion channel activity |
| GO:1902178 | 0.03701 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor apoptotic signaling pathway |
| GO:1902205 | 0.03701 | Inf | 0 | 1 | 1 | regulation of interleukin-2-mediated signaling pathway |
| GO:1902206 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of interleukin-2-mediated signaling pathway |
| GO:1902215 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of interleukin-4-mediated signaling pathway |
| GO:1902233 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of positive thymic T cell selection |
| GO:1902358 | 0.03701 | Inf | 0 | 1 | 1 | sulfate transmembrane transport |
| GO:1902576 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of nuclear cell cycle DNA replication |
| GO:1903210 | 0.03701 | Inf | 0 | 1 | 1 | glomerular visceral epithelial cell apoptotic process |
| GO:1903402 | 0.03701 | Inf | 0 | 1 | 1 | regulation of renal phosphate excretion |
| GO:1903403 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of renal phosphate excretion |
| GO:1903464 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of mitotic cell cycle DNA replication |
| GO:1903610 | 0.03701 | Inf | 0 | 1 | 1 | regulation of calcium-dependent ATPase activity |
| GO:1903611 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of calcium-dependent ATPase activity |
| GO:1903627 | 0.03701 | Inf | 0 | 1 | 1 | regulation of dUTP diphosphatase activity |
| GO:1903629 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of dUTP diphosphatase activity |
| GO:1903631 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of aminoacyl-tRNA ligase activity |
| GO:1903633 | 0.03701 | Inf | 0 | 1 | 1 | regulation of leucine-tRNA ligase activity |
| GO:1903634 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of leucine-tRNA ligase activity |
| GO:1903720 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of I-kappaB phosphorylation |
| GO:1903744 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of anterograde synaptic vesicle transport |
| GO:1903910 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of receptor clustering |
| GO:1904005 | 0.03701 | Inf | 0 | 1 | 1 | regulation of phospholipase D activity |
| GO:1904006 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of phospholipase D activity |
| GO:1904022 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of G protein-coupled receptor internalization |
| GO:1904394 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of skeletal muscle acetylcholine-gated channel clustering |
| GO:1904633 | 0.03701 | Inf | 0 | 1 | 1 | regulation of glomerular visceral epithelial cell apoptotic process |
| GO:1904635 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of glomerular visceral epithelial cell apoptotic process |
| GO:1904675 | 0.03701 | Inf | 0 | 1 | 1 | regulation of somatic stem cell division |
| GO:1904677 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of somatic stem cell division |
| GO:1904837 | 0.03701 | Inf | 0 | 1 | 1 | beta-catenin-TCF complex assembly |
| GO:1904863 | 0.03701 | Inf | 0 | 1 | 1 | regulation of beta-catenin-TCF complex assembly |
| GO:1904864 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of beta-catenin-TCF complex assembly |
| GO:1904934 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of cell proliferation in midbrain |
| GO:1904935 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of cell proliferation in midbrain |
| GO:1905239 | 0.03701 | Inf | 0 | 1 | 1 | regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1905240 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1905414 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of dense core granule exocytosis |
| GO:1905415 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of dense core granule exocytosis |
| GO:1905432 | 0.03701 | Inf | 0 | 1 | 1 | regulation of retrograde trans-synaptic signaling by neuropeptide |
| GO:1905433 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of retrograde trans-synaptic signaling by neuropeptide |
| GO:1990134 | 0.03701 | Inf | 0 | 1 | 1 | epithelial cell apoptotic process involved in palatal shelf morphogenesis |
| GO:1990256 | 0.03701 | Inf | 0 | 1 | 1 | signal clustering |
| GO:1990579 | 0.03701 | Inf | 0 | 1 | 1 | peptidyl-serine trans-autophosphorylation |
| GO:1990697 | 0.03701 | Inf | 0 | 1 | 1 | protein depalmitoleylation |
| GO:1990771 | 0.03701 | Inf | 0 | 1 | 1 | clathrin-dependent extracellular exosome endocytosis |
| GO:2000056 | 0.03701 | Inf | 0 | 1 | 1 | regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:2000057 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
| GO:2000077 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of type B pancreatic cell development |
| GO:2000101 | 0.03701 | Inf | 0 | 1 | 1 | regulation of mammary stem cell proliferation |
| GO:2000103 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of mammary stem cell proliferation |
| GO:2000184 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of progesterone biosynthetic process |
| GO:2000230 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of pancreatic stellate cell proliferation |
| GO:2000577 | 0.03701 | Inf | 0 | 1 | 1 | regulation of ATP-dependent microtubule motor activity, minus-end-directed |
| GO:2000578 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of ATP-dependent microtubule motor activity, minus-end-directed |
| GO:2000606 | 0.03701 | Inf | 0 | 1 | 1 | regulation of cell proliferation involved in mesonephros development |
| GO:2000607 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of cell proliferation involved in mesonephros development |
| GO:2000634 | 0.03701 | Inf | 0 | 1 | 1 | regulation of primary miRNA processing |
| GO:2000635 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of primary miRNA processing |
| GO:2000639 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of SREBP signaling pathway |
| GO:2000683 | 0.03701 | Inf | 0 | 1 | 1 | regulation of cellular response to X-ray |
| GO:2000699 | 0.03701 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor signaling pathway involved in ureteric bud formation |
| GO:2000701 | 0.03701 | Inf | 0 | 1 | 1 | glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation |
| GO:2000702 | 0.03701 | Inf | 0 | 1 | 1 | regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation |
| GO:2000703 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation |
| GO:2000733 | 0.03701 | Inf | 0 | 1 | 1 | regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation |
| GO:2000734 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation |
| GO:2000752 | 0.03701 | Inf | 0 | 1 | 1 | regulation of glucosylceramide catabolic process |
| GO:2000753 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of glucosylceramide catabolic process |
| GO:2000754 | 0.03701 | Inf | 0 | 1 | 1 | regulation of sphingomyelin catabolic process |
| GO:2000755 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of sphingomyelin catabolic process |
| GO:2000970 | 0.03701 | Inf | 0 | 1 | 1 | regulation of detection of glucose |
| GO:2000971 | 0.03701 | Inf | 0 | 1 | 1 | negative regulation of detection of glucose |
| GO:2001017 | 0.03701 | Inf | 0 | 1 | 1 | regulation of retrograde axon cargo transport |
| GO:2001019 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of retrograde axon cargo transport |
| GO:2001031 | 0.03701 | Inf | 0 | 1 | 1 | positive regulation of cellular glucuronidation |
| GO:0016331 | 0.03725 | 1.85972 | 7 | 12 | 181 | morphogenesis of embryonic epithelium |
| GO:0009953 | 0.03730 | 2.20252 | 4 | 8 | 103 | dorsal/ventral pattern formation |
| GO:0014897 | 0.03730 | 2.20252 | 4 | 8 | 103 | striated muscle hypertrophy |
| GO:0055006 | 0.03730 | 2.20252 | 4 | 8 | 103 | cardiac cell development |
| GO:0034109 | 0.03735 | 2.57051 | 2 | 6 | 67 | homotypic cell-cell adhesion |
| GO:0071897 | 0.03735 | 1.92005 | 6 | 11 | 161 | DNA biosynthetic process |
| GO:0006638 | 0.03749 | 2.08390 | 5 | 9 | 122 | neutral lipid metabolic process |
| GO:1903827 | 0.03824 | 1.47877 | 19 | 27 | 507 | regulation of cellular protein localization |
| GO:0034614 | 0.03849 | 1.98280 | 5 | 10 | 142 | cellular response to reactive oxygen species |
| GO:0051348 | 0.03856 | 1.71701 | 9 | 15 | 244 | negative regulation of transferase activity |
| GO:0030316 | 0.03916 | 2.17948 | 4 | 8 | 104 | osteoclast differentiation |
| GO:0009582 | 0.03918 | 2.06553 | 5 | 9 | 123 | detection of abiotic stimulus |
| GO:0032273 | 0.03918 | 2.06553 | 5 | 9 | 123 | positive regulation of protein polymerization |
| GO:0000096 | 0.03931 | 3.36871 | 1 | 4 | 35 | sulfur amino acid metabolic process |
| GO:0019432 | 0.03931 | 3.36871 | 1 | 4 | 35 | triglyceride biosynthetic process |
| GO:0035909 | 0.03931 | 3.36871 | 1 | 4 | 35 | aorta morphogenesis |
| GO:0042311 | 0.03931 | 3.36871 | 1 | 4 | 35 | vasodilation |
| GO:0045940 | 0.03931 | 3.36871 | 1 | 4 | 35 | positive regulation of steroid metabolic process |
| GO:0046329 | 0.03931 | 3.36871 | 1 | 4 | 35 | negative regulation of JNK cascade |
| GO:0048147 | 0.03931 | 3.36871 | 1 | 4 | 35 | negative regulation of fibroblast proliferation |
| GO:0071604 | 0.03931 | 3.36871 | 1 | 4 | 35 | transforming growth factor beta production |
| GO:0072348 | 0.03931 | 3.36871 | 1 | 4 | 35 | sulfur compound transport |
| GO:1904951 | 0.03950 | 1.51196 | 16 | 24 | 441 | positive regulation of establishment of protein localization |
| GO:0051606 | 0.03969 | 1.74697 | 8 | 14 | 224 | detection of stimulus |
| GO:0030901 | 0.03970 | 2.83918 | 2 | 5 | 51 | midbrain development |
| GO:0035176 | 0.03970 | 2.83918 | 2 | 5 | 51 | social behavior |
| GO:0045933 | 0.03970 | 2.83918 | 2 | 5 | 51 | positive regulation of muscle contraction |
| GO:0046503 | 0.03970 | 2.83918 | 2 | 5 | 51 | glycerolipid catabolic process |
| GO:0051703 | 0.03970 | 2.83918 | 2 | 5 | 51 | intraspecies interaction between organisms |
| GO:0030032 | 0.03973 | 2.52893 | 3 | 6 | 68 | lamellipodium assembly |
| GO:0030888 | 0.03973 | 2.52893 | 3 | 6 | 68 | regulation of B cell proliferation |
| GO:0044344 | 0.04011 | 2.31647 | 3 | 7 | 86 | cellular response to fibroblast growth factor stimulus |
| GO:1903524 | 0.04011 | 2.31647 | 3 | 7 | 86 | positive regulation of blood circulation |
| GO:0019827 | 0.04027 | 1.89462 | 6 | 11 | 163 | stem cell population maintenance |
| GO:0051017 | 0.04027 | 1.89462 | 6 | 11 | 163 | actin filament bundle assembly |
| GO:0045732 | 0.04066 | 1.78297 | 8 | 13 | 204 | positive regulation of protein catabolic process |
| GO:0001976 | 0.04089 | 4.34870 | 1 | 3 | 21 | neurological system process involved in regulation of systemic arterial blood pressure |
| GO:0002693 | 0.04089 | 4.34870 | 1 | 3 | 21 | positive regulation of cellular extravasation |
| GO:0003283 | 0.04089 | 4.34870 | 1 | 3 | 21 | atrial septum development |
| GO:0010743 | 0.04089 | 4.34870 | 1 | 3 | 21 | regulation of macrophage derived foam cell differentiation |
| GO:0043586 | 0.04089 | 4.34870 | 1 | 3 | 21 | tongue development |
| GO:0009581 | 0.04092 | 2.04747 | 5 | 9 | 124 | detection of external stimulus |
| GO:0031347 | 0.04104 | 1.43722 | 21 | 30 | 579 | regulation of defense response |
| GO:0014896 | 0.04107 | 2.15691 | 4 | 8 | 105 | muscle hypertrophy |
| GO:0038127 | 0.04107 | 2.15691 | 4 | 8 | 105 | ERBB signaling pathway |
| GO:0048704 | 0.04107 | 2.15691 | 4 | 8 | 105 | embryonic skeletal system morphogenesis |
| GO:0001574 | 0.04143 | 7.44988 | 0 | 2 | 9 | ganglioside biosynthetic process |
| GO:0003223 | 0.04143 | 7.44988 | 0 | 2 | 9 | ventricular compact myocardium morphogenesis |
| GO:0003344 | 0.04143 | 7.44988 | 0 | 2 | 9 | pericardium morphogenesis |
| GO:0006563 | 0.04143 | 7.44988 | 0 | 2 | 9 | L-serine metabolic process |
| GO:0007567 | 0.04143 | 7.44988 | 0 | 2 | 9 | parturition |
| GO:0008354 | 0.04143 | 7.44988 | 0 | 2 | 9 | germ cell migration |
| GO:0010692 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of alkaline phosphatase activity |
| GO:0010873 | 0.04143 | 7.44988 | 0 | 2 | 9 | positive regulation of cholesterol esterification |
| GO:0010966 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of phosphate transport |
| GO:0015886 | 0.04143 | 7.44988 | 0 | 2 | 9 | heme transport |
| GO:0021891 | 0.04143 | 7.44988 | 0 | 2 | 9 | olfactory bulb interneuron development |
| GO:0032836 | 0.04143 | 7.44988 | 0 | 2 | 9 | glomerular basement membrane development |
| GO:0036353 | 0.04143 | 7.44988 | 0 | 2 | 9 | histone H2A-K119 monoubiquitination |
| GO:0043031 | 0.04143 | 7.44988 | 0 | 2 | 9 | negative regulation of macrophage activation |
| GO:0043587 | 0.04143 | 7.44988 | 0 | 2 | 9 | tongue morphogenesis |
| GO:0046113 | 0.04143 | 7.44988 | 0 | 2 | 9 | nucleobase catabolic process |
| GO:0048341 | 0.04143 | 7.44988 | 0 | 2 | 9 | paraxial mesoderm formation |
| GO:0048819 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of hair follicle maturation |
| GO:0060290 | 0.04143 | 7.44988 | 0 | 2 | 9 | transdifferentiation |
| GO:0060339 | 0.04143 | 7.44988 | 0 | 2 | 9 | negative regulation of type I interferon-mediated signaling pathway |
| GO:0060352 | 0.04143 | 7.44988 | 0 | 2 | 9 | cell adhesion molecule production |
| GO:0060539 | 0.04143 | 7.44988 | 0 | 2 | 9 | diaphragm development |
| GO:0060638 | 0.04143 | 7.44988 | 0 | 2 | 9 | mesenchymal-epithelial cell signaling |
| GO:0060896 | 0.04143 | 7.44988 | 0 | 2 | 9 | neural plate pattern specification |
| GO:0061525 | 0.04143 | 7.44988 | 0 | 2 | 9 | hindgut development |
| GO:0062042 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of cardiac epithelial to mesenchymal transition |
| GO:0071609 | 0.04143 | 7.44988 | 0 | 2 | 9 | chemokine (C-C motif) ligand 5 production |
| GO:0071635 | 0.04143 | 7.44988 | 0 | 2 | 9 | negative regulation of transforming growth factor beta production |
| GO:0086015 | 0.04143 | 7.44988 | 0 | 2 | 9 | SA node cell action potential |
| GO:0086018 | 0.04143 | 7.44988 | 0 | 2 | 9 | SA node cell to atrial cardiac muscle cell signaling |
| GO:0086036 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of cardiac muscle cell membrane potential |
| GO:0086070 | 0.04143 | 7.44988 | 0 | 2 | 9 | SA node cell to atrial cardiac muscle cell communication |
| GO:0090037 | 0.04143 | 7.44988 | 0 | 2 | 9 | positive regulation of protein kinase C signaling |
| GO:0090153 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of sphingolipid biosynthetic process |
| GO:0098597 | 0.04143 | 7.44988 | 0 | 2 | 9 | observational learning |
| GO:0099519 | 0.04143 | 7.44988 | 0 | 2 | 9 | dense core granule cytoskeletal transport |
| GO:0099545 | 0.04143 | 7.44988 | 0 | 2 | 9 | trans-synaptic signaling by trans-synaptic complex |
| GO:0099641 | 0.04143 | 7.44988 | 0 | 2 | 9 | anterograde axonal protein transport |
| GO:1901033 | 0.04143 | 7.44988 | 0 | 2 | 9 | positive regulation of response to reactive oxygen species |
| GO:1901724 | 0.04143 | 7.44988 | 0 | 2 | 9 | positive regulation of cell proliferation involved in kidney development |
| GO:1902023 | 0.04143 | 7.44988 | 0 | 2 | 9 | L-arginine transport |
| GO:1905038 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of membrane lipid metabolic process |
| GO:1905383 | 0.04143 | 7.44988 | 0 | 2 | 9 | protein localization to presynapse |
| GO:2000051 | 0.04143 | 7.44988 | 0 | 2 | 9 | negative regulation of non-canonical Wnt signaling pathway |
| GO:2000121 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of removal of superoxide radicals |
| GO:2000392 | 0.04143 | 7.44988 | 0 | 2 | 9 | regulation of lamellipodium morphogenesis |
| GO:2000969 | 0.04143 | 7.44988 | 0 | 2 | 9 | positive regulation of AMPA receptor activity |
| GO:0043410 | 0.04165 | 1.45476 | 20 | 28 | 534 | positive regulation of MAPK cascade |
| GO:0032984 | 0.04201 | 1.77361 | 8 | 13 | 205 | protein-containing complex disassembly |
| GO:0045787 | 0.04211 | 1.56674 | 13 | 20 | 355 | positive regulation of cell cycle |
| GO:0048146 | 0.04221 | 2.48868 | 3 | 6 | 69 | positive regulation of fibroblast proliferation |
| GO:0097120 | 0.04221 | 2.48868 | 3 | 6 | 69 | receptor localization to synapse |
| GO:0070664 | 0.04229 | 2.28741 | 3 | 7 | 87 | negative regulation of leukocyte proliferation |
| GO:1905954 | 0.04229 | 2.28741 | 3 | 7 | 87 | positive regulation of lipid localization |
| GO:0031529 | 0.04264 | 2.77865 | 2 | 5 | 52 | ruffle organization |
| GO:0045777 | 0.04264 | 2.77865 | 2 | 5 | 52 | positive regulation of blood pressure |
| GO:0050775 | 0.04264 | 2.77865 | 2 | 5 | 52 | positive regulation of dendrite morphogenesis |
| GO:1901570 | 0.04264 | 2.77865 | 2 | 5 | 52 | fatty acid derivative biosynthetic process |
| GO:2000351 | 0.04264 | 2.77865 | 2 | 5 | 52 | regulation of endothelial cell apoptotic process |
| GO:0044091 | 0.04297 | 3.26329 | 1 | 4 | 36 | membrane biogenesis |
| GO:0045601 | 0.04297 | 3.26329 | 1 | 4 | 36 | regulation of endothelial cell differentiation |
| GO:0099174 | 0.04297 | 3.26329 | 1 | 4 | 36 | regulation of presynapse organization |
| GO:2000273 | 0.04297 | 3.26329 | 1 | 4 | 36 | positive regulation of signaling receptor activity |
| GO:0071322 | 0.04337 | 1.93847 | 5 | 10 | 145 | cellular response to carbohydrate stimulus |
| GO:0099003 | 0.04341 | 1.68723 | 9 | 15 | 248 | vesicle-mediated transport in synapse |
| GO:0099504 | 0.04356 | 1.72213 | 8 | 14 | 227 | synaptic vesicle cycle |
| GO:0071774 | 0.04454 | 2.25907 | 3 | 7 | 88 | response to fibroblast growth factor |
| GO:0021536 | 0.04478 | 2.44969 | 3 | 6 | 70 | diencephalon development |
| GO:0042130 | 0.04478 | 2.44969 | 3 | 6 | 70 | negative regulation of T cell proliferation |
| GO:2001259 | 0.04478 | 2.44969 | 3 | 6 | 70 | positive regulation of cation channel activity |
| GO:0061572 | 0.04495 | 1.85770 | 6 | 11 | 166 | actin filament bundle organization |
| GO:0035725 | 0.04509 | 2.11315 | 4 | 8 | 107 | sodium ion transmembrane transport |
| GO:0006721 | 0.04571 | 2.72064 | 2 | 5 | 53 | terpenoid metabolic process |
| GO:0046676 | 0.04571 | 2.72064 | 2 | 5 | 53 | negative regulation of insulin secretion |
| GO:0051930 | 0.04571 | 2.72064 | 2 | 5 | 53 | regulation of sensory perception of pain |
| GO:0070988 | 0.04571 | 2.72064 | 2 | 5 | 53 | demethylation |
| GO:0044706 | 0.04585 | 1.79547 | 7 | 12 | 187 | multi-multicellular organism process |
| GO:0009404 | 0.04608 | 4.11963 | 1 | 3 | 22 | toxin metabolic process |
| GO:0010874 | 0.04608 | 4.11963 | 1 | 3 | 22 | regulation of cholesterol efflux |
| GO:0014912 | 0.04608 | 4.11963 | 1 | 3 | 22 | negative regulation of smooth muscle cell migration |
| GO:0034405 | 0.04608 | 4.11963 | 1 | 3 | 22 | response to fluid shear stress |
| GO:0035024 | 0.04608 | 4.11963 | 1 | 3 | 22 | negative regulation of Rho protein signal transduction |
| GO:0048339 | 0.04608 | 4.11963 | 1 | 3 | 22 | paraxial mesoderm development |
| GO:0051797 | 0.04608 | 4.11963 | 1 | 3 | 22 | regulation of hair follicle development |
| GO:0060009 | 0.04608 | 4.11963 | 1 | 3 | 22 | Sertoli cell development |
| GO:0060390 | 0.04608 | 4.11963 | 1 | 3 | 22 | regulation of SMAD protein signal transduction |
| GO:0070230 | 0.04608 | 4.11963 | 1 | 3 | 22 | positive regulation of lymphocyte apoptotic process |
| GO:1901623 | 0.04608 | 4.11963 | 1 | 3 | 22 | regulation of lymphocyte chemotaxis |
| GO:1902884 | 0.04608 | 4.11963 | 1 | 3 | 22 | positive regulation of response to oxidative stress |
| GO:2001026 | 0.04608 | 4.11963 | 1 | 3 | 22 | regulation of endothelial cell chemotaxis |
| GO:0097553 | 0.04646 | 1.99515 | 5 | 9 | 127 | calcium ion transmembrane import into cytosol |
| GO:0098727 | 0.04658 | 1.84571 | 6 | 11 | 167 | maintenance of cell number |
| GO:2000241 | 0.04658 | 1.84571 | 6 | 11 | 167 | regulation of reproductive process |
| GO:0007435 | 0.04682 | 3.16426 | 1 | 4 | 37 | salivary gland morphogenesis |
| GO:0009069 | 0.04682 | 3.16426 | 1 | 4 | 37 | serine family amino acid metabolic process |
| GO:0010762 | 0.04682 | 3.16426 | 1 | 4 | 37 | regulation of fibroblast migration |
| GO:0030225 | 0.04682 | 3.16426 | 1 | 4 | 37 | macrophage differentiation |
| GO:0032633 | 0.04682 | 3.16426 | 1 | 4 | 37 | interleukin-4 production |
| GO:0044331 | 0.04682 | 3.16426 | 1 | 4 | 37 | cell-cell adhesion mediated by cadherin |
| GO:0051693 | 0.04682 | 3.16426 | 1 | 4 | 37 | actin filament capping |
| GO:0071158 | 0.04682 | 3.16426 | 1 | 4 | 37 | positive regulation of cell cycle arrest |
| GO:0071320 | 0.04682 | 3.16426 | 1 | 4 | 37 | cellular response to cAMP |
| GO:0071825 | 0.04682 | 3.16426 | 1 | 4 | 37 | protein-lipid complex subunit organization |
| GO:0010970 | 0.04685 | 1.91000 | 5 | 10 | 147 | transport along microtubule |
| GO:0099111 | 0.04685 | 1.91000 | 5 | 10 | 147 | microtubule-based transport |
| GO:0050764 | 0.04687 | 2.23142 | 3 | 7 | 89 | regulation of phagocytosis |
| GO:1904019 | 0.04719 | 2.09192 | 4 | 8 | 108 | epithelial cell apoptotic process |
| GO:0002685 | 0.04741 | 1.78519 | 7 | 12 | 188 | regulation of leukocyte migration |
| GO:1902275 | 0.04741 | 1.78519 | 7 | 12 | 188 | regulation of chromatin organization |
| GO:0035690 | 0.04743 | 1.54335 | 13 | 20 | 360 | cellular response to drug |
| GO:0008088 | 0.04745 | 2.41189 | 3 | 6 | 71 | axo-dendritic transport |
| GO:0031397 | 0.04745 | 2.41189 | 3 | 6 | 71 | negative regulation of protein ubiquitination |
| GO:0042733 | 0.04745 | 2.41189 | 3 | 6 | 71 | embryonic digit morphogenesis |
| GO:0051052 | 0.04844 | 1.49093 | 16 | 23 | 428 | regulation of DNA metabolic process |
| GO:0060402 | 0.04866 | 1.89608 | 5 | 10 | 148 | calcium ion transport into cytosol |
| GO:0007585 | 0.04890 | 2.66500 | 2 | 5 | 54 | respiratory gaseous exchange |
| GO:0010656 | 0.04890 | 2.66500 | 2 | 5 | 54 | negative regulation of muscle cell apoptotic process |
| GO:0030199 | 0.04890 | 2.66500 | 2 | 5 | 54 | collagen fibril organization |
| GO:0050994 | 0.04890 | 2.66500 | 2 | 5 | 54 | regulation of lipid catabolic process |
| GO:0051931 | 0.04890 | 2.66500 | 2 | 5 | 54 | regulation of sensory perception |
| GO:0030595 | 0.04925 | 1.72820 | 8 | 13 | 210 | leukocyte chemotaxis |
| GO:0033673 | 0.04925 | 1.72820 | 8 | 13 | 210 | negative regulation of kinase activity |
| GO:0032526 | 0.04928 | 2.20444 | 3 | 7 | 90 | response to retinoic acid |
| GO:0006690 | 0.04936 | 2.07112 | 4 | 8 | 109 | icosanoid metabolic process |
| GO:0008344 | 0.04936 | 2.07112 | 4 | 8 | 109 | adult locomotory behavior |
| GO:0032092 | 0.04936 | 2.07112 | 4 | 8 | 109 | positive regulation of protein binding |